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1ChapterGeneral introduCtion 

GEnERAL InTRODUCTIOn
1Adipose tissue, An orgAn
White adipose tissue is an organ which consists primarily of lipid filled adipocytes 
(approximately 50% of the cellular content) which are held together by a network of 
collagen fibres. Other cell types, collectively called the stroma vascular fraction, are 
found in between adipocytes and within the adipose tissue are fibroblasts, stromal 
cells, pre-adipocytes, leukocytes and macrophages [1](Figure 1).
Adipose tissue, an organ
White  adipos  tissue  is  an  organ  which  consists  primarily  of  lipid  filled  adipocytes
(approximatel  50% f the cellular content) which are held together by a network of collagen
fibres. Other cell types, collectively called the stroma vascular fraction, are found in between
adipocytes  and  within  the  adipose  tissue  are  fibroblasts,  stromal  cells,  pre-adipocytes,
leukocytes and macrophages (Figure 1).
Figure 1 Structure of white adipose. (adapted from )
Until 1994 adipose tissue was primarily viewed as a depot for storage of triglycerides during
energy consumption and fatty acid release when energy expenditure exceeded energy intake.
Next to that, its second function was that of an insulating layer under the skin which helps to
regulate body temperature and to cushion and protect body parts. Since the discovery of the
obesity gene leptin in 1994 , it became clear that white adipose tissue also has an important
metabolic  and  immune  function,  which  involved  the  secretion  and  perception  of  peptide
hormones and cytokines.
Energy storage
White adipose tissue is the major site in the body for storage of surplus energy. Energy can be
stored in the form of triglycerides in various anatomical depots i.e. subcutaneous, and visceral
fat depots and a small portion of around 5% will be stored in the liver or in muscle. Storage
capacity is regulated by either growth or shrinkage of the adipose tissue mass. Growth can take
place via adipogenesis, a tightly regulated cellular differentiation process from a fibroblast like
pre-adipocyte to a mature lipid loaded adipocyte .  So,  adipocyte morphology and adipocyte
number are able to adapt in response to the demands of the energy balance . The balance is
determined  by  the  amount  of  fat  synthesis  (lipogenesis)  and  fat  break  down  (lipolysis).  In
lipogenesis, fatty acids are synthesized from acetyl-CoA. This process is responsive to nutritional
and hormonal regulation . In lipolysis, triacylglycerol molecules are hydrolysed into free fatty
acids and glycerol so they can be used as an energy source for β-oxidation in liver, muscle and
Until 1994 adipose tissue was primarily viewed as a depot for storage of 
triglycerides during energy consumption and fatty acid release when energy 
expenditure xceeded energy intake. n xt to that, its second function was that of 
an insulating layer under th  ski which helps to regulate body temperature and to 
cushion and protect body parts. Since the discovery of the obesity gene leptin in 
1994 [2], it became clear that white adipose tissue also has an important metabolic 
and immune function, which involved the secretion and perception of peptide 
hormones and cytokines.
Energy storage
White adipose tissue is the major site in the body for storage of surplus energy. 
Energy can be stored in the form of triglycerides in various anatomical depots 
i.e. subcutaneous, and visceral fat depots and a small portion of around 5% will 
be stored in the liver or in muscle. Storage capacity is regulated by either growth 
or shrinkage of the adipose tissue mass. Growth can take lace via adipogenesis, 
Figure 1 Structure of white adipose. (adapted from [1])
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a tightly regulated cellular differentiation process from a fibroblast like pre-
adipocyte to a mature lipid loaded adipocyte [3]. So, adipocyte morphology and 
adipocyte number are able to adapt in response to the demands of the energy 
balance [4]. The balance is determined by the amount of fat synthesis (lipogenesis) 
and fat break down (lipolysis). In lipogenesis, fatty acids are synthesized from 
acetyl-CoA. This process is responsive to nutritional and hormonal regulation 
[5]. In lipolysis, triacylglycerol molecules are hydrolysed into free fatty acids 
and glycerol so they can be used as an energy source for β-oxidation in liver, 
muscle and other tissues. Some of the released free fatty acids are re-esterified 
to triglycerides in adipocytes. This process is important to be able to directly 
respond to changes in peripheral energy homeostasis and concomitant changes 
in fatty acid requirements [6]. In obesity, levels of free fatty acids are elevated 
in plasma of most subjects [7]. High levels of these circulating free fatty acids 
have been associated with insulin resistance and atherosclerosis [8]. These high 
circulating levels lead to an increased lipid accumulation into non-adipose tissues 
such as muscle, liver, pancreas and heart and may lead to cellular dysfunction or 
even cell death [9, 10]. 
Endocrine organ
Some twenty years ago it has been reported that adipose tissue played a role in the 
secretion of factors that influence appetite and sex steroid metabolism [11, 12]. In 
1994 the ‘obese gene’ leptin was discovered as the first secreted peptide hormone 
by adipose tissue [2]. This progress stimulated the discovery of more new adipose 
tissue secreted protein signals and factors also called adipokines or adipocytokines 
[13, 14]. They function as part of a complex set of physiological control systems 
that regulate local tissue and systemic physiology. A listing with their functions is 
shown in table 1. Dysregulation of adipokine secretion plays a fundamental role in 
the pathogenesis of obesity [15]. Expression of several of these adipokines (Tumor 
necrosis factor alpha (TnF-α), interleukin-6 (Il-6), adiponectin and C - reactive protein 
(CRP)) is often dependent on cell size or volume and location [16]. 
In general, most adipokines are more abundantly expressed and secreted 
in relation to the amount of fat mass. Two well described adipokines are leptin 
and adiponectin. Leptin serves as a metabolic signal which regulates energy 
homeostasis via inhibiting food intake and increasing energy expenditure [17]. 
next to that, its levels are proportional to the amount of adipose tissue mass [18]. 
In obesity, leptin levels are therefore high, however usually there is no reduction 
in feed intake, which is attributed to leptin resistance. Serum leptin levels are 
linked to meal times via circadian oscillation and could be a bridge between 
energy homeostasis and circadian control [19]. Adiponectin levels are negatively 
correlated to adipose tissue mass, and are decreased upon obesity [20]. However, 
an increase in adiponectin is also shown in targeted interventions studies which 
did not induce weight loss [21]. Adiponectin is a modulator of glucose regulation; 
10
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it increases rates of fatty acid oxidation, improves insulin sensitivity and reduces 
inflammation vascular injury [22].
table 1 Major adipokines secreted by adipose tissue. (Continued)
Adipokine Gene symbol Primary source (s) Function
Leptin Lep Adipocytes Satiety signal
Adiponectin Adipoq Adipocytes Insulin sensitizer; 
anti-inflammatory
Resistin Retn Adipocytes Increases insulin resistance; 
promotes endothelial 
dysfunction
Adipsin/complement 
factor D
Cfd Adipocytes, 
monocytes, 
macrophages
Rate limiting enzyme in 
complement pathway, 
stimulates triglyceride storage
Acylation stimulating 
protein
C3 Adipocytes Stimulates triglyceride storage
Apelin Apln Adipocytes Dependent on location of 
receptor, role in cardiovascular 
physiology
Serum amyloid A Saa adipocytes Systemic inflammation and 
atherosclerosis
Vaspin Serpina 12 Adipocytes Insulin sensitivity
Omentin Itln1 Stromal vascular 
cells
Role in insulin mediated 
glucose-uptake
Zinc-alpha2-glycoprotein Azgp1 Adipocytes Lipid mobilization
Lipocalin 2 Lcn2 Adipocytes, 
macrophages
Promotes insulin resistance 
and inflammation through TnF 
secretion from adipocytes
Secreted frizzled-related 
protein 5
Sfrp5 adipocytes Insulin mimetic effects
Retinol binding protein-4 Rbp4 Liver, adipocytes, 
macrophages
Implicated in systemic insulin 
resistance
Chemerin Rarres2 Adipocytes Role in adipogenesis and 
glucose uptake
Plasminogen activator 
inhibitor-1
Pai-1 Stromal vascular 
cells
Fibrinolysis
Visfatin nampt Adipocytes, 
macrophages and 
other cells
Monocyte chemotactic activity
Angiopoietin-like 
protein 2
Angptl-2 Adipocytes, 
other cells
Local and vascular inflammation
Monocyte chemo-
attractant protein 1
Mcp-1 Recruits monocytes to sites of 
injury and inflammation
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table 1 Major adipokines secreted by adipose tissue. (Continued)
Adipokine Gene symbol Primary source (s) Function
Pro inflammatory cytokines
Tumor necrosis 
factor-alpha 
Tnf-α Stromal vascular 
fraction cells, 
adipocytes
Inflammation, antagonism of 
insulin signaling
Angiotensinogen Agt Adipocytes Adipocyte differentiation, size 
and insulin sensitivity 
Interleukin-6 Il-6 Adipocytes, 
stromal vascular 
fraction cells
Changes with source and target
Interleukin-18 Il-18 Stromal vascular 
fraction cells
Broad-spectrum inflammation
CC-chemokine ligand 2 Ccl2 Adipocytes, 
stromal vascular 
fraction cells
Monocyte recruitment
CXC-chemokine ligand 5 Cxcl5 Stromal vascular 
fraction cells 
(macrophages)
Antagonism of insulin signaling 
through the JAK-STAT pathway
Based on [15, 23, 24]
energy bAlAnCe 
In biology energy balance is the homeostasis of energy which is often represented 
by a simple formula: energy intake = energy expenditure + energy stored. Essentially 
this is just a restatement of thermodynamics, since energy cannot be created nor 
destroyed. Food is the main source of our energy. Energy expenditure can be 
compartmentalized into 3 main categories: resting metabolic rate (i.e. energy 
needed for maintenance of main physiological functioning), adaptive thermogenesis 
(i.e. energy expended to digest, metabolize, and store ingested macro nutrients or 
energy to adjust to environmental temperature), and physical activity (i.e. increase 
in metabolic rate caused by use of skeletal muscles for any type of physiological 
movement) [25, 26]. Remarkably, despite substantial daily variation in energy intake 
and expenditure, most adults obtain a stable body weight. Individual body weight 
variance is around 0.5% over periods of 6-10 weeks [27]. net energy balance is 
counteracted by changes in food intake and/or energy expenditure to minimize 
changes in body weight [28]. Weight stability suggests homeostatic control, but 
homeostasis implies active regulation towards a certain physiological condition or 
set-point. From the late 1970’s / early 1980’s the percentage of overweight people 
started to rise and it seems that we are not able to ‘auto regulate’ our body weight 
around a fixed point any longer. This casts some doubt on the fixed set point theory 
as the set point seems to move upward.
12
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One way to explain the obesity epidemic is by the thrifty gene hypothesis. It 
starts from the assumption that through natural selection we evolved to be efficient 
in energy storage for times of famine [29]. Stimulated by overabundance of food 
(introduction of fast food and soft drinks), a sedentary lifestyle (transportation 
systems) and the availability of new technologies (labor saving devices) this makes 
us susceptible to development of obesity and its associated pathologies. This is not 
only the case in the Western world but it has become a global problem, ‘globesity’. 
Interaction of all these parameters results in a dynamic equilibrium ‘settling point’ 
which is dependent on current input [30]. This principle is used by two different 
models, which will be discussed in more detail. 
Set point hypotheses
The set point model can be considered as a thermostat; when the system is disrupted 
by either losing or gaining weight, the weight will be either regained or lost to 
approximate the original settings. Body weight regulation might be secondary to 
regulation of a component of our body composition, such as fat. This led to the 
‘lipostatic’ theory in which total body fat regulation determines body weight [31]. The 
set point model represents a closed loop model in which the controlled quantity can 
be fat mass, body weight or even fat free mass which sends a signal to the central 
control system (Figure 2). The value of the set-point is independent of the operation 
of the system, and, once adjusted, remains the same until readjusted [30]. It is now 
clear that this might be an oversimplified model as more factors become known 
which are able to influence body weight and composition.
In the settling point model it is assumed that there is little active regulation 
of body weight, but that environmental and socioeconomic factors such as diet 
and lifestyle are predominant. Precise regulation takes place without an exact 
predefined set-point, rather they settle at a certain number. An analogy for body 
weight regulation and its energy stores is the levels of water in a lake [32]. A natural 
equilibrium is present in a reservoir, here a lake, due to extra inflow of rain and 
equalisation of outflow to inflow of rain (Figure 3A). When translated into regulation 
of body weight, body energy stores represent the lake while rain is translated into 
input, and depth at outflow is represented by expenditure (Figure 3B).
Several weight loss strategies for humans exist, some more successful than 
others. Reduced energy diets or weight loss medication are generally successful 
/or  energy  expenditur  to  minimize  changes in  body  weight  .  Weight  stability  suggests
homeostatic control, but homeostasis implies active regulation towards a certain physiological
condition or set-point. From the late 1970’s / early 1980’s the percentage of overweight people
started to rise and it seems that we are not able to ‘auto regulate’ our body weight around a
fixed point any longer.  This casts some doubt on the fixed set point theory as the set point
seems to move upward.
One way to explain the obesity epidemic is by the thrifty gene hypothesis. It starts from the
assumption that through natural selection we evolved to be efficient in energy storage for times
of famine . Stimulated by overabundance of food (introduction of fast food and soft drinks), a
sedentary  lifestyle  (transportation  systems)  and  the  availability  of  new  technologies  (labor
saving  devices)  this  makes  us  susceptible  to  development  of  obesity  and  its  associated
pathologies. Thi  is not only the case in the W stern world but  has become a global problem,
‘globesity’. Interaction of all these parameters results in a dynamic equilibrium ‘settling point’
which is dependent on current input . This principle is used by two different models, which will
be discussed in more detail. 
Set point hypotheses
The set point model can be considered as a thermostat; when the system is disrupted by either
losing or gaining weight, the weight will be either regained or lost to approximate the original
settings. Body weight regulation might be secondary to regulation of a component of our body
composition, such as fat. This led to the ‘lipostatic’ theory in which total body fat regulation
determin s body weight . The set point mod l represents a close loop model in which the
controlled quantity can be fat mass, body weight or even fat free mass which sends a signal to
the central control system (Figure 2). The value of the set-point is independent of the operation
of the system, and, once adjusted, remains the same until readjusted . It is now clear that this
might be an oversimplified model as more factors become known which are able to influence
body weight and composition.
In the settling point model it is assumed that there is little active regulation of body weight, but
that  environmental  and  socioeconomic  factors  such  as  diet  and  lifestyle  are  predominant.
Precise regulation takes place without an exact predefined set-point,  rather they settle at  a
certain number.  An analogy for body weight regulation and its energy stores is the levels of
water in a lake . A natural equilibrium is present in a reservoir, here a lake, due to extra inflow of
rain and equalisation of outflow to inflow of rain (Figure 3A). When translated into regulation of
body weight, body energy stores represent the lake while rain is translated into input, and depth
at outflow is represented by expenditure (Figure 3B).
Figure 2. Set point models for the regulation of body weight.
Fat mass,
bodyweight, fat
free mass
Central control
system
Figure 2 Set point models for the regulation of body weight.
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in reaching a body weight loss of 5-9% with weight plateauing after 6 months [33]. 
Also reduction of a specific nutrient such as fat or carbohydrates (Atkins diet) is 
considered as an effective tool for weight loss [34-35]. The biggest problem is 
maintenance of the lower body weight, short term effectiveness is high but long 
term maintenance seems to be more difficult. In a meta-analysis of body weight 
reduction studies it was observed that after 48 months half of the reduction had 
disappeared [33]. Successful maintenance of body weight reduction is dependent 
on several factors. It starts with continued dietary restraint, but it also includes 
eating breakfast every day, frequent self-monitoring, undertaking regular exercise, 
and limiting television viewing [36]. 
Adiposopathy 
Recently, obesity has been recognized as a disease. It became clear, that the 
presence of excessive adipose tissue leads to pathological disruption of adipose 
tissue metabolic processes. This has been called adiposopathy, ‘sick fat’ [37]. 
Several phenotypic changes can be observed: the anatomy of white adipose tissue 
changes by hypertrophy of adipocyte cells, in particular visceral adipose tissue 
accumulates and ectopic lipid storage is seen. Physiology is affected by changes 
in metabolism (increased secretion of free fatty acids), signalling (adipokines) and 
immune homeostasis (altered secretion of adipocytokines). Disturbances in cross talk 
with other organs contribute to the development of metabolic diseases. Important 
was the realization that white adipose depots became inflamed when excessively 
Figure 3 Settling point models for the regulation of body weight. A) Level of water in a lake 
B) A parameter of interest (body energy stores) is regulated by input and expenditure. Adapted 
from [32]
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enlarged (as in obesity). This chronic inflammation is considered the foundation for 
the progression of obesity associated diseases such as insulin resistance, type 2 
diabetes, cardiovascular disease and some forms of cancer [38]. The next question 
asked was why this inflammatory state was aroused. It was proposed that due to the 
excessive expansion of the adipose tissue, hypoxia developed at tissue level [39]. 
Alternative theories for development of adipose tissue inflammation are endoplasmic 
reticulum stress [40] or oxidative stress [41].
Measuring the energy balance, indirect calorimetry
Indirect calorimetry is a method in which total energy expenditure as well as relative 
and absolute substrate specific energy expenditure rates can be measured in vivo 
by means of gas exchange measurements [42]. Specifically designed equipment 
monitors gas volume of oxygen (O2) and carbon dioxide (CO2) at the inlet and outlet 
vents of a chamber which is ventilated with fresh ambient air at a known flow rate by 
positive pressure (Figure 4). 
Figure 4 Indirect calorimetric airflow.
The ratio between carbon dioxide production (VCO2) and oxygen consumption 
(VO2) reflects the nutrient mixture which is oxidized on a whole body level, the 
respiratory exchange rate (RER). Actual substrate oxidation at the tissue level is 
called the respiratory quotient (RQ). The three main energetic substrates that are 
oxidized for energy production are carbohydrates, fat and proteins. Proteins only 
contribute to a small extent to the variation in total daily energy expenditure [43], 
therefore protein is often not included in substrate specific calculations. Therefore, 
RER represents a measure for the relative participation of fat and carbohydrate 
oxidation to total energy expenditure. The general equation is
 RER = 
VCO2
VO2
 1
Depth at outflow
Rain
Body energy stores ExpenditureInput
Chapter 1
Figure 3
Figure 4
Formulas
RER=
VCO2
VO2
B
A
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The overall chemical equation for the metabolism of glucose is 
 C6H12O6 + 6(O2)  6(H2O) + 6(CO2)  2
The overall equation for a typical fatty acid, palmitic acid is
 C16H32O2 + 23O2  16(H2O) + 16(CO2) 3
From the equations Eq1 and 2, RER associated with only glucose oxidation 
equals 1. For fat, it would equal approximately 0.7. RER is different for each consumed 
nutrient mixture because the ratio C to O is higher in fat, hence more oxygen is 
needed for complete oxidation (53.8ml O2 vs. 47.5ml O2) but also more energy is 
generated (39 kJ/g vs. 16 kJ/g) [43]. Also the oxygen cost of ATP production differs 
between the two substrates: 3.93 l/mol vs. 3.72 l/mol respectively. 
Four of the most popular equations to calculate the energy equivalent of oxygen 
have been described by Brouwer (16.07 VO2 + 4.69 VCO2), Elia (15.8 VO2 + 5.18 
VCO2), Lusk (15.79 VO2 + 5.09 VCO2), and Weir (16.3 VO2 + 4.57 VCO2) [44-47]. Even 
and nadkarni showed that the deviation between these formulas is not more than 
1% [43], so all are considered to be suitable. In this thesis, energy expenditure 
calculations are based on the Weir equation, as this is the most popular and used 
equation. The general equation is
 EE = VO2 * [3.815 + (1.232 * RER)]  4
Adipose tissue And diet induCed obesity 
(Mouse As A Model)
It is often difficult to perform experiments in humans as protocols are often unethical 
or unfeasible. The mouse has been acknowledged as a suitable model for man 
as its genome is about 90% identical. next to that, it is possible to make use of 
knockout and overexpression models of specific genes to produce models of human 
disease, or use phenotype driven models. In all these approaches, changes in normal 
functioning of the whole organism can be studied which leads to insights in underlying 
mechanisms of malfunctioning. Eventually this can even lead to potential treatments. 
Some more advantages are the standardizations of performed experiments which 
lead to increased power and usage of less mice. Furthermore, many tools (whole 
gene expression microarrays, antibodies) are available for research on mice and due 
to their small size they are relatively cheap.
Mouse models have become a useful tool for the characterization of molecular 
and physiologic aspects of obesity. An appropriate mouse model for studying 
16
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adipose tissue metabolism in obesity is the C57BL/6J mouse. This strain is known for 
its capacity to develop obesity, hyperglycaemia, and insulin resistance by high fat 
feeding [48-50], but it remains lean when fed a low fat chow diet. The progression from 
being just overweight to obesity and metabolic syndrome closely parallels obesity 
development in humans [51]. High fat diet and time are able to develop obesity and 
insulin resistance gradually [48]. An important role in the development of obesity 
associated diabetes type II is the distribution of fat. Abdominal fat surrounding the 
organs has been shown to be a good predictor for diabetes via waist circumference; 
subcutaneous fat underneath the skin however does not increase the risk [52-54]. In 
C57BL/6J mice an increase in visceral (abdominal) fat upon high fat feeding has been 
shown [49, 55, 56]. Adipocytes grow; develop white adipose tissue inflammation, 
hypoxia, all like humans. Altogether, the C57BL/6J strain is a very suitable model to 
study adipose tissue metabolism.
Two other factors which play an important role in the development of obesity 
are environment and diet. Therefore it is important to take these conditions into 
account when designing a mice intervention. Ambient housing temperature of 
mice was shown to have large effects on physiology. normal standard laboratory 
environments are kept at 20-24°C. This is below the lower critical temperature of 
mice which is between 29-34°C [57]. As a result this will for example influence energy 
balance due to an increase in metabolic rate to cope with the lower temperature. 
When comparing mice to humans it is recommended to house them within the 
thermo neutral zone to avoid cold stress, as we humans also prefer thermoneutrality 
[43, 58, 59]. However this is debatable. Speakman and Keijer argue for a housing 
temperature of 23-25°C which represents a temperature at least 3°C below the lower 
critical temperature [60]. Unfortunately only few investigators have taken notice of 
the importance of housing temperature. Consequently, very little is known about the 
effects on metabolic response.
High availability of high fat / energy dense foods in modern society is a large 
component in the obesity epidemic. This is also mimicked in mouse by feeding 
a westernized diet to induce diet induced obesity. Therefore, it is important to 
consider the composition of the diet. For example, dietary fat source of the diet 
has shown to reshape gut micro biota and alter host adipose tissue inflammatory 
profile [61]. But also macronutrients are important, i.e. protein to vcarbohydrate 
ratio in a high fat diet can delay development of adiposity [62] and even different 
types of sugar contribute to this [63]. Besides composition, also purity of the diet 
is important. Many interventions make use of a chow control. Unfortunately chow 
has a high variability in its nutritional content as it is composed of various plant 
materials. next to that, the ingredients often contain non-nutritive components, 
phytoestrogens in soy, which can influence study results. To be able to observe 
functional effects of different nutrients it is therefore essential to use standardized 
semi-purified diets.
17
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AiMs And outline oF this thesis
Together with the development of the obesity epidemic, it became clear that (dys)-
functioning of adipose tissue is a major contributor to the associated adverse health 
effects. The focus of this thesis is on the adaptive capacity of white adipose tissue 
metabolism to improve the understanding of adipose tissue functioning. This will 
help in finding strategies to fight metabolic disease. There are many possibilities for 
challenging adipose tissue; this thesis focusses on investigating three basic questions. 
1. Does a body weight set-point exist? 
2. How is the diet-induced metabolic response affected by housing at 
thermoneutrality?
3. Does oxygen restriction induce inflammation in white adipose tissue?
Energy content and complex interactions between macronutrients are the 
basis for the ability to adapt our metabolism to various nutritional challenges. To 
investigate the existence of a body weight set-point chapter 2 describes a nutritional 
intervention study which investigates if dietary history influences present metabolism 
and homeostatic settings. In chapter 3 we increased adipose tissue stress by using 
two standard weight loss strategies; a reduction in fat intake and a reduction in 
energy intake. Thereby it was examined if these two strategies influenced metabolic 
regulation differently.
Environmental challenges also result in adaptation of metabolism. Thermoneutrality 
has a significant impact on metabolism and physiology, i.e. increased body weight 
gain. In chapter 4 it is investigated to which extent thermoneutrality affects metabolic 
health parameters imposed by two different semi-purified diets, and if it allows for 
more sensitive detection of biomarkers. 
Lastly we challenged adipose tissue by exposure to oxygen restriction in chapter 5 
to investigate if oxygen restriction leads to inflammation in white adipose tissue. We 
accommodated mice at thermoneutrality and combined this with feeding a high fat 
diet to induce severe diet-induced adiposity without inflammation. 
Realizing that comparisons with other studies are hampered by differences in 
dietary compositions. A standard purified diet was designed which is described in 
chapter 6.
The discussion, the final chapter of this thesis, summarizes and discusses all 
findings in this thesis and concludes with recommendations for future research.
18
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CHAPTER 2
WhAt is the CentrAl question?
Have intake patterns of diets with a different energy content a lasting effect on body 
weight persistence? 
MAin Finding And its iMportAnCe
After switches between semi-purified diets differing only in the fat/sugar ratio, the last 
consumed diet determined energy intake, energy expenditure, body weight, body 
fat stores, circulating hormones and metabolites in C57BL/6J mice. In contrast with 
persistent effects observed in studies using diets with different ingredients, suggesting 
diet induced set points, this study shows that body weight and metabolic parameters 
‘settle’ based on current energetic input and output. This supports the settling point 
theory and underlines the importance of diet choice in physiological studies.
AbstrACt 
Understanding body weight regulation is essential to fight obesity. Mouse studies, 
using different types of diet, showed conflicting results in terms of bodyweight 
persistence after changing from ad libitum high fat diet to an ad libitum low fat 
diet. In this study, we questioned specifically whether the energy content of 
the diet has a lasting effect on energy balance and body weight, using multiple 
switches and 2 purified diets with a different fat/sugar ratio, but otherwise identical 
ingredients. Young-adult obesity prone male C57BL/6J mice were fed single or 
double alternations of semi-purified diets with either 10en% fat (LF) or 40en% fat 
(HF) with starch replaced for fat, while protein content remained equal. After none, 
one or two diet alternations, energy metabolism was assessed at t=5 weeks, t=14 
weeks and t=19 weeks. We observed no systematic continuous compensation in diet 
and energy intake when returning to LF after HF consumption. Body weight, white 
adipose tissue mass and histology, serum metabolic parameters, energy expenditure, 
and substrate usage all significantly reflect current diet intake, independent of diet 
alternations. This contrasts with studies that used diets with different ingredients 
and showed persistent effects of dietary history on body weight, suggesting diet 
dependent metabolic set points. We conclude that body weight and metabolic 
parameters ‘settle’, based on current energetic input and output. This study also 
highlights the importance to consider the choice of diet in physiologic and metabolic 
intervention studies.
Keywords: Indirect calorimetry, high fat diet, adipose tissue
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introduCtion
Obesity is characterized by a surplus amount of white adipose tissue (WAT). This 
excess WAT results from a positive energy balance; an excess energy intake relative 
to energy expenditure (EE). WAT has a major role in energy storage, but also fulfils an 
active metabolic signalling function [1]. One of the signalling molecules secreted by 
WAT is the peptide hormone leptin, that controls adipose tissue mass via a negative 
feedback loop. Upon weight loss, fat mass and leptin levels decrease [2], stimulating 
appetite and suppressing EE to counteract weight loss. Likewise, when fat mass 
increases, leptin levels increase thus suppressing appetite to counteract weight gain 
[3]. In humans, maintenance of a 10% or greater reduction in body weight (BW) is 
accompanied by a reduction in EE beyond that predicted by loss of body mass [4-6]. 
Addition of exogenous leptin is able to counteract this decrease in EE that resulted 
from BW loss [7]. Together, this suggests homeostatic control of BW. This, has been 
developed into the set-point model [8]. The set-point model is supported by more 
extensive analyses for both humans [9] and rodents [10]. 
The concept that a BW set-point protects against weight loss is widely taken for 
granted and is often used to explain BW gain after BW loss. A meta-analysis of BW 
reduction trials showed that half of the BW reduction disappeared within 48 months 
[11], despite moderate BW losses. In addition, a substantial number of people fully 
regained BW. In the nHAnES study, of those who lost 10% BW, 35% regained BW 
after one year [12]. In an analysis of predictors of BW gain, it was concluded that 
maintenance of a lower BW depends on a number of factors, including a genetic 
component [13], but it always includes continued attentiveness to match dietary intake 
to energy balance [14]. This and many other observations [15-17] indicate that once 
weight is gained, it is very difficult to lose it and to remain on the new, lower, BW. 
One can wonder how the homeostatic set-point for BW is determined. It has been 
suggested that this results from previous consumption of a high caloric diet. This 
was previously examined using rats and mice. In particular C57BL/6J mice, which 
are sensitive to diet induced weight gain, are considered a good, human relevant 
model to study pathogenesis of diet induced obesity [18]. Performing dietary 
interventions in this mouse model, as compared to humans, allows for full control of 
diet and physical environment, without influence of social factors. Thus, only internal 
metabolic pressure and stresses applied by the study design are accountable for 
alternations in phenotype. Two studies have been performed in C57BL/6J mice to 
assess homeostatic BW regulation. In both studies, a high caloric diet was used to 
increase BW followed by ad libitum feeding with a low caloric diet. In the most recent 
study reported by Guo et al. [19], two different high caloric semi-purified conditions 
were used, which each were compared to a low caloric non-purified chow diet. In 
both high caloric conditions, the diet contained 59en% fat, 27en% carbohydrate and 
14en% protein, and in one condition an additional high energy drink was provided. 
After reversal to the low caloric chow diet, a persistent higher weight was observed 
in both groups that were first on a high caloric diet, compared to the group that 
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was continuously on the chow diet [19]. These results are consistent with the set-
point model, but differ from those of the study by Parekh et al. [20]. In this earlier 
study by Parekh et al. [20], semi-purified low caloric and high caloric diets were used 
with carbohydrates and fat being exchanged to alter only the energetic content. 
The single alternation from ad-libitum high caloric diet to ad libitum low caloric diet 
resulted in a stable lower BW and normalization of metabolism, comparable to the 
BW of the continuous low fat control group [20]. Identical results were also obtained 
using obesity resistant A/J mice [20]. These results argue against a diet-induced 
BW set-point and are consistent with an alternative model for regulation of body 
adiposity, being the settling point model [21]. 
Thus, two highly controlled studies in mice have examined whether previous 
diet intake patterns have a lasting effect on a newly achieved BW, but resulted in 
different outcomes. The study designs were similar, but only in one case, and not 
in the other, the low caloric diet matched the composition of the high caloric diet. 
Differences in the type of dietary constituents, such as macronutrients or bioactive 
food components, can potentially influence homeostatic control of BW. For that 
reason, we hypothesize that the different outcomes are due to the difference in 
dietary constituents. Physiological changes induced by the dietary constituents, 
other than the caloric content, may also provide the basis for an explanation why 
the body would protect against BW loss in an overweight condition. To confirm that 
the caloric content of the diet per se does not lead to changes in BW set-point, we 
here re-examined the effects of previous dietary patterns on energy balance and BW 
using purified diets. Carbohydrates and fat were exchanged to provide energetic 
differences, but of identical composition, thus excluding effects of differences in 
dietary constituents. In addition, compared to the previous study (Parekh et al., 1998), 
we extended our study by examining not only one, but also two dietary alternations 
and included additional measurements of energy homeostasis. 
MAteriAls And Methods
Ethical approval
All animal care and use was according to the guidelines for use and care given by the 
Dutch Animal Experimentation Act (1996). Permission for this study was granted by 
the Animal Ethical Committee of Wageningen University (DEC 2009146). Male wild-
type C57BL/6JOlaHsd mice were purchased from Harlan (Horst, The netherlands) 
at 8 weeks of age. After a 4 week acclimatization period to the animal facilities and 
a purified low fat diet (LF), mice were stratified to mean BW into a T=0wk (n=12), a 
LF-fed group L (n=36) and a HF-fed group H (n=84).
Animal study and diets
Access to water and food (Research Diet Services BV, Wijk bij Duurstede, The 
netherlands) was ad libitum and renewed on a weekly basis. BW and food 
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consumption were measured once a week. Animals were fed either a purified high 
fat diet (HF) or purified LF (table 1). Both diets contain exactly the same ingredients, 
and are equally supplemented with vitamins and minerals. However, the amount of 
carbohydrate and fat has partly been exchanged. The amount of 40en% fat in the 
HF is based on the average human intake across Europe [22]. Furthermore, the diets 
have a well-balanced fat composition, containing saturated as well as unsaturated 
fat. The T=0wk group was sacrificed at T=0wk for baseline measurements (n=12). 
At T=5wk, 12 mice of each diet group were sacrificed. Groups L and H were then 
each divided into two groups: half of the group remained on the consumed diet, 
and half changed to either LF or HF, which resulted into four groups LL, LH, HL, and 
HH. At T=14wk, another 12 animals per dietary group were sacrificed. Remaining 
mice from groups HL (n=24) and HH (n=24) were subdivided for a second time on 
LF or HF, which resulted in four groups: HHH, HHL, HLH, and HLL. At T=19wk, all 
animals were sacrificed. This study design is schematically shown in Fig. 1. Analyses 
are based on n=12 per dietary group, except for indirect calorimetry (n=9) and WAT 
histology (n=6) for which animals and samples were randomly selected within the 
diet group.
table 1 Composition of purified low fat diet (LF) and high fat diet (HF).
Composition LF HF
Crude protein 220 267
l-cystine 3 3
Starch 386.5 172.5
Maltodextrin 100 100
dextrose 50 50
Sucrose 100 100
Cellulose 50 50
Coconut oil 6.5 31.5
Sunflower oil 36.5 178.5
Mineral premix AIn-93G 35 35
Vitamin premix AIn-93 10 10
Choline bitartrate 2.5 2.5
Cholesterol 0.03 0.097
Energy (kcal/kg) 3865 4700
Energy% from carbohydrate 66.9 36.8
Energy% from fat 10.0 40.2
Energy% from protein 23.1 23.0
Values are in g/kg, unless stated otherwise. 
Energy content is adjusted for energy from vitamin mix.
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Tissue collection
At T=0wk, T=5wk, T=14wk and T=19wk, food was removed 2h before sacrifice in 
the morning (light phase). Mice were anesthetized with 5% isoflurane inhalation 
and blood was collected in Mini collect serum tubes (Greiner Bio-one, Longwood, 
FL) via orbital exsanguination. After blood collection, mice were killed by cervical 
dislocation. Epididymal white adipose tissue (eWAT) was rapidly isolated, weighed 
(left depot) and one portion was snap frozen in liquid nitrogen. The other portion 
was fixed overnight in 4% paraformaldehyde, washed with 70% ethanol, and paraffin-
embedded for histological analysis.
Indirect calorimetry
Energy expenditure (EE) was evaluated at T=-1wk, T=4wk, and T=12wk from the last 
24hours data of an 48 hour measurement by an open circuit LabMaster Metabolism 
Research Platform (TSE systems GmbH, Bad Homburg, Germany) with airflow of 
400ml/min. Mice remained in their home cage which is placed within the system in 
order to reduce potential stress. As our system can handle 12 mice simultaneously, 
subsequent sub-runs were performed with an equal number of mice from all dietary 
groups. We calibrated the O2 and CO2 sensors before each experiment with two highly 
defined mixtures of O2 and CO2. Rates of oxygen consumption (Vo2) and carbon dioxide 
production (Vco2) were monitored for 1 minute every 13 minutes for each animal or 
reference cage. Respiratory exchange ratio (RER) is defined as Vco2 divided by Vo2, and 
EE was calculated with the equation [3.815 + (1.232 x RER)] x Vo2 [23]. Carbohydrate 
(CHox) and fat (Fox) oxidation rates were calculated for every time point according to the 
table of Peronnet [24]. As all diets have 23en% protein content it is therefore unlikely that 
protein will affect RER values. Measured parameters included real-time measurements 
Table 1 Composition of purified low fat diet (LF) and high fat diet (HF).
Composition LF HF
Crude protein 220 267
l-cystine 3 3
Starch 386.5 172.5
Maltodextrin 100 100
dextrose 50 50
Sucrose 100 100
Cellulose 50 50
Coconut oil 6.5 31.5
Sunflower oil 36.5 178.5
Mineral premix AIN-93G 35 35
Vitamin premix AIN-93 10 10
Choline bitartrate 2.5 2.5
Cholesterol 0.03  0.097
Energy (kcal/kg) 3865 4700
Energy% from carbohydrate 66.9 36.8
Energy% from fat 10.0 40.2
Energy% from protein 23.1 23.0
Values are in g/kg, unless stated otherwise. 
Energy content is adjusted for energy from vitamin mix.
Figure 1 Study design. All mice were fed a purified low fat diet (LF) during a four week 
acclimatization period. Twelve mice were sacrificed at the beginning of the intervention 
(T=0wk), remaining mice were randomly divided into intervention groups. T=5wk, L and H, 
T=14wk, LL, LH, HL, and HH, and T=19wk HLL, HLH, HHL, and HHH (n=12/group) in which L 
(low fat diet, 10en% fat) and H (high fat diet, 40en%fat) indicate the order of consumed 
diet(s). Indirect calorimetry was performed longitudinally for the same nine mice at T=-1wk, 
T=4wk and T=12wk represented by an asterisk (*). Mice were sacrificed at T=0wk, T=5wk, T= 
14wk, and T=19wk, represented by †.
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Figure 1 Study design. All mice were fed a purified low fat diet (LF) during a four week ac-
climatization period. Twelve mice were sacrificed at the beginning of the intervention (T=0wk), 
remaining mice were r ndomly ivided into intervention groups. T=5wk, L and H, T=14wk, LL, LH, 
HL, and HH, and T=19wk HLL, HLH, HHL, and HHH (n=12/group) in which L (low fat diet, 10en% 
fat) and H (high fat diet, 40en%fat) indicate the order of consumed diet(s). Indirect calorimetry 
was performed longitudinally for the same nine mice at T=-1wk, T=4wk and T=12wk represented 
by an asterisk (*). Mice were sacrificed at T=0wk, T=5wk, T= 14wk, and T=19wk, represented by †.
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of food and water intake. Relative cumulative frequency (RCF) curve analysis, which is 
a quantitative approach to enable detection of small differences in large datasets, was 
used to transform RER data [25] which was justified as data showed a normal Gaussian 
distribution; the 50th percentile equals mean 24h RER. BW was measured before and 
after the indirect calorimetry measurements for all mice to evaluate energy balance. 
Individual mice were followed longitudinally. Voluntary activity was assessed during 
the calorimetric assessments at T=19 weeks only, due to delivery of the equipment, 
and only in a subset of mice. This indicated that no significant differences in activity 
were present (data not shown).
Serum measurements
Serum levels of leptin and insulin were measured using the mouse serum adipokine 
milliplex multianalyte kit (Millipore Corporation, Billerica, MA) according to the 
manufacturers’s protocol and analyzed using the Bio-Plex 200 system (Biorad, Veenendaal, 
The netherlands). Serum glucose was determined by the GOD-PAP colorimetric assay 
(Roche diagnostics, Woerden, The netherlands). Serum free fatty acids (FFA) levels were 
measured using the nEFA-C kit (Wako chemicals, GmbH, neuss, Germany). Volumes 
were scaled down to analyze samples with a microplate reader (BioTec Synergy HT, Bad 
Friedrichshall, Germany). All measurements were performed in duplicate and averaged. 
Finally, homeostatic assessment of insulin resistance (HOMA2-IR) was calculated using 
fasting glucose and insulin levels as published using the excel program (http://www.dtu.
ox.ac.uk/homacalculator/index.php) [26].
Histology
Paraffin embedded eWAT was sectioned at 5µm and stained by PAS-H (periodic-
acid-schiff-hematoxylin) staining. Slides were coded and blind-scored by eye by two 
independent researchers with a raster on adipocyte size. 
Statistical analysis
Data are shown as means ± SE. Significance of difference between groups is 
determined by analysis of variance (oneway AnOVA) in combination with a Tukey’s 
post-hoc test using Graphpad Prism 5.04 (GraphPad Software Inc., San Diego, CA). 
Data were normally distributed except for HOMA2-IR. When appropriate, a two-
tailed Student’s t-test was performed when means of two groups were compared. 
Differences were considered significant at P < 0.05.
results
Diet induced differences in physiological parameters
Purified high fat diet (HF) feeding increased BW significantly from week 2 onwards 
compared to control low fat diet (LF) feeding (Fig. 2a). After the first diet alternation 
(T=5wk), body weight (BW) of group HL became significantly lower from week 7 
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onwards compared to groups LH and HH, and matched BW of group LL. After 
the second diet alternation (T=14wk), the groups appeared to be divided into two 
significantly different weight groups HLL and HHL vs. HLH and HHH from T=17wk 
onwards (Fig. 2a). There was no effect of dietary history on BW when alternated 
groups are compared to their non-alternated HF or LF controls (t=14wk HL vs. LL 
and LH vs. HH, t=19wk HLH vs. HHH and HHL vs. HLL). Changes in BW are reflected 
by adipose tissue mass; adiposity was modulated according to BW at all data points 
(Fig.  2b and 2c). This was confirmed by histological staining of the epididymal 
adipose tissue (Fig. 3), which showed no difference in adipocyte size between the 
alternated fed groups and the corresponding continuously fed group at T=14wk. 
Dietary energy intake slightly increased throughout the intervention for both LF 
and HF diets when mice did not alternate diets (Fig. 2d). However, when animals 
alternated from diet at T=5wk, their dietary energy intake showed compensation 
before it adjusted to the energy intake of the control group. This was seen for the first 
dietary alternation which resulted in a week over- (HF) or under- (LF) compensation 
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Figure 2 Animal characteristics. Body weights (a), and energy intake (b) are shown for the 19 week intervention period. At 
time points T=5wk and T=14wk, sub-sets of mice alternated diets (dashed line). Diet patterns are represented by letter 
codes L (10en% fat, low fat diet) and H (40en% fat, high fat diet; see table 1 for dietary composition). LF fed animals had 
significant (p<0.05) lower body weights than HF fed animals from week 2 onwards (*), from week 7 onwards (†) and from 
week 17 (‡) onwards. White adipose tissue mass of peri-renal (pWAT; c) and epididymal (eWAT; d) origin at sacrification. 
Different letters denote significant differences (p<0.05; One-Way ANOVA and Tukey’s post hoc) between fat masses. Data 
are means ± SEM (n=12).  
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depending on the newly consumed diet versus those mice that continued on the 
same diet (Fig. 2d). This was also seen after the second dietary alternation for all diet 
groups: the first week after the alternation their energy intake pattern was disturbed 
(over- or under- compensation) and thereafter there was no difference between 
continuously fed and alternated fed groups of mice on either LF or HF (table 2). In 
general energy intake was larger than EE in all groups (table 2, 3). BW increased more 
in the HF fed groups although the difference in intake and EE was equal at T=4wk for 
L and H and at T=12wk for LL and HH. 
Cumulative energy intake (CEI) was equal at T=14wk for group HL vs. group LL, and 
for group LH vs. group HH, although groups HL and LH had a different dietary intake 
history (table 2). Although diet was provided ad libitum to all mice, mice alternating 
from HF to LF (HL and HHL) did not compensate intake to match the dietary energy 
intake levels of the HF group. Their energy intake level was decreased to the level of 
the continuously LF-fed group. It appeared that based on BW patterns and CEI, mice 
follow a pattern related to present consumed diet. Moreover, diet history had no 
effect on final BW and adiposity. To substantiate this phenomenon into more detail, 
we analyzed several serum parameters which are indicative of metabolic health and 
metabolic signaling, including leptin.
Effects of diet intervention on serum metabolic parameters
Fasting serum glucose levels were not significantly different between intervention 
groups, although diet groups (H, LH and HH) who consumed 40en% HF tended 
to show higher levels at each time point. This was also observed for insulin levels 
(table 2), and as a result, assessment of insulin resistance using the surrogate marker 
10 
 
Figure 3 Epididymal adipose tissue histology. Histology of 
epididymal adipose tissue at T=14wk from dietary groups 
LL (a), HL (b), LH (c), HH (d). Tissue was sliced at 5µm and 
subjected to PAS-H staining. See Figure 1 for letter codes. 
Magnification 10x; Bar denotes 100 μm. 
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Leptin levels showed a significant diet dependent difference at T=5wk, T=14wk, and T=19wk. Mice 
fed LF had significantly lower levels of leptin than mice fed HF, independent of dietary feeding in the 
preceding period (table 2). BW and eWAT mass are both significantly correlated with serum leptin 
levels in most groups (data not shown). Fasted free fatty acid (FFA) levels were similar in all groups 
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Figure 3 Epididymal adipose tissue histology. Histology of epididymal adipose tissue at 
T=14wk from dietary groups LL (a), HL (b), LH (c), HH (d). Tissue was sliced at 5µm and subjected 
to PAS-H staining. See Figure 1 for letter codes. Magnification 10x; Bar denotes 100 μm.
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HOMA2-IR index increased significantly suggesting increased insulin resistance in all 
HF-fed groups independent of dietary history (table 2). 
Leptin levels showed a significant diet dependent difference at T=5wk, T=14wk, 
and T=19wk. Mice fed LF had significantly lower levels of leptin than mice fed HF, 
independent of dietary feeding in the preceding period (table 2). BW and eWAT 
mass are both significantly correlated with serum leptin levels in most groups (data 
not shown). Fasted free fatty acid (FFA) levels were similar in all groups (table 2). 
Fuel utilization
To assess whether dietary history influenced whole body energy metabolism, 
indirect calorimetric measurements were performed. Respiratory exchange ratio 
(RER) as a measure for metabolic substrate usage showed a significant difference 
as expected between LF and HF mice at T=4wk, with a higher carbohydrate (CHO) 
oxidation rate and lower fat oxidation rate for the LF-fed mice (table 3). This was 
also observed at T=12wk (table 3). There was no effect of time (T=4wk to T=12wk) 
on substrate utilization for L vs. LL groups and H vs. HH groups (data not shown). 
Relative cumulative frequency (RCF) curves of RER for LH and HH as well as HL and 
LL groups align perfectly, which fits the observation that the RER represents current 
dietary intake independent of dietary history (Fig. 4). Matching fuel oxidation (RER) to 
fuel availability is defined as a measure for metabolic flexibility [27] and in particular 
for the HL group this suggests that their metabolic flexibility was preserved despite 
previous HF consumption. 
EE remained similar between all groups at T=4wk, even though the HF-fed mice 
showed an increased BW. At T=12wk, LF consuming groups LL and HL were equal 
in their mean EE, but both HF consuming groups LH and HH showed a significant 
increase in EE. Again, no significant difference in EE was observed between the mice 
that were continuously fed the same diet as compared to the mice that alternated 
diets (table 3). Interestingly, adiposity (Fig. 2c and 2d) showed a significant 
difference between LF fed groups and HF fed groups, suggesting that fat mass 
could be responsible for the observed difference in EE. When corrected for BW by 
covariance analysis, the differences in EE by diet group were no longer significant. 
Unfortunately, we lack carcass analyses so we cannot fully exclude a contribution of 
(small) differences in lean mass, if at all present. 
disCussion
In this study we examined whether previous purified diet intake patterns have a 
lasting effect on a newly achieved energy balance and BW. We studied one and two 
dietary alternations and observed that energy intake was dependent of the current 
diet and not influenced by a previous diet. BW, WAT mass and histology, serum 
metabolic parameters, EE and RER levels depend on the current diet, without any 
effect of a previous diet.
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Our study, although more rigorous in the sense that we used two dietary 
alternations, confirmed previous findings in that no effect of dietary history 
was seen when mice are fed purified diets with identical ingredients. This setup 
minimizes possible other effects of diets, such as differences in growth due to 
differences in amount or composition of amino acids, micronutrients or bioactive 
food components. Only differences due to energy content and changed amounts 
of fatty acids and starch were assessed. This contrasts with the results of another 
study in which a purified high fat diet and a non-purified chow low fat diet were 
used [19, 28]. Due to the different nature of the diets it cannot be excluded that 
the persistent higher weight in the intervention group is due to differences in 
the type of ingredients, such as protein, which was substantially different, or the 
presence of bioactive food components such as phytoestrogens in the soy bean 
meal and soy oil, or to any of the other differences in the diets, such as cholesterol 
[29]. This further supports efforts of many groups to use identical purified diets 
in order to exclude unintended effects due to differences in diet composition 
[30, 31]. Experimental data from studies with rats also report controversial results 
with respect to persistency of obesity. Both persistent obesity has been reported 
[32, 33] as well as reversal of obesity [33, 34] sometimes even in the same report 
table 3 Effect of diet on whole body energy metabolism.
4wk* 12wk†
L H LL LH HL HH
Respiratory Exchange 
Ratio (RER)
24h 0.948±0.006* 0.823±0.002 0.979±0.005a 0.869±0.002b 0.984±0.005a 0.874±0.002b
12h light 0.912±0.008* 0.815±0.003 0.963±0.007a 0.870±0.003b 0.972±0.008a 0.870±0.003b
12h dark 0.984±0.005* 0.832±0.003 0.995±0.005a 0.868±0.003b 0.997±0.006a 0.879±0.002b
Substrate 
Utilization 
CHO (%) 76.22±5.615* 39.90±2.051 80.79±4.151 a 55.61±1.841 b 81.93±2.983 a 56.09±2.578 b
FAT (%) 23.77±5.614* 60.10±2.051 17.15±3.415 a 44.39±1.841 b 18.07±2.983 a 43.91±2.578 b
Energy expenditure 
(kcal/h)
24h 0.511±0.005 0.520±0.004 0.500±0.003a 0.563±0.004b 0.497±0.004a 0.543±0.003c
12h light 0.468±0.004* 0.486±0.003 0.469±0.003a 0.540±0.003b 0.471±0.004a 0.511±0.003c
12h dark 0.547±0.004 0.555±0.003 0.520±0.002a 0.580±0.003b 0.536±0.003c 0.565±0.002d
Average 
EE (kcal/d)
11.99±0.42* 13.04±0.21 11.99±0.42a 13.52±0.65a 11.93±0.56a 13.04±0.21a
* H was greater than L at T=4wk (p<0.05, student’s t-test). † Different superscript letters denote 
differences (p < 0.05) between the diet groups within one time-point T=12wk (One way AnOVA and 
Tukey’s post hoc). Substrate utilization (%) is calculated over 24hr based on RER-values and the table of 
Peronnet (Peronnet & Massicotte, 1991).
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using chow as control (Hill et al., 1989). Our study suggests that dietary composition 
may have a role and it is of interest to specifically assess the role of various nutrients, 
in particular those that induce metabolic alterations, such as diets with saturated 
fats in future studies. 
To analyze the effects of dietary history in more depth, we measured several 
serum metabolic and hormonal parameters. The lack of significant differences in 
time in the serum glucose, insulin, and FFA profiles of the mice may be related to 
the healthy fatty acid composition of the diet. The diet only contains 5% of saturated 
fats as compared to high fat palm oil and lard diets, which contain a high amount 
of saturated fat, in particular palmitic acid [35]. Saturated fatty acids are considered 
to be more obesogenic. This obesogenic potential increases BW gain, particularly 
via adipose tissue, which increases the risk of adipose tissue dysfunction. However, 
when we analyze our data using the HOMA2-IR index, an initial insulin resistance is 
12 
 
Fuel utilization 
To assess whether dietary history influenced whole body energy metabolism, indirect 
calorimetric measurements were performed. Respiratory exchange ratio (RER) as a measure for 
metabolic substrate usage showed a significant difference as expected between LF and HF mice 
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independent of dietary history (Fig. 4). Matching fuel oxidation (RER) to fuel availability is 
defined as a measure for metabolic flexibility [27] and in particular for the HL group this 
suggests that their metabolic flexibility was preserved despite previous HF consumption.  
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Figure 4 Respiratory exchange ratio (RER). Pooled (n=9) 24h RER data transformed into relative cumulative frequency 
(rcf) distributions in week 4 (a): groups L (grey line), and H (black line), and in week 12 (b): groups LL (grey line), LH 
(dashed black line), HL (dashed grey line), and HH (black line). See Figure 1 for letter codes. In each graph the solid 
line marks the 50th percentile. An asterisk indicates a significant higher mean RER for LF fed mice at T=4wk (L) and at 
T=12wk (LL and HL, p<0.05). Mean 24h RER curves at week 4 (c) and week 12 (d). The grey area represents the 12 
hour dark period. At weeks 4 and 12, HF fed mice have a lower RER than LF fed mice (p<0.05). 
 
EE remained similar between all groups at T=4wk, even though the HF-fed mice showed an 
increased BW. At T=12wk, LF consuming groups LL and HL were equal in their mean EE, but both 
HF consuming groups LH and HH showed a significant increase in EE. Again, no significant 
Figure 4 Respiratory exchange ratio (RER). Pooled (n=9) 24h RER data transformed into relative 
cumulative frequency (rcf) distributions in week 4 (a): groups L (grey line), and H (black line), and in 
week 12 (b): groups LL (grey line), LH (dashed black line), HL (dashed grey line), and HH (black line). 
See Figure 1 for letter codes. In each graph the solid line marks the 50th percentile. An asterisk 
indicates a significant higher mean RER for LF fed mice at T=4wk (L) and at T=12wk (LL and HL, 
p<0.05). Mean 24h RER curves at week 4 (c) and week 12 (d). The grey area represents the 12 hour 
dark period. At weeks 4 and 12, HF fed mice have a lower RER than LF fed mice (p<0.05).
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suggested in the current HF-fed groups, in agreement with expectation, independent 
of dietary history (table 2). 
The decreased EE that is seen during weight loss may be a relative short term 
effect, induced by lower levels of leptin. Lowering of leptin levels is known to increase 
food intake, which is mediated via AMPK in the hypothalamus [36]. Injection of leptin 
was shown to counteract the reduced EE [37]. The effects of leptin can fit a set-point 
as well as a settling theory, depending on the time scale of the effects. Our data 
show that leptin levels in mice fed LF after a previous period of HF feeding return to 
levels corresponding with control (LL) mice (Table 2), and are significantly different 
from HF-fed mice. Dietary history did not influence this reversal of leptin levels. As an 
alternative model for BW regulation Flatt proposed that BW is determined by the past 
history of energy imbalance [38]. This idea does not explain why a body would defend 
an unhealthy overweight or obese state. Our data are best explained by the theoretical 
settling point model. This non-regulated passive model is, as is the set-point model, 
based on engineering control systems. The system ‘settles’ at a point defined by the 
unregulated parameter (inflow being nutritional input or outflow being EE). The level 
of the reservoir, here WAT mass, settles to an equilibrium determined by inflow, here 
diet. If we place our data into the context of this model, we observe a different settling 
point in BW for either LF and HF consumption, each being independent of previous 
dietary history. We observed a rise in EE when BW and fat mass increased, and a 
decrease when BW and fat mass declined as a result of different dietary intake, which 
follows the model. This is however not necessarily due to an increase in lean body mass 
as suggested by Speakman et al. [39]. It could also be just due to an increase in fat 
mass [40]. nevertheless, both are sound with the expectation that EE follows weight 
changes [4], and moreover, that correction of EE by BW might mask true biological 
differences [41]. Thus, we empirically show that this settling point model is valid and 
that there is no effect of diet history on this equilibrium.
In conclusion, our results indicate that physiological parameters related to BW 
depend on the current dietary intake, with no indication of an effect of diet history 
in this specific time frame. A settling point is reached for each of these specific 
diets, LF and HF, respectively. Our data implicate that adherence to a healthy energy 
balanced diet will reverse a higher BW and may counteract possible harmful effects 
of a previous consumed unhealthy diet that provides excess energy and vice versa 
in C57BL/6J mice. The latter is supported by normalization of adipocyte size and 
number, and normalization of HOMA index. These aspects may be considered in 
effective BW loss and BW maintenance strategies.
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CHAPTER 3
AbstrACt
Restriction of a high fat diet (HFD) and a change to a low fat diet (LFD) are two 
interventions that were shown to promote weight loss and improve parameters of 
metabolic health in obesity. Examination of the biochemical and molecular responses 
of white adipose tissue (WAT) to these interventions has not been performed so 
far. Here, male C57BL/6JOlaHsd mice, harboring an intact nicotinamide nucleotide 
transhydrogenase gene, were fed a purified 40 energy% HFD for 14 weeks to induce 
obesity. Afterwards, mice were divided into three dietary groups: HFD (maintained 
on HFD), LFD (changed to LFD with identical ingredients), and HFD-CR (restricted 
to 70% of the HFD). The effects of the interventions were examined after 5 weeks. 
Beneficial effects were seen for both HFD-CR and LFD (compared to HFD) regarding 
physiological parameters (body weight and fat mass) and metabolic parameters, 
including circulating insulin and leptin levels. Macrophage infiltration in WAT was 
reduced by both interventions, although more effectively by HFD-CR. Strikingly, 
molecular parameters in WAT differed between HFD-CR and LFD, with increased 
activation of mitochondrial carbohydrate and fat metabolism in HFD-CR mice. Our 
results confirm that restriction of the amount of dietary intake and reduction of the 
dietary energy content are both effective in inducing weight loss. However, the 
larger decrease in WAT inflammation and increase in mitochondrial carbohydrate 
metabolism emphasize potential superior effectiveness of dietary restriction in 
weight loss strategies. 
Keywords: Caloric restriction, fat restriction, nutrition, metabolic health, white 
adipose tissue
42
EFFECTS OF DIETARY EnERGY OR FAT RESTRICTIOn
3
introduCtion
Obesity would be less of a problem if it was not a major risk factor for non-
communicable diseases such as cardiovascular diseases, type 2 diabetes, and some 
sorts of cancer [1]. Obesity is a condition of superfluous white adipose tissue (WAT) 
mass. next to its function as an energy reservoir, WAT is recognized as an endocrine 
organ responsible for secretion of adipocytokines [2, 3]. Changes in this secretory 
function of adipose tissue have been associated with obesity and with dysfunction of 
the adipose tissue. Adipose tissue dysfunction may result in ectopic lipid deposition 
which is detrimental for normal tissues [4]. Together with a state of chronic low grade 
inflammation, an increased risk for development of non-communicable diseases 
is created.
To improve or even restore health in an obese condition, a negative energy 
balance is needed, leading to fat mass reduction and thus to weight loss. Indeed, 
a small weight reduction of 5% already leads to improved health outcomes [5].This 
can be achieved by either restriction of calorie intake maintaining the same dietary 
composition, or by a reduction of fat intake, that is, by changing the macronutrient 
composition of the consumed diet. Both have been shown to be successful in 
humans: caloric restriction (CR) improves glycaemic control [6] and reduction of fat 
intake, without intentional restriction of energy intake, induces weight loss [7]. The 
optimal macro nutrient composition of weight reducing diets is still under debate.
When allowed ad libitum access to a high fat diet (HFD), C57BL/6J mice develop 
insulin resistance and obesity in resemblance to disease progression in humans [8]. 
Like in humans, weight loss in diet induced obese rodents can be obtained with 
various diet intervention strategies. However, only few studies investigated this from 
a nutritional point of view. Reduction in body weight, fat mass, and several metabolic 
parameters were obtained using a standard percentage of CR, a 30% reduction, 
of a HFD [9], so without changing the macronutrient composition. A substantial 
improvement of an obese condition, reduction of body weight and improvement 
of insulin sensitivity, was also obtained by a reduction of the fat percentage in 
the diet (i.e. by a change from a HFD to a low fat diet (LFD) [10]. These studies 
showed that dietary energy restriction and dietary fat reduction are both effective 
in weight reduction in diet-induced obesity (DIO). However, a number of questions 
remain. In particular, it is not known how these interventions impact adipose tissue 
at the functional and molecular level and to which extent this differs between these 
intervention strategies. This information is important in the development of dietary 
anti-obesity interventions.
The aim of this study is to compare the effects on adipose tissue of two different 
body weight loss strategies; a standard 30energy% (en%) CR (i.e. energy restriction 
of HFD) and a change from ad libitum HFD to ad libitum LFD (i.e. restriction of 
fat intake). These interventions were done using purified diets containing the same 
ingredients, with only the amounts of carbohydrate and fat differing between the 
diets. C57BL/6JOlaHsd mice were used. Similar to other C57BL/6J sub-strains, 
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C57BL/6JOlaHsd is sensitive to DIO [8]. This sub-strain has an intact nicotinamide 
nucleotide transhydrogenase (Nnt) gene, which is in contrast to most C57BL/6J sub-
strains that were used in other studies investigating weight loss by HFD restriction or 
a change to LFD. Intact and functional nnT was recently shown to be important for 
cellular redox control [11]. 
In this study the interventions started from an obesogenic condition, that is, after 
14 weeks of HFD feeding. The effects of both interventions were examined after 
5 weeks, which we expected to be at the end of the adaptation period based on 
previous studies [12].
We report here that a 30en% restriction of a HFD induces more pronounced effects 
than a change to LFD, in particular regarding WAT inflammation and expression of 
mitochondrial carbohydrate metabolism genes.
MAteriAls And Methods
Animal study and diets
Male wild-type C57BL/6JOlaHsd mice were purchased from Harlan (Horst, The 
netherlands) at 8 weeks of age and were housed individually in a controlled 
environment (12h light/dark cycle, 55% humidity, temperature at 22°C). Access to 
water and food (Research Diet Services BV, Wijk bij Duurstede, The netherlands) 
was ad libitum and renewed every week. Mice were acclimatized to the housing 
conditions for four weeks on a low fat 10en% purified diet (LFD, Supplemental 
table 1; as published [12]). During a 14 week run-in, mice were given a 40en% high fat 
purified diet (HFD, Supplemental table 1; as published [12]) to induce obesity. After 
the run-in, 36 mice were stratified on body weight into 3 groups: HFD continued 
on HFD, LFD was changed to the purified LFD, and HFD-CR received 70% of the 
individual HFD consumption —as measured over weeks 10-12 during the run-in— on 
a daily basis 2 hours before the start of the dark phase. After 5 weeks of intervention 
at the age of 31 weeks, all mice were killed. All analyses are based on 12 mice per 
dietary group, except for histological analysis (n=5-6). Body weight and food intake 
were monitored weekly. The experimental protocol was approved by the animal 
welfare committee of Wageningen University, Wageningen, The netherlands.
Tissue collection
Food was removed 2 hours before mice were killed in the morning. Mice were 
anesthetized by 5% isoflurane inhalation. Blood was collected in Mini collect serum 
tubes (Greiner Bio-one, Longwood, FL) via orbital exsanguination, and processed as 
published [12]. After blood collection, mice were killed by cervical dislocation. The 
left portion of epididymal and peri-renal WAT (eWAT and pWAT, resp.) were isolated, 
weighed and snap frozen in liquid nitrogen, and stored at -80°C. The right-sided 
portions of eWAT were fixed overnight in 4% paraformaldehyde, washed with 70% 
ethanol, and subsequently embedded in paraffin.
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Adipose tissue morphology
Paraffin embedded eWAT was sectioned at 5µm and immunohistochemically 
stained to measure mean adipocyte area as published [13]. Macrophage infiltration 
was determined as a marker for tissue inflammation. Briefly, eWAT sections were 
deparaffinized and incubated with a monoclonal antibody against the macrophage 
marker MAC-2 (Cedarlane Laboratories Limited, Burlington, Ontario, Canada), using 
chemicals from Vector laboratories, Burlingame, California, United states, unless 
stated otherwise. Briefly, endogenous peroxidase was inactivated by incubation 
for 30 minutes in 1% H2O2 in methanol. Sections were rinsed with PBS after which 
they were blocked with 5% normal goat serum in PBS-BSAc (Aurion, Wageningen, 
the netherlands). Sections were incubated overnight at 4°C with a monoclonal anti-
MAC2 antibody (diluted 1:5000 in PBS-BSAc). next, sections were rinsed in PBS 
and incubated for 60 min at room temperature (RT) with a secondary goat anti-rat 
biotinylated antibody diluted 1:200 in PBS BSAc, rinsed again, and incubated for 
60 min at RT with Vectastain elite ABC reagent (dilution 1:1000). After rinsing, the 
sections were incubated for 2 min at RT with 3, 3’-diaminobenzidine solution (dilution 
1:200), rinsed, counter stained with haematoxylin QS and mounted with vectamount. 
Cells were considered to stain positively for MAC-2 when a brown substrate was 
present in the cytoplasm of the cells. Tissues were examined under an Axiokop 2 
light microscope (Zeiss, Göttingen, Germany) and digital images were taken using 
an Axiocam MRC 5 camera (Zeiss). The number of crown like structures (CLS) were 
counted per 1000 adipocytes per mouse and macrophage infiltration was expressed 
as a total number of CLS per 100 adipocytes. 
Serum measurements
Serum levels of leptin and insulin were measured using the mouse serum adipokine 
milliplex multianalyte kit (Millipore Corporation, Billerica, MA) according to the 
manufacturers’ protocol using the Bio-Plex 200 system (Biorad, Veenendaal, The 
netherlands). Serum glucose was determined by the GOD-PAP colorimetric assay 
(Roche diagnostics, Woerden, The netherlands). Serum free fatty acids (FFA) levels 
were measured using the nEFA-C kit (Wako chemicals, GmbH, neuss, Germany). 
Volumes were scaled down to analyze samples with a micro plate reader (BioTec 
Synergy HT, Bad Friedrichshall, Germany). All measurements were performed in 
duplicate and averaged. Homeostatic assessment of insulin resistance (HOMA2-IR) 
was calculated using fasting glucose and insulin levels as published using the excel 
program (http://www.dtu.ox.ac.uk/homacalculator/index.php; [14]).
RNA/DNA isolation and cDNA synthesis
RnA isolation was performed as published [15]. All samples were purified with 
Rneasy columns (Qiagen) according to the manufacturers’ instructions. 
Total DnA was extracted from homogenized eWAT by digestion with Proteinase K 
in a lysis buffer (50 mM Tris-HCL, pH 7.5, 0.5% SDS and 12.5 mM EDTA, pH 8.0). 
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Homogenate samples were incubated overnight at 56°C. Proteinase K was inactivated 
by a 10-minutes incubation at 70°C. Samples were then incubated with 40 µg/ml 
RnAse A (Sigma-Aldrich, St. Louis, USA) for 1h at 37°C. After centrifugation, the 
aqueous phase was mixed and extracted with an equal amount of phenol-chloroform-
isoamylacohol and twice with chloroform. DnA was precipitated by 96% ethanol and 
sodium acetate (3M, pH 5.2). DnA was washed with 750 µl of cold 70% ethanol, air-
dried and re-suspended in 30 µl of RnAse DnAse free water. RnA/DnA concentration 
and purity were assessed with the nanodrop spectrophotometer (IsoGen Life 
Science, Maarsen, The netherlands). RnA integrity was checked by capillary zone 
electrophoresis (Experion, Bio-Rad). DnA concentration was adjusted to 40 ng/µl 
with RnAse DnAse free water. RnA of all individual samples was reversely transcribed 
using the iScript cDnA synthesis kit (Bio-Rad).
Gene expression by quantitative RT-PCR (qRT-PCR)
Differential transcript expression was assessed by qRT-PCR using iQ SYBR Green 
Supermix (Bio-rad) and the MyIQ single-color real-time PCR detection system (Bio-
rad). A standard curve for all transcripts including reference transcripts was made 
using serial dilutions of a pool prepared from all cDnA samples. Relative levels 
of gene expression were obtained using two reference genes (Ribosomal protein 
s15 (Rps15) and Calnexin (Canx)) in duplicate and averaged. Target genes, primer 
sequences, and annealing temperatures are shown in table 1. The expression of 
the gene of interest was normalized against the geometrical mean of the reference 
genes Rps15 and Canx, which were chosen based on stable gene expression levels, 
previous experience (i.e. Duivenvoorde, et al. 2011) and genorm (Ghent University 
Hospital, Ghent, Belgium) analysis).
Mitochondrial density
Relative mitochondrial density was determined as the ratio of mitochondrial DnA 
to nuclear DnA, as published [16]. The mean of the control group (HFD) was set as 
1.0. The primer pair’s sequences used were as follows: mitochondrial DnA (forward) 
5’-CCGCAAGGGAAAGATGAAAGAC-3’ and (reverse) 5’-TCGTTTGGTTTCGGGGTTT 
C-3’ [16]; nucleic DnA (forward) 5’-CTTAGAGGGACAAGTGGCGTTC and (reverse) 
5’- CGCTGAGCCAGTCAGTGTAG-3’ [17].
Citrate synthase activity
Snap frozen eWAT was homogenized in liquid nitrogen and diluted to a fixed protein 
concentration of 0.8 µg/µl in PBS-0.5% Triton X-100 buffer containing 1% protease 
inhibitor cocktail. Citrate synthase (CS) activity was measured spectrophotometrically 
using the CS Assay Kit (Sigma Aldrich) according to the manufacturers’ protocol. 
Briefly, eWAT homogenates were transferred to 10mM DnTB (5, 5’-dithiobis-(2-
nitrobenzoic acid)) and 30mM acetyl-CoA. CS activities were measured for 60 min 
at 412 nm at 25°C after addition of 10 mM oxaloacetate. CS activities were then 
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calculated using the slope of the linear increase according to the manufacturer’s 
protocol. The mean of the control group (HFD) was set as 1.0. 
Liver triglycerides
Triglyceride kit reagent (triglycerides Liquicolor kit, Human, Wiesbaden, Germany) 
was used according to protocol as described [18]. Briefly, snap frozen liver was 
homogenized and dissolved in a 10mM Tris, 2 mM EDTA, and 0.25M sucrose buffer 
with pH7.5. Input was corrected for wet tissue weight.
Statistical analysis
Data are expressed as mean ± SEM; statistical analyses were performed with 
GraphPad Prism 5.04 (Graphpad software, San Diego, CA, USA). All measurements 
within the different treatment groups were checked for normality with D’Agostino 
& Pearson normality test. qRT-PCR data was log2 transformed before statistical 
analysis. normal distributed data was analyzed by One way analysis of variance 
and Tuckey’s multiple comparison post hoc analysis. Test results of serum FFA, 
and gene expression data of Esrra, Ppargc1a, Mpc1, Mpc2, Pdha1, Pdhb, Pdk1 and 
Fasn were not normally distributed and therefore analyzed by non-parametric 
Kruskall-Wallis test and Dunn’s multiple comparison post hoc test. P<0.05 was 
considered significant.
table 1 Primer sequences and annealing temperature of primers used for quantitative RT-PCR. 
Genes Forward primer 5’-3’ Reverse primer 5’-3’ T(C°)
Canx* GCAGCGACCTATGATTGACAACC GCTCCAAACCAATAGCACTGAAAGG 58.5
Cpt1a AAAGATCAATCGGACCCTAGACA CAGCGAGTAGCGCATAGTCA 60.0
Cpt1b ACCCCTAAGGATGCCATTCTTG GCGGAAGCACACCAGGCAGTA 57.0
Esrra ATCCAGGGGAGCATCGAGTA AAAGGCAAAGGGTCCACCTC 60.0
Fasn AGTTAGAGCAGGACAAGCCCAAG TTCAGTGAGGCGTAGTAGACAGTG 60.0
Mpc1 GACTTTCGCCCTCTGTTGCT GCAGATGGCCGCTTACTCAT 58.5
Mpc2 ACCTACCACCGACTCATGGA AGTTTCTCTGCAGGTCTGGC 60.0
Lipe TGGAACTAAGTGGACGCAAGCC TCAAGGTATCTGTGCCCAGTAAGC 58.0
Pdha1 CTGCCTATTGCAGGTCTGGT CTTCTCGAGTGCGGTAGCTT 60.0
Pdhb GAAAGGCAAGGGACCCACAT CCTCCTTCCACAGTCACGAG 60.0
Pdk1 GCTACTCAACCAGCACTCCTT GGTCGCTCTCATGGCATTCT 60.0
Pnpla2 ACCACCCTTTCCAACATGCTACC GCTACCCGTCTGCTCTTTCATCC 58.0
Ppargc1a CCCTGCCATTGTTAAGACC TGCTGCTGTTCCTGTTTTC 60.0
Rps15* CGGAGATGGTGGGTAGCATGG ACGGGTTTGTAGGTGATGGAGAAC 58.5
S100a8 ACTTCGAGGAGTTCCTTGCG TGCTACTCCTTGTGGCTGTC 58.0
* Genes denoted with an asterisk were used as reference genes.
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results
LFD and HFD-CR decreased body weight and adiposity
Body weight of DIO mice declined immediately after the change from HFD to either 
HFD restriction (HFD-CR) or LFD. Mean body weight stabilized after 3 weeks in 
LFD mice, while it further declined till the end of the 5-week intervention period in 
HFD-CR mice (Figure 1A). There were no differences in eWAT and pWAT weights 
between LFD and HFD-CR mice, but both were significantly lower than control HFD 
mice (Figure 1B, 1C). In contrast, weight gain/loss was significantly different between 
all group comparisons; HFD gained 4.2±0.5g, while LFD and HFD-CR lost 4.1±0.4g 
Figure 2  Cumulative energy intake (A) and percentage of energy intake from macronutrients (B, fat, carbohydrate
(CHO),  protein)  during  5-week  intervention.  Numbers  in  bars  represent  corresponding  energetic  value  (Kcal)  of
various macronutrients. Data are means ± SEM (n=12). *** P<0.001
Adipocyte area and number of macrophages were decreased
To quantify the effects of the dietary interventions on the morphology and inflammatory status
of  eWAT,  adipocyte  area and  macrophage  infiltration were  investigated in accordance  with
weight  loss.  Adipocyte  area  was significantly  reduced  in  LFD  and  HFD-CR mice  in  a  similar
manner (Figure 3A). Strikingly, inflammatory status of eWAT was considerably improved by a
reduction of  CLS by  LFD,  with  an  even further  significant  reduction by  HFD-CR (Figure  3B).
Representative pictures of these CLS are shown in Figure 3C.
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Figure 1 Changes in body weight (A) and adipose tissue mass of 14-week DIO mice, followed 
by a 5-week diet intervention of ad libitum high fat diet (40en% fat, HFD), ad libitum low fat diet 
(10en% fat, LFD) or restricted high fat diet (30% restriction of HFD, HFD-CR). B and C represent 
white adipose tissue mass of epididymal (B) and peri-renal (C) origin immediately post mortem. 
Data are means ± SEM (n=12). *** P<0.001 
Figure 2 Cumulative energy intake (A) and percentage of energy intake from macronutrients 
(B, fat, carbohydrate (CHO), protein) during 5-week intervention. numbers in bars represent 
corresponding energetic value (Kcal) of various macronutrients. Data are means ± SEM (n=12). 
*** P<0.001
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and 9.0±0.5g (p<0.0001), respectively, due to the intervention. Cumulative food 
intake (Kcal) during the 5-week intervention was also different between all group 
comparisons (Figure 2). Although mean dietary energy intake level was the lowest in 
HFD-CR, the contribution of lipids to total energy availability from the diet remained 
clearly higher for HFD-CR mice in comparison to LFD mice (Figure 2). 
Adipocyte area and number of macrophages were decreased
To quantify the effects of the dietary interventions on the morphology and 
inflammatory status of eWAT, adipocyte area and macrophage infiltration were 
investigated in accordance with weight loss. Adipocyte area was significantly reduced 
in LFD and HFD-CR mice in a similar manner (Figure 3A). Strikingly, inflammatory 
status of eWAT was considerably improved by a reduction of CLS by LFD, with an 
even further significant reduction by HFD-CR (Figure 3B). Representative pictures of 
these CLS are shown in Figure 3C.
Serum parameters
Health status was also determined by measuring serum levels of insulin, glucose, 
leptin, and FFA. Serum insulin levels were significantly lowered in LFD and HFD-CR 
(Figure  4A). Glucose levels were significantly lower for HFD-CR (Figure 4B). The 
Figure 2  Cumulative energy intak  (A) and percentage of en rgy intake from macronutrients (B, fat, carbohydrate
(CHO),  protein)  during  5-week  intervention.  Numbers  in  bars  represent  corresponding  energetic  value  (Kcal)  of
various macronutrients. Data are means ± SEM (n=12). *** P<0.001
Adipocyte area and number of macrophages were decreased
To quantify the effects of the dietary interventions on the morphology and inflammatory status
of  eWAT,  adipocyte  area and  macrophage  infiltration were  investigated in accordance  with
weight  loss.  Adipocyte  area  was significantly  reduced  in  LFD  and  HFD-CR mice  in  a  similar
manner (Figure 3A). Strikingly, inflammatory status of eWAT was considerably improved by a
reduction of  CLS by  LFD,  with  an  even further  significant  reduction by  HFD-CR (Figure  3B).
Representative pictures of these CLS are shown in Figure 3C.
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Figure 3 Adipose tissue morphology. (A) Mean adipocyte area after a 5-week diet interven-
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represents dark phase. Data are means ± SEM (n=5-6). *** P<0.001 
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calculated HOMA2-IR insulin resistance index showed a similar significant reduction 
for LFD and HFD-CR (Figure 4C) indicating a similar improvement in glucose 
homeostasis for the two dietary interventions. Moreover, a significant reduction 
was observed for serum leptin levels and FFA (Figures 4D and 4E), suggesting 
improvement in lipid homeostasis as well. This is supported by reduced hepatic 
triglycerides levels in both groups (Figure 4F).
Mitochondrial density was not affected by both interventions
Caloric restriction of HFD or a switch to LFD did, unexpectedly, not affect eWAT 
mitochondrial density (Figure 5A). This was also reflected by equal levels of eWAT 
CS activity (Figure 5B).
Gene expression in eWAT was altered mainly by HFD-CR 
To investigate the molecular consequences of the dietary interventions for 
metabolic functions in WAT, we selected target genes for metabolism related 
pathways: mitochondrial biogenesis, carbohydrate metabolism, fat metabolism and 
inflammation. HFD-CR has been reported to increase mitochondrial metabolism [19, 
Figure 4 Serum and tissue parameters. (A) Insulin levels, (B) glucose levels, (C) calculated 
HOMA2-IR insulin resistance index, (D) leptin levels, and (E) free fatty acids (FFA) levels in 
serum, and (F) hepatic triglycerides levels of mice after a 5-week diet intervention of high fat 
ad libitum diet (40en% fat, HFD), low fat ad libitum (10en% fat, LFD) or high fat restriction (30% 
restriction of HFD, HFD-CR). Data are means ± SEM (n=12, except for liver triglycerides n=8). 
* P<0.05 *** P<0.001 
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20] which is induced by estrogen related receptor alpha (ESRRA), which is linked 
to oxidative metabolism, and peroxisome proliferator activated receptor gamma 
co-activator 1 alpha (PPARGC1A), which is a master regulator of mitochondrial 
biogenesis [21]. We observed increased expression of Ppargc1α for HFD-CR and LFD 
(compared to HFD) with the largest increase in HFD-CR. In contrast, Esrrα expression 
levels were not significantly changed relative to the HFD control, although HFD-CR 
showed significantly higher expression relative to LFD (Figure 6A). Pyruvate is the 
end product of glycolysis and a major substrate for the tricarboxylic acid (TCA) cycle 
in mitochondria, which leads to ATP formation, fatty acid synthesis, or via malate 
to glyceroneogenesis. Recently, the genes and transcripts for the heterocomplex 
of mitochondrial pyruvate carrier and importer (MPC) have been identified [22]. We 
analyzed the nutritional transcript regulation for both isoforms Mpc1 and Mpc2. 
Here, only a significant up regulation of Mpc1 was found as a result of HFD-CR 
(Figure 6B). Mpc2 expression levels were not significantly changed relative to the HFD 
control, although HFD-CR showed a higher expression relative to LFD (Figure 6B). 
After import into mitochondria, pyruvate needs to be converted into acetyl-CoA 
for use in the TCA cycle. Pyruvate dehydrogenase E1 alpha 1 (Pdha-1) and pyruvate 
dehydrogenase (lipoamide) beta (Pdhb) catalyze this reaction and we observed an 
up regulation of both Pdha-1 and Pdhb in HFD-CR but not in LFD mice, compared 
to the HFD control. Previous studies in our lab have shown a strong up-regulation of 
pyruvate dehydrogenase kinase, isoenzyme 1 (Pdk1) as a result of long term HFD-CR 
[20]. In support, 5 weeks of HFD-CR also showed a significant up regulation of Pdk1, 
but not in LFD (Figure 6B). next to carbohydrate metabolism, we investigated crucial 
transcripts of fat metabolism. As a measure of fat synthesis we measured fatty acid 
synthase (Fasn), which showed an up regulation upon HFD-CR only. We found no 
effects by either dietary intervention on mitochondrial import of fatty acids preceding 
Figure 5 Mitochondrial density in eWAT after a 5-week diet intervention of high fat ad libitum 
diet (40en% fat, HFD), low fat ad libitum (10en% fat, LFD) or high fat restriction (30% restric-
tion of HFD, HFD-CR) as measured by the mitochondrial DnA copy number versus the nuclear 
DnA by q-PCR and citrate synthase (CS) activity assay. Data are means ± SEM (n=10). Ratio of 
mtDnA/nDnA and CS activity levels of HFD mice was set to 1.0.
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mitochondrial fatty acid oxidation, assessed by carnitine palmitoyl transferase 1 alpha 
and beta (Cpt1a and Cpt1b, resp.) gene expression levels (Figure 6C).
In adipose tissue the rate limiting enzyme for lipolysis is encoded by adipose 
triglyceride lipase, which officially is named patatin-like phospholipase domain 
containing 2 (Atgl/Pnpla2). Its expression is regulated by nutritional status and is 
associated with rates of adipose tissue lipolysis. Levels of hormone sensitive lipase 
(Hsl/Lipe) are known not to be regulated by nutritional status and are decreased in 
acute fasting and increase after prolonged restriction [23]. Here, assessing Atgl as 
well as Hsl expression, we show that lipolysis is not affected, although there seems 
to be a tendency for increased transcript levels in the HFD-CR mice as compared to 
the LFD mice (Figure 6D).
S100 calcium binding protein a8 (S100a8) transcript levels were investigated as 
a marker for inflammatory status of the adipose tissue. We observed a reduction by 
both weight loss strategies LFD and HFD-CR (Figure 6E).
disCussion
In this study, a 14 week period of high fat feeding was used to induce DIO in male 
C57BL/6JOlaHsd mice. From this starting point, we intervened with a standard 
Figure 6 Gene expression profiling after a 
5-week diet intervention of high fat ad libitum 
diet (40en% fat, HFD), low fat ad libitum 
(10en% fat, LFD) or high fat restriction (30% 
restriction of HFD, HFD-CR) as measured by 
qRT-PCR on selected target genes. (A) Mito-
chondrial biogenesis (Esrra, Ppargc1a), (B) mi-
tochondrial carbohydrate metabolism (Mpc1, 
Mpc2, Pdha1, Pdhb, and Pdk1), (C) fatty acid 
metabolism (Cpt1a, Cpt1b, and Fasn) (D) 
lipolysis (Lipe and Pnpla2) and (E) inflamma-
tion (S100a8). 
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percentage of restriction (30%) of intake of a purified high fat diet (40en% fat, HFD-CR) 
or with a change to a purified low fat diet (10en% fat, LFD). These interventions 
strategies were applied for 5 weeks to mediate weight loss and improve health. Our 
findings confirmed the beneficial effects of both strategies, HFD-CR and LFD, with 
regards to physiological (body weight and adiposity) and metabolic parameters 
(insulin, HOMA2-IR, leptin, and FFA). Macrophage infiltration in eWAT was reduced 
by both interventions, but, remarkably, more by HFD-CR, whereas the reduction in 
adipocyte size is comparable. Similarly, eWAT expression of in particular mitochondrial 
carbohydrate metabolism genes was more affected by HFD-CR than by LFD.
Recent studies have shown that adipose tissue inflammation plays an important 
role in the pathogenesis of obesity as reviewed by Goossens [24]. As there was no 
statistical difference in fat mass and insulin resistance between HFD-CR and LFD 
mice, we expected to find no differences in eWAT infiltration by macrophages. 
However, we noticed that there was a higher reduction of CLS by HFD-CR compared 
to LFD which corresponded with reduced transcript levels of the inflammatory 
marker S100a8. This confirms the findings of Wang et al. who showed a reduction 
by HFD-CR of chemokines CCL2/monocyte chemoattractant protein-1 (MCP-1) and 
CXCL2/macrophage inflammatory protein-2 (MIP -2) mRnA expression levels (which 
act on monocytes and neutrophil granulocytes respectively), and CD11c+/CD11b+ 
cells (marker for activated macrophages or dendritic cells), independent of body 
weight [25].
Despite the same amount of fat mass after the restriction period, HFD-CR mice did 
not only display a stronger reduction in macrophage infiltration, but also had a more 
prominent regulation of mitochondrial biogenesis, lipid synthesis and, especially, 
carbohydrate metabolism. HFD-CR did not result in a change in intake of a specific 
macronutrient, but rather reduced overall macronutrient intake, resulting in a lower 
energy intake. The change to LFD on the other hand changed macronutrient intake and 
concomitantly lowered energy intake. While carbohydrate intake was higher in the LFD 
than in HFD-CR (and in HFD for that matter), fat intake was lower (Figure 2). These data 
strongly suggests that in particular the lowering of energy intake, and not so much the 
lowering of fat intake, is of primary importance to obtain beneficial metabolic effects 
of a diet intervention. Our results however, contrast with previous studies showing that 
when HFD is restricted to the caloric intake of LFD fed mice, insulin resistance and 
hepatic steatosis are not prevented [26, 27]. The lack of more pronounced effects of 
the LFD may be due to a stronger decrease in energy intake during HFD restriction 
compared to the LFD (even though fat intake was higher in HFD-CR). 
Alternatively, differences between the previous studies and our study may be 
explained by the use of different C57BL/6J sub-strains; with (our study) or without a 
functional nnt gene. Although all C57BL/6J mice are known for their susceptibility to 
DIO [28], differences in macronutrient handling are likely to exist between different 
sub-strains in view of the role of nnT in, for example, the TCA cycle [29] and insulin 
release from pancreatic beta-cells [30].
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A major difference in feeding regimen is whether the animals eat ad libitum 
(LFD mice) or whether they receive their food as a restricted single portion (HFD-CR 
mice). Feed was provided to the HFD-CR mice once a day prior to the dark phase. 
The mice consumed their portion very rapidly and were subsequently ‘fasted’ until 
the next feeding time. This is supported by indirect calorimetry data showing that 
restricted mice shift to a cyclic pattern in which the initial phase shows elevated fatty 
acid synthesis (RER > 1.1), followed by prolonged fatty acid oxidation (RER = 0.7) as 
observed by ourselves (Supplemental Figure 1) and others [31]. 
Another possibility is that the rate of restriction or the difference in protein 
intake is responsible for the differences found between LFD and HFD-CR. In a recent 
study with rats it was shown that energy restriction, but not diet composition and 
protein level, impacted weight loss and adiposity [32]. In humans, ad libitum access 
to food with a variety in the macronutrient composition promoted dietary adherence 
during weight loss and maintenance [33]. Energy restriction, however, has shown 
consistently to produce weight loss and beneficial health effects. Extrapolation of 
our results from mice to the human situation remains difficult as we do not really 
mimic free living conditions in this experiment (i.e. only one kind of diet is available). 
The long fasting period due to the feeding regimen is further substantiated by 
decreased serum levels of FFA (Figure 4E), which have shown to be correlated to the 
rate of lipolysis and fatty acid flux in adipose tissue [34]. Altogether these findings 
suggest that food restriction forces the animals into a highly dynamic metabolic 
pattern, which may contribute to increased metabolic flexibility, possibly contributing 
to the enhanced health effects in the HFD-CR regimen. 
The expression profile of eWAT showed enhanced mitochondrial carbohydrate 
metabolism as well as increased lipogenesis (Fasn). It is striking that the two 
intervention groups are not regulated in a similar way, even though LFD mice are 
in the same physiological state as HFD-CR mice. Our molecular profiles showed no 
effects on mitochondrial fatty acid beta oxidation as carnitine palmitoyl transferase 
transcripts were not regulated. But we do see an increase in Fasn regulation, 
indicative of fatty acid biosynthesis. Together with the increase in carbohydrate 
metabolism this may suggest a shift to metabolism of carbohydrates, possibly to 
prevent energy depletion from WAT. Alternatively, it may be associated with a higher 
turnover of triglycerides in WAT as has also been observed after long term HFD-CR 
(Duivenvoorde et al., 2011). 
PPARGC1A is considered to be the master regulator of mitochondrial biogenesis. 
A strong body of evidence shows that increased expression of Ppargc1a is associated 
with increased mitochondrial density in response to calorie restriction [20, 35, 
36]. Here, we show a strong up-regulation of Ppargc1α as a response to HFD-CR. 
However, we do not see this reflected in levels of mitochondria as measured by ratio of 
mitochondrial to nuclear DnA nor by CS activity. This could indicate that PPARGC1A 
is stimulated via a different regulation pathway. Alternatively, the absence of an 
increased mitochondrial density may be due to the time-frame of the current study 
54
EFFECTS OF DIETARY EnERGY OR FAT RESTRICTIOn
3
and it may be speculated that increased mitochondrial density will follow changes 
in Ppargc1a and will become evident only after long term HFD-CR. Although most 
papers show a strong correlation between measurements of mitochondrial density 
in WAT, one recent study reported a lack of association between several measured 
mitochondrial parameters (Cyt c, COXIV, Core 1, ATPS, and Ppargc1a) in several 
organs, including WAT upon (LFD) CR in Wistar rats [37]. To be able to interpret 
markers of mitochondrial density, it is important to understand the relation between 
these markers in time.
In summary, using a mouse model of DIO, we demonstrated differential effects 
of LFD and HFD-CR weight loss strategies on inflammatory status of eWAT and 
on molecular mitochondrial carbohydrate and lipid metabolism of eWAT. From a 
physiological point of view, it seems that there is little difference in response between 
LFD and HFD-CR as both interventions mediate a more healthy profile. However, 
with a focus on molecular regulation, HFD-CR showed a more evident response by 
increasing both fat and carbohydrate metabolism, together with a more pronounced 
reduction in eWAT inflammation. Therefore, HFD-CR could be marked as a more 
effective approach.
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supplemental table 1 Diet composition.
Component
LFD 
(g/kg feed)
HFD 
(g/kg feed)
AL intake LFD
1X
Al intake HFD
1x
HFD-CR
0.7x
Crude protein 220 267 220 267 154
L-cysteine 3 3 3 3 2.1
Starch 386.5 172.5 386.5 172.5 120.8
Maltodextrin 100 100 100 100 70
Dextrose 50 50 50 50 35
Sucrose 100 100 100 100 70
Cellulose 50 50 50 50 35
Coconut oil 6.5 31.5 6.5 31.5 22.1
Sunflower oil 36.5 178.5 36.5 178.5 125.0
Mineral premix AIn-93G 35 35 35 35 24.5
Vitamin premix AIn-93 10 10 10 10 7
Choline bitartrate 2.5 2.5 2.5 2.5 1.8
Cholesterol 0.03 0.097 0.03 0.097 0.068
Energy (kcal/kg) 3865 4700
Energy% from carbohydrate 66.9 36.8 36.8
Energy% from fat 10.0 40.2 40.2
Energy% from protein 23.1 23.0 23.0
supplemental figure 1 Respiratory exchange ratio (RER) of 14-week DIO mice, followed by a 
5-weeks continuation of ad libitum high fat diet (40en% fat, HFD), or a 5-weeks restricted high 
fat diet (30% restriction of HFD, HFD-CR). Data are means ± SEM (n=3-6).
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CHAPTER 4
AbstrACt
Scope
Mice are usually housed at 20°C to 24°C. At thermoneutrality (28°C) larger diet-
induced differences in obesity leading to increased differences in metabolic health 
parameters are expected. This is tested.
Methods
We performed a 14 week dietary intervention in C57BL/6J mice at 28°C and assessed 
adiposity and metabolic health parameters for a semi-purified low fat (10 energy %) 
diet (LFD) and a moderate high fat (30 energy%) diet (MHFD). 
Results
A large and significant diet-induced differential increase in body weight, adipose 
tissue mass, adipocyte size, serum leptin level, and, to some extent, cholesterol level 
was observed. no adipose tissue inflammation was seen. no differential effect of the 
diets on serum glucose, free fatty acids, triacylglycerides (TAG), insulin, adiponectin, 
resistin, PAI-1, MMP-9, sVCAM-1, sICAM-1, sE-selectin, IL-6, ApoE, fibrinogen levels 
or HOMA index was observed. Also in muscle no differential effect on mitochondrial 
density, mitochondrial respiratory control ratio or mRnA expression of metabolic 
genes was found. Finally, in liver no differential effect on weight, TAG level, aconitase / 
citrate synthase activity ratio was seen. 
Conclusions
LFD and MHFD induce prominent body weight differences at thermoneutrality, 
which is not paralleled by metabolic differences. Our data rather suggest that 
thermoneutrality alters metabolic homeostasis.
Keywords: obesity, metabolic health, adipose tissue function, biomarkers, serum 
parameters.
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introduCtion 
Obesity is a major societal and health care problem that is still increasing [1]. Obesity 
is strongly associated with a number of multifactorial chronic diseases, including 
type II diabetes mellitus, cardiovascular diseases (CVD) and even several types 
of cancer. Obesity predisposes to these chronic diseases, but the relation is not 
absolute. Indeed, healthy obese individuals, without type II diabetes and CVD, 
exist. Similarly, a substantial number of cardiometabolic patients are lean [2, 3]. This 
suggests modulating effects of environmental and genetic factors. 
Obesity is the consequence of chronic excess energy intake relative to energy 
expenditure. The excess energy is stored as tri-glycerides (TAG) in white adipose 
tissue (WAT). The main determinants of energy expenditure are maintenance of the 
organism (determining the basic metabolic rate), heat production to maintain body 
temperature (thermogenesis) and the energy that is used for different activities, 
such as physical activity and digestion of food [4]. The amount of energy that is 
used for thermogenesis is strongly dependent on the environmental temperature 
and decreases with increasing temperature until the lower critical temperature, 
where the thermoneutral window starts [5]. At thermoneutrality, the energy that is 
required to maintain a normal body temperature is at its lowest. Thermoneutrality 
will therefore increase the propensity to become obese. Conversely, cold exposure 
can reduce obesity [6]. Although it is clear that thermoneutrality will increase 
obesity, the metabolic consequences of temperature on obesity development 
are less clear and the interaction between thermoneutrality and diet has hardly 
been investigated.
To unravel the relation between nutrition and obesity and its vascular and 
metabolic co-morbidities, mouse models are widely used. One of these is C57BL/6J, 
a mouse strain that, like humans, is sensitive to diet-induced obesity. Indeed, on 
high fat/high carbohydrate ‘Western’ diets C57BL/6J mice accumulate an excess 
amount of WAT [7]. They gradually develop insulin resistance, mitochondrial 
dysfunction, hepatosteatosis and at a later stage, systemic inflammation. This results 
in a phenotype that is similar to humans with metabolic syndrome, although in many 
ways the mouse phenotype seems milder. Mice have their lower critical temperature 
at 28°C ([5] and references therein), but are usually housed at temperatures 
between 20°C and 24°C. At these housing temperatures a substantial part of the 
ingested energy is used for thermogenesis to keep up body temperature. This may 
mask, for example, bioenergetics aspects of weight reduction [8]. It also influences 
diet-induced obesity, since C57Bl/6J mice show a larger difference in adiposity 
between a high fat diet and a low fat diet at thermoneutrality compared to the 
difference in adiposity that was seen at a normal housing temperature [9]. If this 
increased differential effect of metabolism of diet on the development of obesity 
would be accompanied by pronounced differential effects on metabolic parameters 
related to insulin resistance and CVD, it would allow to more sensitively examine 
the relationship between diet, obesity, insulin resistance and vascular disease. 
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This would facilitate more sensitive detection of biomarkers that could be used to 
substantiate health claims. 
To investigate whether housing at thermoneutrality will not only result in large 
diet-induced differences in adiposity and but also in pronounced differences in 
associated metabolic parameters in serum and the major metabolic organs, adipose 
tissue, liver and muscle, we performed a dietary intervention in C57BL/6J mice at 
28°C and assessed energy metabolism, serum and metabolic parameters for a low fat 
(10 energy% (en%)) diet (LFD) and a moderate-high fat (30 en%) diet (MHFD). For the 
dietary intervention we used semi-purified AIn93-based diets with a fat composition 
that is based on the average human fat intake in The netherlands, therefore containing 
both saturated and unsaturated fats [10]. Thirty en% fat is the average human fat 
intake, while 10 en% is standard for a mouse diet. We observed large differences 
in WAT mass, adipocyte size and leptin levels, but hardly any differences in a large 
number of other metabolic parameters in serum, WAT, liver and muscle.
MAteriAls And Methods
Animals, diets, study design
Ten-week-old wild-type male C57BL/6JOlaHsd mice (Harlan, Horst, The netherlands), 
were individually housed at 28°C, humidity 40-55%,12h light-dark cycle (7.00 h 
lights on) with ad libitum food and water. The experimental protocol was approved 
by the Animal Welfare Committee of Wageningen University, Wageningen, The 
netherlands (DEC number 2008127). The mice were fed AIn93 based semisynthetic 
diets (Table  S1), differing in the amount of fat (replacing carbohydrates); 10 en% 
(low fat diet; LFD) versus 30 en% (moderate-high fat diet; MHFD). Twelve animals 
were sacrificed at t=0 wks (at the time of diet switch, but after 3 weeks at 28°C) and 
another 12 per dietary group at t=14 wks. Mitochondrial respiration analysis was 
performed at t=14 weeks in LFD and MHFD groups of 6 animals that were run in 
parallel. Further details in supplementary materials and methods (MM).
Indirect Calorimetry
O2 consumption, CO2 production, food, and water intake were measured as described 
before [11]. Details in supplementary MM. 
Sacrifice
From 08:00 h onwards, mice were fasted for 2 hours and killed after isoflurane 
anesthesia (4%). Blood collection was performed by orbital exsanguination and 
serum was prepared in serum collection tubes (Greiner Bio one B.V., Alphen aan 
de Rijn, The netherlands). Organs were isolated, weighed and either immediately 
snap-frozen in liquid nitrogen and stored at -80°C untill analyses or placed in 4% 
buffered paraformaldehyde for 24h. Details in supplementary MM. For respirometry 
measurements, mice were sacrificed by cervical dislocation and the entire leg 
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muscle was dissected from both hind limbs. The tissue was further processed and 
mitochondria were isolated as described [12]. 
Histological analyses
Paraffin-embedded eWAT was sectioned at 5µm and stained with Periodic Acid 
Schiff reagent and counterstained with haematoxylin. Average adipocyte size 
was determined of ≥ 400 adipocytes per animal in at least two different sections 
using Zeiss Axiovision software (release 4.7). Fixed hepatic sections were stained 
with Oil red O (Sigma) for neutral lipids and quantified as described [13]. Details in 
supplementary MM.
High-resolution respirometry
Freshly isolated leg muscle mitochondria were subjected to high-resolution 
respirometry using an Oxygraph-2k (OROBOROS Instruments, Innsbruck, Austria). 
Details in supplementary MM.
Serum parameters 
Serum levels were measured in duplicate using commercial kits for glucose (GOD-
PAP kit (Roche, Woerden, The netherlands)), free fatty acids (FFA, nEFA HR(2) kit 
(Wako Chemicals GmbH, neuss, Germany)), glycerol (glycerol kit (Instruchemie, 
Delfzijl, the netherlands)), triacylglyceride (TAG; Triacylglyceride liquicolor kit, 
Human GmbH, Wiesbaden, Germany), HDL-cholesterol (HDL-Cholesterol kit, Human 
GmbH) and total-cholesterol levels (total-cholesterol liquicolor kit, Human GmbH). 
Hepatic TAG were measured in triplicate after tissue homogenizatrion and dilution 
(Triacylglyceride liquicolor kit, Human GmbH). Serum levels of leptin, resistin, insulin, 
monocyte chemoattractant protein-1 (MCP-1), interleukin 6 (IL-6), tumor necrosis 
factor alpha (TnF-α), and plasminogen activator inhibitor-1 (PAI-1), soluble vascular 
cell adhesion molecule 1 (sVCAM-1; CD106), soluble intercellular adhesion molecule 
1 (sICAM-1, CD54), soluble E-selectin, (sE-selectin) and matrix metallopeptidase 9 
(MMP9), apolipoprotein E (ApoE), fibrinogen, and adiponectin were measured in 
duplicate with mouse serum kits (Millipore corporation, Billerica, USA) according to 
the manufacturer’s protocol using the Bio-plex 200 system with Bio-plex manager 
software (Biorad Laboratories, Veenendaal, The netherlands).
AdditionAl inForMAtion in suppleMentAry MM.
Mitochondrial DNA quantification
Quantitative real time RT-PCR was performed with primers as described [14] and 
IQ SYBR Green supermix in an IQ5 (Biorad) with a program of 3 minutes at 95°C, 
40 cycles of 15 seconds at 95°C, and 45 seconds at 60°C. Data are expressed as 
amount of mitochondrial DnA over nuclear DnA, with the mean of t=0 group set at 
1.00. Additional information in supplementary MM.
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Activity of mitochondrial enzymes
Aconitase activity was determined essentially as described [15]. Citrate synthase is 
measured using the Citrate Synthase assay kit (Sigma-Aldrich, St. Louis, USA). Details 
in supplementary MM.
Real-time quantitative polymerase chain reaction (Q-PCR)
RnA isolation from muscle and gene expression analysis were performed as 
described [16]. Details in supplementary MM.
Statistics
Data are shown as mean ± SEM. Statistical analyses were performed using Graphpad 
Prism v5.04 (Graphpad Software Inc., San Diego, CA, USA). Data were checked for 
normality using the Shapiro-Wilk test. The qRT-PCR data were log2 transformed 
and tested. Statistically significant differences were analyzed by analysis of variance 
(AnOVA) and post-hoc Tukey tests, or with Student’s unpaired t-test if means of 
2 groups were compared. P < 0.05 was considered significant.
results
Mice were housed at 28°C and were fed for a 14 weeks (wks) intervention period 
either a low fat diet (LFD) or a moderate-high fat diet (MHFD), resulting in a prominent 
weight increase in both groups (Figure 1A) and gave rise to a significant difference in 
body weight gain (Figure 1B). Indeed, from week 11 on mean body weights differed 
significantly between the dietary groups. It should be noted that the mean body 
weight increase on the LFD at 28°C was already more than the mean body weight 
increase on the MHFD at 21°C (body weight of the same strain of mice at 21°C on 
MHFD increased with 3.5 ± 0.4 g between t=0 wks and t =15 wks; data from [17]). 
Energy intake was significantly 4.4% higher on the MHFD (Figure 1C), which most 
likely explains the significant difference in weight gain (Figure 1B). As expected, the 
difference in macronutrient composition between the diets (LFD vs MHFD) resulted 
in a significant difference in the respiratory exchange ratio (RER, Figure S1A), with 
the RER 50th percentile of relative cumulative frequency over 24 hours being 0.92 for 
the LFD and 0.86 for the MHFD (Figure S1B). Assuming that there was no difference 
in protein metabolism between the diets, this constitutes a significant change from 
a mean 75% glucose and 25% fat oxidation on the LFD to 58% glucose and 42% 
fat oxidation on the MHFD, showing that the diets enforced a different metabolic 
substrate use. 
The increased body weight is matched by a significantly increased amount of 
adipose tissue, as shown for the epididymal fat pad (Figure 1D). Absolute liver 
weight is increased with time, but no difference is seen between the LFD and the 
MHFD (Figure 1E). not only the amount of WAT is increased, also the mean size 
of adipocytes is significantly increased in the MHFD group compared to the LFD 
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Figure 1 Mean body weight with time (A). Total body weight gain (at 14 weeks (wks) compared 
to t=0) (B), cumulative (t=0 to t=14wks) energy intake (C), mean epididymal white adipose 
tissue (eWAT) weight (D), and mean liver weight (E) of C57BL/6J mice kept at 28°C on low 
fat diet (LFD, grey) and on moderately high fat diet (MHFD, black). *: p<0.05, **: p<0.01, 
***: p<0.001. Data are shown as mean ± SEM (n=12). Mean epididymal white adipocyte size 
(t=0: n=4; t=14wks LFD: n=4; t=14wks MHFD: n=4) (F) Representative images of epididymal 
white adipose tissue (G-I) at t=0 LFD (G), t=14wks LFD (H) and t=14wks MHFD (I). Bar is 50µm 
and G-I are at equal magnification. Mean hepatic lipid droplet area (t=0: n=4; t=14wks LFD: 
n=4; t=14wks MHFD: n=8) (J). Representative images of liver at t=0 (K), at t=14wks on LFD 
(L) and at t=14wks on MHFD (M) stained for lipid droplets. 
group (Figure 2). Epididymal WAT was further stained for macrophage infiltration to 
examine adipose tissue inflammation, which was expected in view of the increased 
adipose tissue mass and adipocyte size. However, no signs of inflammation and no 
visual differences between the LFD and the MHFD groups could be observed in the 
number of MAC positive cells at t=14wks, or when either of these groups is compared 
to t=0 LFD. In all cases MAC positive cells were rarely seen (data not shown). 
After establishing that the LFD and the MHFD impose substantial differences 
in adiposity and metabolic substrate use, we assessed whether this would 
be reflected by substantial differences in vascular and metabolic disease-risk 
biomarkers. Therefore, serum levels of various adipokines and proteins associated 
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Figure 2 Mean serum peptide parameters of C57BL/6J mice kept at 28°C, at t=0, at t=14wks 
on a low fat diet (LFD, grey; n=12) and at t=14wks on a moderately-high fat diet (MHFD, black; 
n=12). *: p<0.05; ***: p<0.001; only significant differences are indicated. Data are shown as 
mean ± SEM.
with endothelial activation/cardiovascular risk or inflammation were analyzed and 
as expected, a significant difference between the LFD and the MHFD at t=14wks 
is seen for leptin levels (Figure 3), reflecting the differences in adiposity. Contrary 
to expectations, no difference between LFD and MHFD was seen at t=14wks for 
any of the other serum proteins that were analyzed; we observed no difference in 
the serum levels of insulin, adiponectin, resistin, plasminogen activator inhibitor-1 
(PAI-1), matrix metallopeptidase 9 (MMP-9), soluble vascular cell adhesion molecule 1 
(sVCAM-1; CD106), soluble intercellular adhesion molecule 1 (sICAM-1, CD54), 
soluble E-selectin, (sE-selectin), interleukin-6 (IL-6), apolipoprotein E (ApoE) or 
fibrinogen (Figure 3). The levels of MCP-1 and tumor necrosis factor alpha (TnFα) 
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were below the detection limit. The levels of these parameters were also compared 
to t=0, i.e.  analyzed with time. For mice on the MHFD, sVCAM was significantly 
decreased, while an increase was observed for leptin, PAI-1 and IL-6. Leptin was 
also increased in mice fed the LFD (Figure 3). Levels of IL-6 and MMP-9 were and 
stayed very close to the detection limit, while MCP-1 and TnFα remained below the 
detection limit, which indicates absence of inflammation in the animals, in agreement 
with the histological data of WAT. 
Little difference in serum adipokines and proteins associated with cardiovascular 
and metabolic risk were seen between the LFD and the MHFD. We therefore examined 
the effect of thermoneutrality on serum parameters of metabolism, i.e. glucose and 
lipids intermediates, which are associated with cardiovascular and metabolic risk. 
There was however no difference in serum glucose levels between LFD and MHFD, 
nor did we observe a change with time (Figure 4A). The calculated HOMA2-IR index, 
a measure indicative for insulin resistance, did not differ between the LFD and the 
MHFD at t=14wks, but is significantly higher than at t=0, due to a 40% increase in 
insulin levels between these time points (Figure 4B). no difference in FFA levels 
between the LFD and the MHFD groups at t=14wks was seen, with slightly, but non 
significantly, lower levels compared to t=0 (Figure 4C). There is no difference in TAG 
levels between the LFD and the MHFD groups and neither with time (Figure 4D). 
Figure 3 Mean serum glucose concentration (A), HOMA2-IR index (B), mean free fatty acids 
concentration (C), mean triacylglycerides concentration (D) and mean total cholesterol 
(E) concentrations of C57BL/6J mice (n=12) kept at 28°C, at t=0, at t=14wks on low fat diet 
(LFD, grey; n=12) and at t=14wks on moderately-high fat diet (MHFD, black; n=12). *: p<0.05, 
**:p<0.01; only significant differences are indicated. Data are shown as mean ± SEM.
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Figure 4 Muscle. Mean muscle mitochondrial density of C57BL/6J mice kept at 28°C, at 
t=0, at t=14wks on low fat diet (LFD, grey; n=12) and at t=14wks on moderately-high fat diet 
(MHFD, black; n=12) (A). Mean respiratory control ratio (RCR) on malate/pyruvate (B) and on 
malate/glutamate/succinate (C) and respiration on malate/pyruvate (D) and malate/glutamate/
succinate (E) of isolated muscle mitochondria of C57BL/6J mice kept at 28°C, at t=14wks on 
low fat diet (LFD, grey; n=6 except LFD GMS traces n=4) and at t=14wks on moderately-high 
fat diet (MHFD, black; n=6). Mean relative mRnA expression levels (F) of Acacb (acetylCoA car-
boxylase beta), Cpt1b (muscle carnitine palmitoyltransferase 1), Hmox1 (heme oxygenase 1), 
PGC1α (Ppargc1a, peroxisome proliferator-activated receptor gamma coactivator 1-α), Pdk4 
(mitochondrial pyruvate dehydrogenase kinase isozyme 4), and Vegfa (vascular endothelial 
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Total cholesterol levels were significantly different between the LFD and the MHFD 
groups at t=14wks. On MHFD, this increase was also significant compared to t=0, 
while the LFD did not differ from t=0 (Fig 4E). The higher cholesterol levels in mice 
on the MHFD most likely reflect the increased diet cholesterol content. For HDL-
cholesterol, no difference with time nor between LFD and MHFD was observed (data 
not shown). With the exception of total cholesterol, the examined parameters of 
metabolism were hardly affected by the diet at 28°C. 
A significant decrease in mitochondrial density in muscle has been reported in 
C57BL/6J mice on high fat diets at ambient temperatures [14, 18]. Since mice kept 
at 28°C gained substantial weight, more than in the referenced studies, we analyzed 
mitochondrial density in muscle tissue. In contrast to the referenced studies, no 
difference was observed in our C57BL/6J mice housed at 28°C in muscle mitochondrial 
density, not with time nor between LFD and MHFD (Figure  5A). Furthermore, no 
qualitative differences were seen between mitochondria isolated from muscle of 
mice fed LFD or MHFD; the respiratory control ratios on malate/pyruvate as well as 
on malate/glutamate/succinate were not significantly different between these two 
dietary groups (Figure 5B, 5C). Also no difference in mitochondrial respiration on 
malate/pyruvate male (Figure 5D) was seen. However, a difference between LFD 
and MHFD in state 3 and in maximal mitochondrial respiration was seen on malate/
glutamate/pyruvate as substrates (Figure 5E). These results indicate an adaptation 
of muscle mitochondrial substrate metabolism to the diet. Because also indirect 
calorimetry showed a significant difference in substrate metabolism between the 
two diets on a whole body level, we investigated the metabolism of skeletal muscle 
in more detail as this tissue is the largest metabolic organ. We did this by assessing 
the expression of a number of genes crucially involved in substrate metabolism. no 
difference was observed, neither between MHFD and LFD groups nor with time, in 
the expression of the genes acetyl-CoA carboxylase beta (Acacb, rate limiting in fatty 
acid synthesis), carnitine palmitoyltransferase 1b (Cpt1b, encoding the protein that 
determines lipid import into mitochondria for beta-oxidation), heme oxygenase  1 
(Hmox1, an indicator of oxidative stress), pyruvate dehydrogenase kinase isozyme 4 
(Pdk4, a regulator and inhibitor of glucose metabolism), peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (Ppargc1a/PGC1α, which governs 
mitochondrial biogenesis) and vascular endothelial growth factor (Vegfa/VEGF, a 
signal molecule that stimulates angiogenesis) (Figure 5F). 
growth factor a) of muscle of C57BL/6J mice kept at 28°C, at t=0, at t=14wks on low fat diet 
(LFD, grey; n=12) and at t=14wks on moderately-high fat diet (MHFD, black). Gene expression 
was determined by real-time quantitative RT- PCR using Rps15 (Ribosomal protein S15) and 
Hprt (Hypoxanthine phosphoribosyltransferase 1) as stable reference genes. Expression at t=0 
is set at 1.00. *: p<0.05; **: p<0.01; only significant differences are indicated. Data are shown 
as mean ± SEM (n=12, except for MHFD Ppargc1a which is n=5).
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Besides WAT and muscle, also liver plays a crucial role in lipid and glucose 
metabolism. Liver is among the first organs that are differentially affected by long term 
high fat diets, giving rise to lipid accumulation, ultimately leading to hepatosteatosis. 
However, no significant differences were observed for hepatic TAG levels between 
the LFD and MHFD groups as measured either by histology (Figure 6A - 6D) or 
enzymatic assay (Figure 6E). We also assessed hepatic aconitase activity. Aconitase is 
Figure 5 Aconitase levels (A), Citrate synthase levels (B) and Aconitase over citrate synthase 
ratio (C) of C57BL/6J mice kept at 28°C, at t=0, at t=14wks on low fat diet (LFD, grey) and at 
t=14wks on moderately high fat diet (MHFD, black). *: p<0.05. **:p<0.01; only significant differ-
ences are indicated. Data are shown as mean ± SEM (n=12).
a mitochondrial enzyme that is sensitive to oxidative damage. A decreased aconitase 
activity is used as a marker for (mitochondrial) oxidative stress and it could be 
expected that aconitase activity is lower in liver of the MHFD group. In contrast to this 
expectation, we observed a significant lower hepatic aconitase activity in mice on the 
LFD compared to the MHFD (Figure 6F). When we normalized this for the activity of 
another TCA cycle enzyme, citrate synthase (Figure 6G), this difference disappeared 
(Figure 6H). The most straightforward interpretation of these results is that there is no 
differential effect of the diets on this marker of oxidative stress in the liver.
disCussion
In the present study, we assessed whether housing at thermoneutrality (28°C) would 
lead to pronounced differences in metabolic phenotype between a LFD and a MHFD, 
which would allow for sensitive detection of biomarkers to be used to substantiate 
claims on food. As expected, we observed a large difference in body mass, in adipose 
tissue mass, in leptin levels, in adipocyte size, and in 24-h substrate use between 
the two dietary groups of mice kept at thermoneutrality. The latter is reflected 
in a difference in maximal muscle mitochondrial oxygen consumption on malate/
glutamate/pyruvate. However, we saw hardly any difference in a range of metabolic 
parameters at 28°C. The metabolic parameters that were measured include various 
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adipokines and metabolic and peptide serum markers related to CVD/metabolic 
syndrome, adipose tissue inflammation, parameters of muscle substrate and energy 
metabolism (mitochondrial density, mitochondrial respiratory control ratio and levels 
of mRnA of metabolic genes) and metabolic parameters of the liver (TAG levels and 
aconitase/citrate synthase). Our data thus showed that thermoneutrality resulted in 
large diet-induced differences in body composition, but this was not paralleled by 
large diet-induced differences in metabolic parameters. 
The absence of metabolic differences between the diets could be due to several 
reasons. One of these is a smaller differential effect of the diets at 28°C on body 
weight and adiposity. Although a perfect comparative experiment that compares 
LFD and MHFD in the same mouse strain at 21°C is not available, this seems not to 
be the case, since not only the body weight, but also the difference in body weight 
increase between the LFD and the MHFD at 28°C is larger than that of mice of the 
same strain and age which were fed the same MHFD for a similar amount of time (15 
weeks, including 3 week run in), but were housed at 21°C (118%, based on data from 
[17]). Similarly, the difference in leptin levels, a biomarker for adiposity, between 
the LFD (23.0 ± 4.3 ng/ml) and the MFHD (48.4 ± 8.2 ng/ml) was 7.5 fold larger than 
the leptin levels on the MHFD at 21°C (3.4 ± 0.4 ng/ml). Both parameters show that 
thermoneutrality increases body weight and adiposity differences that are larger 
than those induced at 21°C, since the increase on MHFD at 21°C without subtracting 
the increase on LFD, is larger than the difference between LFD and MHFD at 28°C. 
One might argue that body weight increase and leptin levels on the MHFD was small 
at 21°C, however in a second experiment using a MHFD with the same en% fat, but 
of a different carbohydrate composition, the increase in body weight and leptin level 
at 21°C was comparable [16]. The diets induce a larger differential effect at 28°C than 
at 21°C, but it may be that the en% fat in the MHFD is too low to induce differential 
metabolic effects, also at 21°C. Therefore, our data may be explained by the fact 
that we did not reach a critical threshold, despite the level of adiposity and the 
differences in adiposity. 
How do our data at 28°C on the MHFD compare to data of mice of the same 
strain and age on the same diet at 21°C [13, 17]? We see no difference at t=0 wks 
or t=14 wks for circulating PAI-1, adiponectin, TnFα (below background) or MCP-1 
(below background). The FFA and TAG levels were even slightly, but non significantly, 
lower at 28°C compared to the levels at 21°C, both at t=0 wks and t=14 wks (data 
at 21°C from [13, 17]; data not shown). On the other hand, insulin levels, which did 
not differ at t= 14 wks between the LFD and the MHFD (1.76 ± 0.36 ng/ml and 1.86 
± 0.19 ng/ml, respectively; figure 3), were significantly higher at t=14 wks at 28°C, 
than either at t=0 wks (after 3 weeks at 28°C; 0.80 ± 0.07 ng/ml) or at 21°C on the 
MHFD both at t=0 wks (0.16 ± 0.02 ng/ml) and at t=15 wks (0.29 ± 0.08 ng/ml) (data 
at 21°C from [17]). The difference in insulin levels between t=0 wks and t=14 wks 
was also statistical significant at 21°C. Levels of resistin (7.0 ± 0.5 vs 1.4 ± 0.7 ng/mL) 
and IL-6 (35.0 ±1.7 vs 5.5 ± 0.6) at 14 wks on the MHFD were five times higher at 
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28°C compared to 15 wks at 21°C (data at 21°C from [13, 17]). In fact, resistin and 
IL-6 levels were already higher after the run in period of 3 weeks at 28°C on the 
LFD (Figure 3). Similarly, already after the run in period of 3 weeks at 28°C on the 
LFD, hepatic TAG was more (oil red O area 4421 ± 1903 μm2) than at 21°C after 15 
weeks on the MHFD (oil red O area 321 ± 155 μm2; data taken from [13]. Again, the 
difference between the LFD and the MHFD was not significant (Figure 6). These 
data suggest that the thermoneutral temperature alters metabolic homeostasis, 
but allows accommodation of differences in diet-induced body composition. This is 
supported by an observed hepatic TAG content (13,151 ± 1,800 µm2) of mice of the 
same strain at 21°C fed a similar 40en% semi purified diet [19], which is in the same 
range as that of mice on a MHFD (30en% fat diet, hepatic TAG: 18,832 ± 2,041 µm2) 
at 28°C, but in contrast to 28°C (Figure 6D), at 21°C a clear difference is seen with 
the LFD (hepatic TAG: 516 ± 111 µm2). 
Based on our results, thermoneutrality does not seem to be a condition that will 
allow for more sensitive detection of biomarkers as compared to standard housing 
temperatures. 
The question arises which temperature provides the best comparison to humans. 
This has been recently discussed [5]. Briefly, the lower critical temperatures of mice 
is about around 28°C [5]. However, humans preferably reside 3 - 5°C below their 
critical temperature. This suggests that for comparison mice should be housed 
at 23°C - 25°C. These temperatures should be further decreased to 20°C - 22°C 
when bedding is available, or for group housing [5]. It thus seems that standard 
housing temperatures are well suited both for the identification of diet-sensitive 
biomarkers as well as for translatability to humans. Although other views exist on 
the optimal temperature for comparison to humans [20-22], our results agree with 
existing data that show that environmental temperatures can have a profound effect 
on physiology (e.g. [8, 9, 23]). This implies that environmental temperature should 
carefully be controlled (and properly described), in nutrition and pharmaceutical 
studies in rodents, and likely also in humans. It also implies that interventions at 
various environmental temperatures may increase our understanding of metabolism. 
Housing at thermoneutrality results primarily in an increase in WAT mass. WAT is 
well equipped to store excess energy; it has an enormous capacity to enlarge. WAT 
enlargement is the result of hyperplasia as well as hypertrophy of adipocytes [24]. 
normally in obesity, a condition of chronic energy excess, functional failure of WAT 
initiates a vicious cycle that includes pro-inflammatory signaling [25]. Leptin has been 
suggested to play a chemotactic role in macrophage recruitment to adipose tissue 
[26], but our data do not support this. Despite enhanced obesity, the thermoneutral 
condition seems to allows for continued WAT functionality. This may be the result of 
a lower metabolic rate due to a reduced level of thermogenesis at thermoneutrality, 
compared to mice that are kept at 20°C - 24°C [27]. It may be speculated that cold 
stress at normal housing temperatures together with the energy excess of in particular 
(M)HFD will ultimately result in allostatic overload [28], which will lead to adipose 
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tissue dysfunction and, subsequently, metabolic complications, which will be easier 
attained and consequently be more pronounced in animals on a MHFD relative to 
a LFD. However this continued WAT functionality may also be explained by the fact 
that the adipose tissue did not yet met its expansion limit. Human adipocytes have 
a large capacity to expand up to 150 (or even 200) µm in diameter [29], which is 
highly similar to mouse adipocyte sizes [30]. The diffusion distance of oxygen in WAT 
lies around 100µm [31] When we assume that adipocytes are perfect spheres, the 
average adipocyte area in this study is 3,957µm2 for LFD which equals a diameter of 
71.0µm and an average of 6,469 µm2 for MHFD equals a diameter of 90.6µm. These 
numbers suggest that in our study adipose tissue has not yet reached the diffusion 
limit of oxygen and therefore complications of local tissue hypoxia are maybe not 
yet present. This is supported by the absence of differences in expression of Hmox1 
and Vegf, which display hypoxia sensitive expression ([32] and [33], respectively), 
in muscle (Figure 5). Moreover, housing at thermoneutral temperature facilitates 
enlargement of adipocytes but without signs of inflammation as we show here, while 
previous findings in mice kept at 21°C showed indeed infiltration of macrophages to 
be positively associated to adipocyte size, which were in the same size range as we 
observed [34].
Thermoneutrality apparently protects WAT against dysfunction, while cold stress 
predisposes to adipose dysfunction. A this moment it is debated which mechanisms 
underlie adipose tissue dysfunction and several hypotheses have been postulated. 
One recent hypothesis focuses on adipose tissue lipid flux [35]. In this hypothesis a 
reduced lipid flux in and out of adipocytes, but in particular a lower lipid re-cycling, is 
thought to underlie the metabolic complications associated with obesity. Regretfully, 
we have not assessed adipose tissue lipid flux in our animals and thus cannot evaluate 
this hypothesis. However, it seems likely that the higher levels of thermogenesis that 
are required in animals at normal housing temperatures will impose a higher metabolic 
flux, compared to animals that are kept at thermoneutrality. This is supported by the 
higher energy intake (MHFD: 85.2 ± 2.5 kcal/week) and leaner phenotype of the mice 
kept at 21°C relative to mice kept at 28°C (MHFD: 67.7 ± 3.4 kcal/week). Our data 
therefore do not seem to support this hypothesis. 
In conclusion, based on our results we reject the hypothesis that thermoneutrality 
will enhance diet-induced differences in metabolic parameters. While diet-induced 
body weight and adiposity differences were enhanced, this was not the case for 
metabolic differences. Our data rather suggest that thermoneutral housing alters 
metabolic homeostasis.
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table s1 Composition of the low fat diet (LFD) and the moderately-high fat diet (MHFD). 
Ingredients LFD MHFD
Acid casein 220.0 220.0
L-Cystine 3.0 3.0
Carbohydrates 634.5 534.5
Cornstarch 63%
Maltodextrin 21%
Sucrose 16%
Cellulose (Arbocel B800) 50.0 50.0
Lard 31.5 101.5
Corn oil 13.5 43.5
Mineral premix AIn-93G 35.0 35.0
Vitamin premix AIn-93 10.0 10.0
Choline bitartrate 2.5 2.5
Total (g) 1,000.0 1,000.00
Energy density (kcal/kg) 3875 4375
Carbohydrate (en%) 67 50
Fat (en%) 10 30
Protein (en%) 23 20
Values are g/kg, unless stated otherwise.
table s2 nucleotide sequences of the primer pairs used for quantitative real time RT-PCR. 
Gene forward (5’-3’) reverse (5’-3’)
Acacb ACTGTGGAGTATCTCGTTAACCTTCTG GGACTGTCGGGCTACCTTGAG
Cpt1b GGCCAGAGAGGCCAGACCCAT CCTGGGGTTTATTCAGCACAGCTCAG
Hmox1 ATTGAGCTGTTTGAGGAG TGCAGGGGCAGTATCTTG
Ppargc1a CACGCAGCCCTATTCATTGTTCG GACTCCCGCTTCTCGTGCTCTTT
Pdk4 TCAGTGACTCAAAGACGGGAAACC TGTGGTGAAGGTGTGAAGGAACG
Vegfa AAGCCAGCACATAGGAGAGATGAG TCTTTGGTCTGCATTCACATCTGC
Rps15* CGGAGATGGTGGGTAGCATGG ACGGGTTTGTAGGTGATGGAGAAC
Hprt* TGACACTGGTAAAACAATGCAAACTTTG GAGGTCCTTTTCACCAGCAAGCT
Acacb is acetylCoA carboxylase beta; Cpt1b is muscle carnitine palmitoyltransferase 1; Hmox1 
is heme oxygenase 1; Ppargc1a (PGC1α) is peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha; Pdk4 is mitochondrial pyruvate dehydrogenase kinase isozyme 4, and Vegfa 
(VEGF) is vascular endothelial growth factor a. Rps15 is Ribosomal protein S15; Hprt is hypoxanthine 
phosphoribosyltransferase 1. * indicates reference genes
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Figure s1 Respiratory Exchange Ratio (RER) plotted with time (A) and as percentage cumula-
tive relative frequency (PCRF) curve at 12 weeks (B) of C57BL/6J mice kept at 28°C on low fat 
diet (LFD, grey, n=6) and on moderately high fat diet (MHFD, black, n=6). B: arrows indicate 
average 24h RER. *: p<0.05.
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Animals, diets, study design
Ten-week-old wild-type male C57BL/6JOlaHsd mice (Harlan, Horst, The netherlands) 
were housed individually in macrolon type 2 cages. This strain of C57BL/6J mice 
has the functional nnt gene encoding nicotinamide nucleotide transferase which is 
absent in many other C57BL/6J strains (1). The housing environment was kept within 
the thermoneutral zone (28°C), with a humidity of 40-55% and a 12h light-dark cycle 
(7.00 h lights on). The experimental protocol was approved by the Animal Welfare 
Committee of Wageningen University, Wageningen, The netherlands (DEC number 
2008127). Food and water were given ad libitum and were replaced once a week, 
and concomitantly food intake and body weight were measured. The mice were 
given AIn93 based semisynthetic diets (Table 1; Research Diet Services B.V., Wijk bij 
Duurstede, The netherlands), which differed in the amount of fat; 10 en% (low fat 
diet; LFD) versus 30 en% (moderate-high fat diet; MHFD). The en% was calculated 
using 38 kJ/gr fat and 17 kJ/g for protein and carbohydrate. The fat consisted of 70% 
lard and 30% corn oil. In the MHFD, the fat replaced a part of the carbohydrates. 
The mice (males, 10 weeks (wks) of age) were fed the LFD during the three-week 
acclimatization period at 28°C, at the end of which they were stratified over the 
treatment groups according to their body weight. Twelve animals were sacrificed 
at t=0 wks (at the time of diet switch, but after 3 weeks at 28°C) and another 12 
of each of the dietary groups at t=14 wks. Mitochondrial respiration analysis was 
performed at t=14 weeks in LFD and MHFD groups of 6 animals that were run in 
parallel. All analyses were performed on n=12, except for Q-PCR of PGC1α, which 
was n=5, indirect calorimetry which was n=6, mitochondrial respirometry which was 
n=6, except for LFD on malate/glutamate/succinate which was n=4 and histological 
analysis (n given below). 
Indirect Calorimetry
To measure O2 consumption, CO2 production, and, simultaneously, food and water 
intake, mice (at t = 12 wks) were housed for 48h at 28°C in a laboratory animal 
monitoring system that allows the continuous measurement of these parameters 
(LabMaster, TSE Systems GmbH, Bad Homburg, Germany). Indirect calorimetry was 
performed as described before (2). Data obtained in the first 24h were considered 
as adaptation and were excluded from data analyses. Rates of oxygen consumption 
(VO2, ml/h) and carbon dioxide production (VCO2, ml/h) were calculated by TSE 
software using the reference cage as measurement of oxygen and carbon dioxide 
inflow, and used to calculate the respiratory exchange ratio (RER = VCO2/VO2). 
Percent relative cumulative frequency (PRCF) curve analysis was used to transform 
24h RER data for quantitative analysis (3). RER values were converted to glucose and 
lipid oxidation using the table of Peronnet (4).
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Sacrifice
From 08:00 h onwards, mice were fasted for 2 hours and then anesthetized with a 
mixture of oxygen and nitric oxide (1:1) with isoflurane (4%). Blood collection was 
performed by orbital exsanguination, whereafter the mice were sacrificed by cervical 
dislocation. Organs were isolated, weighed and either immediately snap-frozen in 
liquid nitrogen or placed in 4% buffered paraformaldehyde. Serum was prepared 
by incubating the blood for one hour on ice in serum collection tubes (Greiner Bio 
one B.V., Alphen aan de Rijn, The netherlands), centrifuged at 1520g for 10 minutes 
and subsequently collected and aliquoted. Serum and frozen organs were stored 
at -80°C for subsequent analyses. The organs were fixed in 4% paraformaldehyde 
in 0.1 M phosphate buffer pH 7.4 for 24h at 4°C, then incubated for another 24h at 
4°C in PBS, and then transferred to 70% alcohol for further histological analyses. For 
the respirometry measurements, mice were sacrificed by cervical dislocation and 
the entire leg muscle was dissected from both hind limbs. The tissue was further 
processed and mitochondria were isolated as described (5). 
Histological analyses
Fixed pieces of epididymal white adipose tissue were dehydrated, cleared and 
paraffin-embedded. Five µm sections were cut using a Reichert microtome 
(Reichert-Jung 2030, Cambridge Instruments, Heidelberg, Germany) and mounted 
on Superfrost plus slides (Menzel-Gläser, Menzel GmbH & co KG, Braunschweig, 
Germany). The sections were stained with Periodic Acid Schiff (PAS) reagent and 
counterstained with haematoxylin. Tissues were examined under an Axiokop 2 
light microscope (Zeiss, Göttingen, Germany) and digital images were taken using 
a Axiocam MRC 5 camera (Zeiss). Average adipocyte size was determined on the 
digital images by measuring the bound width, bound height and surface area of 
400 adipocytes per animal in at least two different sections using Zeiss Axiovision 
software (release 4.7). Frozen liver sections (7 µm) were fixed with 3.7% buffered 
formalin. neutral lipids were stained with Oil red O (Sigma). The stained areas were 
quantified as described previously using Photoshop software (Version 12.0.4, Adobe, 
San Jose, CA, USA). Briefly, contrast was enhanced with automatic contrast tool, red 
pixels were selected with the colour range selecting tool, and total selected area was 
measured in µm2 (6). Ten pictures taken from two different sections per animal (n=4 
for t=0 and LFD and n=8 for MHFD) were quantified. 
High-resolution respirometry
Freshly isolated leg muscle mitochondria were subjected to high-resolution 
respirometry using an OROBOROS Oxygraph-2k (OROBOROS Instruments, 
Innsbruck, Austria) by incubation of 0.2 mg of mitochondrial protein in mitochondrial 
respiration buffer (100  mM sucrose, 50 mM KCl, 20 mM TES, 1 mM EDTA, 4 mM 
KH2PO4, 2 mM MgCl2, 0.1% (w/v) FA-free BSA, 3 mM malate; at pH 7.2) in two oxygraph 
chambers at 37°C (2 mL). After successive addition of the following substrates 
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the corresponding respiration states were measured: 5 mM pyruvate (malate/
pyruvate) or 10 mM glutamate plus 10 mM succinate (malate/pyruvate/glutamate) for 
measurement of state 2 respiration; 1 mM adenosine-di-phosphate (ADP) for state 
3 respiration; cytochrome c addition after state 3 assessment was done to confirm 
intactness of mitochondria; and 1 µg/mL oligomycin was used for state 4 respiration. 
Maximal respiratory capacity, state uncoupled, was obtained by titration with the 
chemical uncoupler carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP, 
0.5 µM/step). All chemicals used were obtained from Sigma-Aldrich, Zwijndrecht, 
The netherlands.
Serum parameters
Serum levels were measured using commercial kits for free fatty acids (FFA, 
nEFA HR(2) kit (Wako Chemicals GmbH, neuss, Germany), glycerol (glycerol kit 
(Instruchemie, Delfzijl, the netherlands)), triacylglyceride (TAG) and hepatic TAG 
(triacylglyceride liquicolor kit), and HDL-cholesterol and total-cholesterol (HDL-
cholesterol or total-cholesterol liquicolor kit (all from Human GmbH, Wiesbaden, 
Germany)). All analyses were performed according to the manufacturers’ protocols, 
but the volumes were scaled down to allow for analysis with a plate reader 
(BioTek Synergy HT, Bad Friedrichshall, Germany). For hepatic TAG measurement, 
approximately 30 mg liver tissue was ground in liquid nitrogen, weighed, added 
to homogenization buffer (100 mM Tris, 2 mM EDTA, 0.25M sucrose, pH 7.5) and 
further homogenized using a disposable pestle in a Eppendorf tube. Tissue was 
diluted in water (20 µg/µl) and 4 µl sample or standard was added to a 96-wells 
plate in triplicate. 100 µl kit reagent was added followed by an incubation for 
45 minutes at room temperature. Serum samples were measured in duplicate and 
averaged, and concentrations were calculated using standard curves. Serum levels 
of leptin, resistin, insulin, monocyte chemoattractant protein-1 (MCP-1), interleukin 
6 (IL-6), tumor necrosis factor alpha (TnF-α), and plasminogen activator inhibitor-1 
(PAI-1) were measured using the mouse serum adipokine kit (Millipore corporation, 
Billerica, USA). Soluble vascular cell adhesion molecule 1 (sVCAM-1; CD106), soluble 
intercellular adhesion molecule 1 (sICAM-1, CD54), soluble E-selectin, (sE-selectin) 
and matrix metallopeptidase 9 (MMP9) were measured with mouse cardiovascular 
disease panel 1, and apolipoprotein E (ApoE), fibrinogen, and adiponectin with 
mouse cardiovascular disease panel 2 (Millipore corporation, Billerica, USA). The 
sera were diluted 5 times (adipokine kit), 100 times (CVD1 kit), or 5000 times (CVD2 
kit). The assays were conducted according to the manufacturer’s protocol and 
measured using the Bio-plex 200 system with Bio-plex manager software (Biorad 
Laboratories, Veenendaal, The netherlands). For glucose analysis, sera were 
10 times diluted in 0.3 M trichloroacetic acid (Merck, Darmstadt, Germany) and 
centrifuged for 5 minutes at 1750 g. The supernatant was 1:5 mixed with glucose 
oxidase solution (GOD-PAP kit, Roche, Woerden, The netherlands) in a 96-wells 
plate and after 30 minutes incubation at room temperature, the extinction at 490 nm 
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was measured using a 96 wells plate reader (BioTek). Concentrations were calculated 
using a glucose standard curve (Sigma-Aldrich, Zwijndrecht, The netherlahnds). 
Mitochondrial DNA quantification
After grinding leg muscle tissue in liquid nitrogen, DnA was isolated with the 
QIAamp DnA mini kit (Qiagen, Venlo, The netherlands). DnA was quantified 
using the nanodrop nD-1000 spectrophotometer (Isogen Life Sciences, Maarssen, 
The netherlands). Quantitative real time RT-PCR was performed with primers as 
described (7) and IQ SYBR Green supermix in an IQ5 (Biorad) with a program of 
3 minutes at 95°C, 40 cycles of 15 seconds at 95°C, and 45 seconds at 60°C. Single 
product amplification was verified by an integrated post-run melting curve analysis. 
Exponential amplification efficiency was verified during each PCR run using a standard 
dilution series made from pooled DnA samples. Data are expressed as amount of 
mitochondrial DnA over nuclear DnA, with the mean of t=0 group set at 1.00.
Activity of mitochondrial enzymes.
Liver tissue was ground in liquid nitrogen and further homogenized using a disposable 
pestle in a microtube with ice cooled 50 mM Tris-HCl, pH 7.4. Protein concentration 
was measured using the DC Protein Assay (Bio-Rad). For both activity assays, all steps 
were performed on ice, until the final measurement. Maximal aconitase activity was 
determined as described (8) with minor modifications. Briefly, aconitase activity was 
determined by conversion of citrate to into isocitrate and then to α-ketoglutarate. 
The resulting formation of nADPH is determined. For this, the liver homogenate 
was diluted in TrisHCl (50 mM, pH 7.4) to a final concentration of 0.2 µg/µl. An equal 
amount of assay mixture was added, containing TCM buffer (50 mM TrisHCL, 50 mM 
citric acid monohydrate, 1 mM MnCl2; pH 7.4), 0.4 mM nADP+ and nADP+ isocitrate 
dehydrogenase (4U/ml). Absorbance at 340 nm was measured during 1  hour at 
37°C in a plate reader (BioTek) in 4 replicates and averaged. The aconitase activity 
is calculated from the slope of the linear part of the curve for each sample. Citrate 
synthase is measured using the Citrate Synthase assay kit (Sigma-Aldrich, St. Louis, 
USA). The analysis is performed according to the manufacturer’s protocol and 
measured in triplicate in a plate reader (BioTek) for 1 h at 25°C. For the assay 8 µg 
of protein is diluted in 186 µL of assay buffer, then 2 µL of 30 mM acetyl CoA and 
10 mM DTnB are added and the reaction was started with the addition of 10 µl of 
oxaloacetic acid. Citrate synthase activity was calculated from the slope of the linear 
part of the curve and averaged per sample.
Real-time quantitative polymerase chain reaction (Q-PCR)
RnA isolation from muscle was performed as described (9). cDnA was synthesized 
with the iScript kit (Biorad) according to the manufacturer’s protocol. Quantitative 
PCR was performed using the conditions described above using the primers listed 
in table 2. PCR amplification of the target genes and 2 reference genes (Rps15 and 
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Hprt) to obtain relative levels of gene expression, was performed in duplicate and 
averaged. The expression of the genes of interest was normalized for the reference 
genes using the Genorm normalization factor (10).
Statistics
All data are shown as mean ± standard error of the mean. Statistical analyses were 
performed using Graphpad Prism v5.04 (Graphpad Software Inc., San Diego, CA, 
USA). Data were checked for normality using the Shapiro-Wilk test. The qRT-PCR data 
were log2 transformed and tested. Statistically significant differences were analyzed 
by analysis of variance (AnOVA) and post-hoc Tukey tests, or with Student’s unpaired 
t-test if means of 2 groups were compared. P < 0.05 was considered significant.
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CHAPTER 5
AbstrACt
Background
Excessive white adipose tissue expansion as in obesity is generally associated with 
chronic inflammation of white adipose tissue (WAT) which contributes to obesity 
associated complications. Low oxygen availability in WAT is hypothesized to be the 
initiator of this inflammatory response.
Hypothesis
We examined the hypothesis that local tissue hypoxia is responsible for the initiation 
of inflammation in WAT.
Research design and methods
Diet induced obese male C57BL/6JOlaHsd mice,housed at thermoneutrality were 
exposed to mild environmental oxygen restriction (OxR, to 13% oxygen) for five 
days and compared with mice kept at normoxia, after which WAT and serum were 
collected. Body composition, systemic metabolic parameters, WAT macrophage 
infiltration as marker for tissue inflammation) and whole genome microarray analysis, 
and circulating adipokines were measured.
Results
Five days OxR decreased body weight and fat mass, and increased blood levels of 
haemoglobin and haematocrit, as well as lactate to glucose ratio, which indicated 
systemic hypoxia. no difference in adipose tissue inflammation was found, which 
was supported by down regulation of inflammation associated transcript levels of 
S100a8, Saa1, and Saa3. Serum metabolomics revealed an increase of branched chain 
amino acid Valine and propionyl-carnitine. Adipokines CCDC3, CCK, and Adiponectin 
are reduced by OxR on transcript (Cck) or serum protein level (Adiponectin), or 
both (CCDC3).
Conclusions
Mild oxygen restriction does not increase WAT inflammation in obese mice. However, 
a systemic adaptation together with a metabolic response in WAT was observed.
Keywords: Hypoxia, white adipose tissue, inflammation, metabolomics, microarray
88
EFFECTS OF OXYGEn RESTRICTIOn On OBESE ADIPOSE TISSUE 
5
introduCtion
Storage of excess energy leads to increased adipose tissue mass. It is well appreciated 
that adipose tissue is not merely a storage depot, but that it also produces and 
secretes a wide range of adipokines which are involved in homeostatic regulation 
[1, 2]. One of these adipokines is tumour necrosis factor alpha (TnF-α), which is 
a pro-inflammatory cytokine that is synthesized and secreted by white adipose 
tissue (WAT), and that provided the first direct link between WAT and low grade 
inflammation [3]. WAT inflammation is now accepted to contribute to obesity-
associated complications like insulin resistance and, hyperinsulinemia leading to 
type 2 diabetes, and cardio vascular diseases [4]. As these diseases represent the 
major medical problems associated with obesity, it is of great interest to unravel the 
mechanisms that underlie the change from healthy WAT to inflamed WAT. Of note, a 
subset of obese individuals are metabolically healthy, and remain insulin sensitive [5, 
6]. This indicates that not the amount of adipose tissue, but another trigger initiates 
the inflammatory state of WAT. One such a trigger may be WAT hypoxia. Hypoxia 
occurs when oxygen availability does not meet the needs of the surrounding tissue. 
In the obese state adipocytes are able to expand to a diameter of 150-200µm, which 
is larger than the average diffusion distance of oxygen in WAT [7, 8]. This implicates 
blockage of oxygen diffusion by large adipocytes which results in hypoxic tissue 
areas. Additionally, a reduction in blood flow can result in adipose tissue hypoxia [9]. 
Indeed, adipose tissue hypoxia has been demonstrated in several mouse and human 
studies [10-13]. Co-localization between hypoxic areas and macrophage infiltration 
suggests a direct link between hypoxia and inflammation of WAT [11], but this has not 
yet been fully elucidated.
This effect of hypoxia as a trigger for adipose tissue dysfunction has been studied 
in C57BL/6J male mice that were fed a chow, low fat, diet and housed at 21°C. 
These mice were exposed to environmental hypoxia (8% O2) to challenge WAT. 
Remarkably, these mice showed reduced, rather than increased WAT inflammation, 
when compared to control mice exposed to an ambient level of 21% O2. However 
translation to an obese condition is difficult, since these mice were lean and not 
obese, and it is expected that adipocyte sizes were in the normal range due to low 
fat feeding [14].
Within the thermal neutral zone the energy needed for maintenance, basal 
metabolic rate (BMR) is at its lowest [15]. Indeed, compared to housing of C57BL/6J 
mice at 22°C [16], housing at thermoneutrality results in increased enlargement of 
adipocytes and fat mass. However, despite the larger adipocyte sizes, less WAT 
inflammation was observed at thermoneutrality [17]. This is most likely due to 
decreased metabolic stress resulting from a decreased thermogenic metabolism.
Here we made use of these observations to study the effects of hypoxia on adipose 
tissue function. We tested the hypothesis that local tissue hypoxia is responsible for 
the development of adipose tissue inflammation and dysfunction under conditions 
of obesity. We used diet induced obese (DIO) male C57BL/6JOlaHsd mice as a 
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model, which were housed at thermoneutrality to induce a non-inflamed obese 
state. To challenge adipose tissue, DIO mice were exposed to environmental oxygen 
restriction (OxR) of 13% O2 for 5 days to reduce systemic oxygen availability and 
induce local tissue hypoxia. We choose to use 13% O2, since this is a level of oxygen 
that obese individuals may encounter when living at high altitudes (±4000m), flying 
in an airplane [18], or due to apnoea [19]. We assessed body composition, systemic 
metabolic parameters, WAT inflammation, and performed a whole genome microarray 
analysis of WAT to examine effects induced by mild environmental hypoxia.
We report that exposure to 5 days of oxygen restriction in DIO C57BL6J mice 
resulted in systemic decreased oxygen availability but did not increase inflammation 
in epididymal WAT. Indicating, that also in obese conditions hypoxia is not the 
trigger of inflammation. We were able to identify biomarkers of metabolic response 
to mild oxygen restriction, which are serum levels of branched chain amino acids and 
adiponectin and WAT levels of CCDC3.
MAteriAl And Methods
Animal study
Male wild-type C57BL/6JOlaHsd mice (n=36), aged 9 weeks, were purchased from 
Harlan (Horst, The netherlands). Mice were acclimatized to the thermo neutral 
(29-30°C) animal facility (12h light/dark cycle, 55 ±15% humidity) for 3 weeks. We 
studied mice at thermoneutrality to exclude effects of thermogenic metabolism 
as a confounder. During these 3 weeks mice were fed a purified low fat diet 
(supplemental table 1; [20]), followed by purified high fat diet (supplemental 
table 1) for 12 weeks. Access to water and food (Research Diet Services BV, Wijk 
bij Duurstede, The netherlands) was ad libitum and renewed every week. Body 
weight, food consumption, and body composition (EchoMRI 100V, EchoMedical 
Systems, Houston,TX) were measured weekly from week 7 onwards. After 11 weeks 
of high fat feeding the (adult) DIO mice were stratified on fat mass into a control 
(C, n=18), and an oxygen restriction (OxR, n=18) group. OxR mice were acclimatized 
to indirect calorimetric chambers for 48h under normal ambient 20.9% oxygen, 
followed by 120h (5 days) with 13% O2 as described {Duivenvoorde, (under revision) 
#890}, and killed directly thereafter (n=18). Activity levels were measured by 
infrared light-beam frames surrounding the cages. All animal care and use was 
according to the guidelines for use and care given by the Dutch experimentation 
act (1996). Permission for this study was granted by the Animal Ethical Committee 
of Wageningen University (DEC2012056).
Tissue and blood collection
In the light phase food was removed 2h before the mice were scheduled to be killed 
in the morning. Mice were directly killed by decapitation, and blood was partially 
collected in 60µl heparinised capillary tube (Hirschmann Laborgeräte, Eberstadt, 
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Germany) for determination of whole blood haematocrit levels. Capillary tubes were 
centrifuged in a micro-haematocrit centrifuge at 3000g for 5min. Haemoglobin levels 
were measured using an automated haemoglobin monitoring system (Hemocue 201 
Plus, HemoCue Ltd, Angelholm, Sweden) with 10µl micro cuvettes. Remaining blood 
was collected via a funnel into a mini collect serum tube (Greiner Bio-one, Longwood, 
FL, USA) and spun down 10min at 5780g at 4°C. Epididymal white adipose tissue 
(eWAT) was excised rapidly, weighed (left portion) and snap frozen in liquid nitrogen. 
The right portion was fixed overnight in 4% paraformaldehyde, washed with PBS and 
paraffin embedded for histological analysis.
Tissue analysis
Lactate in eWAT was determined using the Lactate Assay Kit II (Biovision, Mountain 
View, USA). Preparation and measurements of the samples were carried out according 
to the manufacturer’s protocol. The lactate concentration in eWAT is expressed as 
µmol/mg of total protein.
Citrate synthase and aconitase activity were determined as previously published [17]. 
Histology 
Paraffin embedded epididymal WAT was sliced at 5 µm and stained with a MAC-2 
antibody recognizing macrophages for detection of crown like structures (CLS) as 
published [16].
Serum metabolite analysis
For metabolome analysis, 3 µL of serum samples (n=10) were mixed with 97 µL of 
methanol solution containing 0,1% formic acid and deuterated internal standards 
(Aminoacids and acylcarnitines, nonderivatised kit, Chromsystems). The final 
solutions were vortexed and stored overnight at -80°C. After centrifugation (24, 
400 x g, 10 min, 4°C), the 80 µL of supernatant was transferred to a glass vial and 
used for direct injection mass spectrometry analysis. Remaining supernatant was 
pooled and used for quality control purposes.
The samples were measured on 5500 QTrap (AB Sciex, CA, USA) by direct 
analysis infusion with settings as follows: polarity was set to positive mode with 
ionspray voltage 5500 V, capillary temperature 450°C, Curtain Gas - 25 arb, Ion 
Source Gas (GS1/GS2) - 35 arb. Methanol containing 0.1% formic acid was chosen as 
a mobile phase. Flow rate was set at 0.05 mL/min (0.0 – 1.0 min) and 0.30 mL/min 
(1.0 – 1.5 min). Compounds were measured in multiple reaction monitoring mode 
under optimized parameters of declustering potential and collision energy for each 
mass transition. Unit resolution was set for isolation ions in mass analyzer.
Data were processed by software Chemoview 2.0 (AB Sciex, CA, USA). The 
obtained dataset was interpolated and statistically evaluated in R software (http://
www.R-project.org/). First step in the data processing was reduction of systematic 
error by data interpolation by means of quality control samples applying LOESS 
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method. Coefficient of variation (CV) was calculated for all compounds in quality 
control samples. Compounds with values higher than 30% CV were rejected from 
further processing. Metabolomic data were considered as compositional data and 
clr transformation and centering was applied on the dataset [21]. For statistical 
evaluation, several approaches were chosen: - an unsupervised method (principal 
component analysis), and a supervised method (discriminant function analysis). Box 
plots were generated for all metabolites to compare groups. 
Serum adipokine analysis
Adiponectin was determined with a mouse serum kit (Biorad laboratories, Veenendaal, 
the netherlands) according to the manufacturer’s protocol. 
Mouse Coiled Coil Domain Containing Protein 3 (CCDC3) was determined using 
a sandwich CCDC3 Elisa kit (Mybiosource, San Diego, Ca, USA) according to the 
manufacturer’s protocol, except that serum was diluted 1:2 with serum matrix.
Cholecystokinin (CCK) was determined by a competitive ELISA (Sigma Aldrich) 
according to the manufacturer’s protocol, except that serum was diluted 1:8 using 
kit 1x assay diluent E.
RNA isolation, cDNA synthesis and microarray hybridization
RnA isolation from eWAT was performed as described (van Schothorst et al 2005), 
with quality and purity checked and approved as published [22]. For transcriptome 
analysis, as part of a larger hybridization experiment, Agilent whole mouse 
genome microarrays were used (G4852A, Agilent Technologies, Santa Clara, CA, 
USA). Preparation of the samples and the microarray hybridization was conducted 
according to the manufacturer’s protocol with a few modifications as described 
previously (van Schothorst et al 2007). Briefly, cDnA was synthesized using 200ng 
eWAT RnA with the Agilent low input Quick amp labelling kit without addition of 
spikes (10 mice per group). All samples were individually labelled with Cy5, while 
for the reference pool, 5 random samples per intervention group were pooled on 
an equimolar basis. 
Normalization and statistical analysis of microarray data
normalization was performed as published [22] using Feature Extraction version 
10.7.3. Of the 39430 entrez genes and 16251 linc RnA’s, 30734 probes were 
considered significant. Principal component analysis was performed using 
GeneMaths XT (Applied Maths, Sint-Martens-Latem, Belgium). Differential gene 
expression was analysed by unpaired Student’s t-test between OxR and Control. 
P value < 0.01 was considered statistically significant. Fold change is expressed 
as the ratio of OxR over Control and we focused on the significant genes with an 
absolute fold change > 1.25. Interpretation of functional changes was essentially 
done as described [23]. Briefly, pathway analysis was performed by Metacore 
(GeneGo Inc St. Joseph, MI) and genes were classified based on GO-annotation. 
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Initial categorization was refined using biological databases (MGI, nCBI, nextprot, 
BioCarta, genecards) and scientific literature. As processes overlap, we bundled 
some processes and renamed them.
Quantitative real time reverse transcriptase-PCR (qRT-PCR)
One µg of total RnA of all individual samples was used for cDnA synthesis using the 
iScript cDnA synthesis kit (Bio-Rad, Veenendaal, The netherlands). qRT-PCRs were 
performed as described (Duivenvoorde et al., 2011). Data were normalized according 
to the geometrical mean of the reference genes ribosomal protein S15 (Rps15) and 
β-2 microglobulin (B2m), which were chosen based on stable and appropriate gene 
expression levels by microarray analysis, and least CV over all samples. Primers were 
designed using nCBI Primer-Blast (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). 
Primer sequences and PCR annealing temperatures are in table S2.
Statistical analysis
Data are provided as means±SEM. Significance of difference between Control and 
OxR was determined by unpaired Student’s t-test. For comparison within a group 
(Fig 1A-C) a paired Student ‘s t-test was performed. For comparison over time 
(Fig 1D-F) a one way AnOVA was performed in combination with Dunnett’s multiple 
comparison post hoc test using Graphpad Prism 5.04 (GraphPad Software Inc., San 
Diego, CA, USA). Differences were considered significant at p<0.05.
results
Five days of oxygen restriction (OxR) decreased body weight and fat 
mass 
After 12 weeks of high fat DIO, all mice were characterized as obese, with a mean fat 
mass of 41% of body weight. There were no differences between C and OxR mice 
in body weight, fat mass, and lean mass (Fig 1A, 1B, and 1C) before the start of the 
intervention. After 5 days OxR intervention, body weight declined significantly, which 
is accompanied with a significant decline in fat mass (to 39% of body weight) and 
lean mass (Fig 1A-C). Feed, drink, and activity levels were significantly decreased as 
a first response to OxR. However, after one to two days all parameters returned to 
baseline (Fig 1D-F). 
OxR increases haemoglobin and haematocrit
As an indication for reduced systemic oxygen supply, we measured haemoglobin 
and haematocrit levels. These were indeed significant increased as a result of oxygen 
restriction (Fig 2A and 2B). Furthermore, increased levels of lactate in epididymal 
WAT suggest a switch to glycolytic metabolism and is indicative for tissue hypoxia 
and its metabolic adaptations ([24], Fig 2C). This was confirmed by a decrease in 
blood glucose and an increase in lactate-to-glucose ratio (Fig 2D and 2E).
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Figure 1 Physiological characteristics of C57BL/6J mice upon oxygen restriction. Body weight 
(A) fat mass (B) and lean mass (C) of Control (C, n=12) and oxygen restricted (OxR, n=12) 
C57BL/6J mice. Pre-OxR (n=6) is before intervention with OxR, and Post-OxR (n=6) indicates 
after OxR intervention. 24h drink (D) and feed (E) intake preceding (-24-0) and following 5 days 
OxR intervention in indirect calorimetric system (n=6-12). Data are means ± SEM. * p<0.05, 
** p<0.01, *** p<0.0001
Figure 2 Metabolic effects of OxR intervention. OxR increased hematocrit (A, n=12) and he-
moglobin levels (B, n=5-6) in blood, and adaptation in eWAT on lactate levels (C, n=10). Serum 
glucose levels were decreased (D, n=12), and resulting from that lactate to glucose levels were 
increased (Control was set to 1.0). Citrate synthase (D, n=6-7) and aconitase activity (E, n=10) 
tended to decrease. Data are means ± SEM. * p<0.05, ** p<0.01, *** p<0.0001
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An increase in macrophage infiltration is absent in OxR
Most adipose tissue macrophages have been found surrounding death adipocytes 
forming so-called crown-like structures (CLS)[25]. Here, we visualised and quantified 
the amount of CLS (Fig 3) which showed no difference between the two groups. This 
suggests an absence of increased inflammation in OxR exposed mice.
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Figure 2 Metabolic effects of OxR intervention. OxR increased hematocrit (A, n=12) and hemoglobin levels (B, n=5-6)
in blood, and adaptation in eWAT on lactate levels (C, n=10). Serum glucose levels were decreased (D, n=12), and
resulting from that lactate to glucose levels were increased (Control was set to 1.0). Citrate synthase (D, n=6-7) and
aconitase activity (E, n=10) tended to decrease. Data are means ± SEM. * p<0.05, ** p<0.01, *** p<0.0001
An increase in macrophage infiltration is absent in OxR
Most adipose tissue macrophages have been found surrounding death adipocytes forming so-
called crown-like structures (CLS). Here, we visualised and quantified the amount of CLS (Fig 3)
which showed no difference between the two groups. This suggests an absence of increased
inflammation in OxR exposed mice.
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Figure 3 Macrophage infiltration in eWAT. Adipose tissue macrophage infiltration as assessed by quantification of
MAC-2  stained  crown  like  structures  (CLS)  show  a  tendency  of  decreased  levels  by  OxR  (n=12).  Representative
pictures illustrate levels of CLS after in Control and OxR.
Control OxR
Figure 3 r hage infiltration in eW T. Adipose tissue m crophage infiltration as assessed 
by quantification f MAC-2 stain d crown like structures (CLS) show a tendency of decreas d 
levels by OxR (n=12). Representative pictures illustrate levels of CLS after in Control and OxR.
White adipose tissue metabolism is affected by OXR
Citrate synthase and aconitase are both enzymes of the mitochondrial TCA cycle. 
Citrate synthase is commonly shown as a quantitative enzyme marker for mitochondrial 
density. Here we show a reduction of citrate synthase and aconitase in response to 
OxR, which indicates a reduction in mitochondrial density (Fig 2F and 2G). 
Serum metabolomics defines an OxR fingerprint
Amino acids and lipids (carnitines) have been shown to play a potential role in the 
development of metabolic diseases [26]. Here we investigated whether a specific 
‘fingerprint’ develops by the OxR challenge. The orthogonal partial least squares 
(OPLS-DA) score plot (Supplemental Fig 1) showed clear separation between control 
and OxR groups. When analysing the individual metabolites, we found a significant 
increase of branched chain amino acid Valine (p=0.0203), as well as an increase of 
Leucine/ Isoleucine, touching significance (p=0.0542). We also observed significant 
increased levels of amino acids Alanine, Glutamic acid, Methionine, Proline, and 
Threonine. Of the carnitines analysed, only propionylcarnitine (C3) was significantly 
increased while tetradecanoylcarnitine (C14), tetradecenoylcarnitine (C14:1), 
palmitoylcarnitine (C16) and palmitoleylcarnitine (C16:1) were significantly decreased 
(Table 1).
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table 1 Serum amino acids and carnitines.
Amino acids C OxR p-values
Alanine 488.3±38.8 780.6±54.1 0.0003*
Arginine 242.7±36.0 331.0±42.7 0.1297
Citruline 66.27±3.3 57.7±2.5 0.0553
Glutamic acid 99.06±14.9 159.5±13.5 0.0082*
Glycine 333.3±13.9 400.6±36.0 0.0875
Histidine 47.3±3.1 56.1±4.0 0.0954
Lysine 393.8±26.1 440.1±33.0 0.2817
Methionine 67.1±7.2 97.6±12.2 0.0422*
Ornithine 116.8±12.8 116.9±10.0 0.9976
Phenyl alanine 101.1±9.0 123.5±8.7 0.0926
Proline 108.6±9.0 189.9±24.4 0.0046*
Threonine 24.0±1.8 34.9±2.5 0.0020*
Tryptophan 42.9±2.5 44.5±3.6 0.7168
Tyrosine 111.2±10.2 145.1±12.9 0.0524
Valine 139.7±10.9 184.7±14.1 0.0203*
Isoleucine/Leucine 309.3±34.8 406.7±31.1 0.0542
Carnitines
C0 20.3±1.0 22.2±1.1 0.2049
C2 10.1±0.5 9.2±0.8 0.2976
C3 0.19±0.01 0.27±0.02 0.0026*
C14 0.05±0.003 0.04±0.002 0.0008*
C14:1 0.06±0.004 0.05±0.003 0.0094*
C14:2 0.02±0.001 0.02±0.002 0.1500
C16 0.14±0.007 0.12±0.005 0.0214*
C16:1 0.05±0.004 0.04±0.003 0.0101*
C18 0.04±0.002 0.04±0.001 0.1888
C18:1 0.18±0.01 0.16±0.01 0.0894
C18:2 0.11±0.005 0.10±0.008 0.6606
* p<0.05
Gene expression in epididymal WAT was altered between OxR and 
C mice
Gene expression in eWAT was measured after 5 days of oxygen restriction and 
compared to control mice. 354 probes were differentially expressed by OxR of which 
69 unique down-regulated genes and 43 unique up-regulated genes had an absolute 
fold change >1.25 (tables 2 and 3). Up regulated genes were grouped into five 
categories: response to OxR, signalling, adipocyte cytoskeleton and matrix proteins, 
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inflammation, and oxidative stress defence (Fig 4). Down regulated genes were 
grouped into six main categories: adipocyte cytoskeleton and membrane proteins, 
metabolism, lipid mediators, inflammation, cholesterol, and histone regulation/
modification (Fig 4). 
table 2 Genes down regulated by OxR with a fold change <-1.25 and p< 0.01. (Continued)
Gene symbol Gene name FC P value
Adipocyte cytoskeleton and matrix proteins
1100001G20Rik RIKEn cDnA 1100001G20 gene -2.1 0.0073
A2ld1 Gamma-glutamylamine cyclotransferase -1.3 0.0033
Acta1 Actin, alpha 1, skeletal muscle -1.7 0.0022
Col4a5 Collagen, type IV, alpha 5 -1.3 0.0070
Gkn3 Gastrokine 3 -1.5 0.0003
Hapln3 Hyaluronan and proteoglycan link protein 3 -1.3 0.0058
Itgbl1 Integrin, beta-like 1 -1.4 0.0030
Krtap11-1 Keratin associated protein 1-1 -1.4 0.0013
Lctl Lactase-like -1.6 0.0019
Lrtm1 Leucine richrepeats and transmembrane domains 1 -1.6 0.0004
Maoa Monoamine oxidase A -1.3 0.0008
Mme Membrane metallo endopeptidase -1.5 0.0009
Myom1 Myomesin 1 -1.3 0.0057
Serpina3b Serine (or cysteine) peptidase inhibitor, clade A, 
member 3B
-1.4 0.0071
Serpina3m Serine (or cysteine) peptidase inhibitor, clade A, 
member 3M
-1.7 0.0004
Tinag Tubulointerstitial nephritis antigen -1.8 0.0013
Tpm1 Tropomyosin 1, alpha -1.4 0.0026
Trdn Triadin -1.9 0.0082
Metabolism 
Acoxl Acyl-Coenzyme A oxidase-like -1.4 0.0061
Aldh1a7 Aldehyde dehydrogenase family1, subfamily A7 -1.7 0.0095
Apoc4 Apolipoprotein C-IV -1.4 0.0005
Atp1a4 ATPase, na+/K+ transporting, alpha 4 polypeptide -1.7 0.0087
Bcat1 Branched chain aminotransferase 1, cytosolic -1.3 0.0066
Cox8b Cytochrome c oxidase subunit VIIIb -1.9 0.0055
Fabp12 Fatty acid binding protein 12 -1.4 0.0042
Glul Glutamate-ammonia ligase (glutamine synthetase) -1.3 0.0026
Grb14 Growth factor receptor bound protein 14 -1.6 0.0003
Gys2 Glycogen synthase 2 -1.8 0.0029
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table 2 Genes down regulated by OxR with a fold change <-1.25 and p< 0.01. (Continued)
Gene symbol Gene name FC P value
Lrpap1 Low density lipoprotein receptor –related protein 
associated protein 1
-1.3 0.0031
Mpst Mercaptopyruvate sulfurtransferase -1.5 0.0020
nudt14 nudix (nucleoside diphosphate linked moiety X)-type 
motif 14
-1.3 0.0001
Ppic Peptidylprolyl isomerase C -1.3 0.0028
Rwdd3 RWD-domain containing 3 -1.4 0.0009
Sfxn5 Sideroflexin 5 -1.3 0.0011
Tph2 Tryptophan hydroxylase 2 -2.7 0.0033
Tst Thiosulfate sulfurtransferase, mitochondrial -1.4 0.0065
Lipid mediators
Cyp2c44 Cytochrome P450, family 2, subfamily c polypeptide 44 -1.8 0.0003
D3Bwg0562e DnA segment, Chr3, Brigham & Women’s Genetics 0562 
expressed
-1.9 0.0096
Enpp5 Ectonucleotide pyrophosphatase/phosphodiesterase 5 -1.4 0.0099
Hpgd Hydroxyprostaglandin dehydrogenase 15 (nAD) -1.3 0.0004
Mgst2 microsomal glutathione S-transferase 2 -1.5 0.0033
Pemt Phosphatidylethanolamine n-methyltransferase -1.3 0.0075
Pla2g2e Phospholipase A2, group IIE -2.5 0.0001
Pla2g5 Phospholipase A2, group V -1.9 0.0056
Slco3a1 Solute carrier organic anion transport family, member 3a1 -1.5 0.0003
Inflammation
Ccl8 Chemokine (C-C motif) ligand 8 -1.8 0.0002
Clec9a C-type lectin domain family 9, member a -1.4 0.0014
S100a8 S100 calcium binding protein A8 (calgranulin A) -2.8 0.0001
Saa1 Serum amyloid A 1 -1.8 0.0077
Saa3 Serum amyloid A 3 -2 0.0025
Cholesterol
Dhcr24 24-dehydrocholesterol reductase -1.6 0.0006
nsdhl nAD(P) dependent steroid dehydrogenase-like -1.3 0.0078
Tm7sf2 Transmembrane 7 superfamily member 2 -1.3 0.0001
Histone regulation/modification
H2-K1 Histocompatibility 2, K1, K region -1.3 0.0037
H2-Q10 Histocompatibility 2, Q region locus 10 -1.3 0.0060
Zmynd15 Zinc finger, MYnD-type containing 15 -1.4 0.0002
Miscellaneous
Ccdc3 Coiled coil domain containing 3 -1.4 0.0094
Cck Cholecystokinin -4.4 0.0041
Hfe Hemochromatosis -1.4 0.0034
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table 2 Genes down regulated by OxR with a fold change <-1.25 and p< 0.01. (Continued)
Gene symbol Gene name FC P value
Unknown
6030419C18Rik
9130204L05Rik -1.8 0.0047
A_55_P1981992 -1.3 0.0018
B230311B06Rik -1.3 0.0032
BC054084 -1.4 0.0023
Chr1:138579972-138587381_F -1.5 0.0026
Chr10:93819821-93976621_F -1.3 0.0008
chr8:89996710-90049453_F -1.3 0.0050
EnSMUST00000090166 -1.4 0.0007
nAP060515-1 -1.3 0.0019
Categorized transcripts were subsequently sorted based on alphabetical order
table 3 Genes up regulated by OxR with a fold change > 1.25 and p<0.01. (Continued)
Gene symbol Gene name FC P value
Response to OxR
Alas2 Aminolevulinic acid synthase 2, erythroid 2.1 0.0013
Ankrd37 Ankyrin repeat domain 37 1.6 0.0008
Beta-s Hemoglobin subunit beta-1-like 2.1 0.0009
Chrdl1 Chordin-like 1 1.9 0.0017
Cish Cytokine inducible SH2-containing protein 1.7 0.0094
Edn1 Endothelin 1 1.3 0.0067
Gm5226 2 0.0007
Hba-a1 Hemoglobin alpha, adult chain 1 1.9 0.0045
Hba-a2 Hemoglobin alpha, adult chain 2 1.9 0.0073
Hbb-b1 Hemoglobin, beta adult major chain 2 0.0017
Hbb-b2 Hemoglobin, beta adult minor chain 1.9 0.0005
Slc25a37 Solute carrier family 25, member 37 1.3 0.0003
Slc4a1 Solute carrier family 4 (anion exchanger), member 1 1.5 0.0006
Signalling 
1300014l06Rik PX domain containing 1 1.4 0.0020
Enc1 Ectodermal-neural cortex 1 1.3 0.0087
Hic1 Hypermethylated in cancer 1 1.3 0.0042
Htra3 HtrA serine peptidase 3 1.4 0.0076
Rgs16 Regulation of G-protein sugnalling 16 1.3 0.0082
Tmem198 Transmembrane protein 198 1.3 0.0021
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table 3 Genes up regulated by OxR with a fold change > 1.25 and p<0.01. (Continued)
Gene symbol Gene name FC P value
Adipocyte cytoskeleton and matrix proteins
Has2 Hyaluronan synthase 2 1.3 0.0095
St6galnac5 ST6 (alpha-n-acetyl-neuraminyl-2,3-beta-galactosyl 1.5 0.0044
Zdhhc22 Zinc finger, DHCC-type containing 22 2.1 0.0013
Tubb3 Tubulin, beta 3 class III 1.4 0.0049
Inflammation
Darc Duffy blood group, chemokine receptor 1.3 0.0008
Fam46c Family with sequence similarity 46, member C 1.4 0.0070
Tnfsf9 Tumor necrosis factor (ligand) superfamily, member C 1.3 0.0091
Oxidative stress defence
Gstm1 Gluthathione S-transferase, mu 1 1.5 0.0023
Gstm4 Gluthathione S-transferase, mu 4 1.4 0.0024
Miscellaneous
Gnat2 Guanine nucleotide binding protein, alpha transducing 2 1.3 0.0058
Prpf4b PRP4 pre-mRnA processing factor 4 homolog B (yeast) 1.3 0.0026
Unknown
2700081O15Rik 1.3 0.0084
4930415C11Rik 1.4 0.0013
chr1:107866276-107887102_R 1.3 0.0059
chr8:106037800-106070025_F 1.3 0.0044
chr8:74431707-74442440_F 1.3 0.0008
chr10:69819062-69871640_F 1.3 0.0052
chr14:28218945-28241903_R 1.3 0.0019
chr17:47006033-47023558_R 1.3 0.0020
Ensmust00000073543 1.3 0.0066
Fam171b 1.3 0.0076
Gm10447 1.3 0.0021
Gm16516 1.3 0.0005
Gm9992 1.7 0.0001
Categorized transcripts were subsequently sorted based on alphabetical order.
Microarray results were confirmed by qRT-PCR
Genes from three different functional categories were selected and their expression 
was confirmed by qRT-PCR. They represent inflammation (S100 calcium binding 
protein A8, S100a8) and adaptation to oxygen restriction (ankyrin repeat domain 37 
(Ankrd37) and aminolevulinic acid synthase (Alas)) (Fig 5). 
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Metabolic serum proteins altered by OxR
We then focuses on proteins with a potential role in systemic regulation; adiponectin, 
coiled coil domain containing protein and cholecystokinin. Previous studies have 
shown an inverse relation between serum adiponectin and fat mass [27]. Recently, 
adiponectin has been appointed as a marker of metabolic dysregulation [28]. Here, 
we find a reduction of adiponectin by OxR (Fig 6A). Ccdc3 and Cck were further 
investigated, because OxR resulted in altered transcript levels of these potential 
peptide hormones CCDC3 (also known as favin) is a newly discovered secretory 
protein of WAT vessel origin [29]. Serum CCDC3 levels showed a downward trend 
by OxR corresponding to its gene expression decrease in eWAT (Fig 6B). CCK is well 
known for its role as peptide hormone of the gastrointestinal system responsible for 
stimulating the digestion of fat and protein, and as hunger suppressant [30]. Serum 
levels of CCK were not influenced by OxR (Fig 6C).
Figure 4 Categorization of the 112 unique genes that were found to be differentially regulated 
(p<0.01, absolute fold change >1.25) by OxR. Filled black bars represent up regulated genes 
and open bars represent down regulated genes.
Figure 5 Confirmation of microarray results by real time qRT-PCR. Change in gene expression 
levels by OxR over values observed in control group of Alas, Ankrd37, and S100a8 was analysed 
by qRT-PCR (closed circles), relative to stable reference genes B2m and Rps15. Data obtained 
with microarray analysis is shown for comparison by open circles. Data are presented as means 
±SEM (n=10).
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disCussion
Diet induced obese C57BL/6J mice exposed to ambient OxR (13%) for 5 days 
had a systemic decrease of oxygen availability as shown by increased circulating 
haemoglobin and haematocrit levels, and an increased lactate to glucose ratio in 
WAT. This is further supported by the gene expression profile, where genes that are 
indicative of limitations in oxygen availability are up regulated, including marker genes 
Ankrd37 [31] and Alas2 [32]. Remarkably, we found in white adipose no difference 
in crown like structures representing tissue inflammation. This was supported by a 
decrease in in marker genes of inflammation, including s100a8. These results suggest 
that hypoxia is most likely not the first step which leads to inflammation of white 
adipose tissue.
Induction of inflammation related transcripts as Tnfa, interleukin 1(Il-1), interleukin 
6 (Il-6), monocyte chemotactic protein 1 (MCP1), plasminogen activator inhibitor 1 
(PAI-1), macrophage migration inhibitory factor (MIF ), inducible nitric oxide synthase 
(iNOS), matrix metallopeptidase 9 (MMP9), and matrix metallopeptidase 2 (MMP2) 
indicate that hypoxia is able to induce inflammation in primary adipocytes and cell 
lines in vitro [10, 12]. However, we find that none of these genes is regulated in WAT 
due to OxR intervention in vivo. We also see no difference in CLS accumulation 
which is consistent with the down regulation of i.e. inflammation associated genes 
chemokine (C-C motif) ligand 8 (Ccl8), C-type lectin domain family 9 member A 
(Clec9a), S100 calcium binding protein A8 (S100a8), serum amyloid A1 (Saa1), and 
serum amyloid A3 (Saa3), as macrophages are known for their more active secretion 
of inflammatory cytokines than adipocytes. These findings fit with recent in vitro 
findings, showing a reduction of the nF-kB signalling and MCP-1 secretion in human 
primary adipocytes due to hypoxia [33]. Adipocytes are major producers of serum 
amyloid A (SAA) family members in the non-acute phase in humans [34], especially 
Figure 6 WAT transcript levels and serum levels of peptide proteins. Raw expression of gene 
transcripts as analysed by microarrays (left) and their serum levels (right) of metabolism associ-
ated parameters Ccdc3 (A), Cck (B), and Adiponectin (C) of control (open bar) and OxR (closed 
bar) mice. Data are means ±SEM (n=10). * p<0.05


 





 






















 




  

















 


 




  



















A B C
102
EFFECTS OF OXYGEn RESTRICTIOn On OBESE ADIPOSE TISSUE 
5
hypertrophic adipocytes [35] that are known to be associated with obesity and insulin 
resistance [36]. Moreover, WAT encoded and secreted SAA3 is linked to attraction 
of monocytes and thus an inflammatory state [37]. In contrast, in the mouse model 
containing human SAA1 (hSAA1) expressed specifically in WAT, no evidence was 
found that adipose tissue-derived hSAA1 influences the development of insulin 
resistance or obesity-related inflammation [38]. Here, we identified reduced levels of 
Saa transcripts by OxR, as well as of other markers of WAT inflammation, including a 
downward trend in the number of CLS.
We expected to stress adipose tissue in DIO mice by OxR leading to increased 
WAT inflammation. But we did not find any other hallmarks for deterioration of 
adipose tissue health, such as increased secretion of cytokines. However, we do 
show a serum metabolome profile with increased levels of branched chain amino 
acids (BCAA; Valine, isoleucine/leucine) and C3 carnitine in OxR mice. This profile 
matches metabolic serum profiling of obese versus lean humans, where this predictive 
branched-chain amino acid signature correlates with insulin resistance [26]. In rodents 
a down-regulation of the expression of adipose tissue BCAA metabolizing enzymes 
has been shown in obesity and insulin resistance [39]. This confirms our findings of 
decreased Bcat1 expression levels in WAT by OxR. Our data may imply that adipose 
tissue hypoxia is responsible for the serum metabolome profile that is associated 
with insulin resistance in humans
Hypoadiponectimia is an important biochemical hallmark in the pathogenesis 
of obesity-related disorders [40, 41]. Our present study demonstrated that serum 
adiponectin is markedly decreased by OxR. This supports the finding that hypoxia 
deregulates adiponectin in adipocytes in vitro [42] and in adipose tissue in vivo [12]. 
It would be interesting to investigate adiponectin levels in WAT to know whether less 
adiponectin is produced or less adiponectin is secreted, as Adipoq transcript levels 
remained unaltered.
Coiled-coil domain containing 3 (CCDC3) has recently been identified as an 
adipocyte secreted protein, with increased levels in a genetic model of obesity as 
well as during adipocyte differentiation [29]. The expression of CCDC3 is specifically 
increased in visceral adipose tissue in abdominally obese subjects, and is suggested 
as potential biomarker for estimating visceral adiposity [43]. Here, we found 
decreased Ccdc3 transcript levels in epididymal WAT by OxR, which was similar 
to decreased CCDC3 serum levels. Why CCDC3 levels are decreased upon lower 
oxygen availability remains unanswered and needs further investigation. 
Presence of cholecystokinin (CCK) in white adipose tissue has been shown first 
in human visceral WAT of a non-obese subject [44]. CCK is involved in the regulation 
of appetite through autocrine/paracrine mechanisms. Here, we show a reduction 
of CCK on transcript level by OxR without an effect on serum level. A well-known 
symptom of exposure to oxygen restriction is a reduction of food intake [45, 46]. 
Therefore, a reduction in CCK transcript levels is remarkable as CCK is responsible 
for short term satiety signalling. However, as there are no changes in serum levels of 
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CCK it may be that only local regulation in WAT takes place or that nervous signalling 
is involved. Why CCK levels are decreased in WAT remains unclear. In summary, 
5 days of reduced oxygen availability did not increase in inflammation in epididymal 
WAT, but rather suggests a decrease. Strikingly, OxR did induce a serum metabolome 
profile of branched chain amino acids, which is associated with insulin resistance in 
humans. Furthermore, decreased serum levels of adiponectin, an adipose derived 
peptide hormone with insulin sensitizing properties, were seen. Therefore, it seems 
that reduced oxygen availability contributes to health deterioration in obesity. 
Branched chain amino acid, CCDC3 and adiponectin may be markers for systemic or 
adipose tissue hypoxia. 
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supplemental table 1 Diet composition.
Components LFD HFD
Casein 220 267
Wheat starch 386.5 172.5
Maltodextrin 100 100
Dextrose 50 50
Sucrose 100 100
Fat* 43 210
Cholesterol 0.03 0.097
Cellulose 50 50
Mineral mixture 35 35
Vitamin mixture 10 10
Choline bitartrate 2.5 2.5
L-cysteine 3 3
Energy (Kcal kg-1) 3865 4700
Percentage of energy from carbohydrate 66.9 36.8
Percentage of energy from fat 10.0 40.2
Percentage of energy from protein 23.1 23.0
Values are in grams per kilogram, unless stated otherwise. Energy content is adjusted for energy from 
the vitamin mix. *Fats consist of 18% (w/w) coconut oil, 70% sunflower oil, and 12% flaxseed oil. LFD as 
published (Hoevenaars, et al. 2012.).
supplemental table 2 Primers and annealing temperature for qRT-PCR.
Gene Forward 5’-3’ Reverse 5’-3’ T (°C)
Alas TCAGACACAATGACCCAGGC CGAAGGTCAGGGCTCCATAC 58
Ankrd37 CAGGTGCTGACCTCAACCAAC CCAAGCAAGATCTTCAGCTGTC 58
Ccdc3 CCCGGCTCAACCTTACTGG GAAATTGACTCCGTGTGGCA 56.5
Cck ACTGCTAGCGCGATACATCC CATCCAGCCCATGTAGTCCC 58
S100a8 ACTTCGAGGAGTTCCTTGCG TGCTACTCCTTGTGGCTGTC 58
B2m* CCCCACTGAGACTGATACATACGC AGAAACTGGATTTGTAATTAAGCAGGTTC 60
Rps15* CGGAGATGGTGGGTAGCATGG ACGGGTTTGTAGGTGATGGAGAAC 58
*genes denoted with an asterisk were used as reference genes
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supplemental figure 1 Supervised OPLS-DA score plot of serum metabolome data of control 
vs. OxR mice. Two component model based on 27 measured serum metabolites. Control mice 
are represented by filled squares and open circles depict OxR mice. OPLS-DA, orthogonal 
partial least squares discriminant analysis.
Suppl mental figure 1 Supervised OPLS-DA s ore plot of serum m tabolome data of control vs. OxR mice. Two 
component model based o  27 measured serum metabolites. Control mice are represented by filled squares and 
open circles depict OxR mice. OPLS-DA, orthogonal partial least squares discriminant analysis.
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CHAPTER 6
AbstrACt
Experimental replication is fundamental for practicing science. To reduce variability 
it is essential to control sources of variation as much as possible. Diet is an 
important factor that can influence many processes and functional outcomes in 
studies performed with rodent models. This is especially true for, but not limited 
to, nutritional studies. To compare functional effects of different nutrients, it is 
important to use standardized, semi-purified diets. Here, we propose and describe 
a standard reference diet, the BIOCLAIMS standard diet (BIOsd). The diet is AIn-93 
based, but further defined with dietary and experimental requirements taken into 
account that allow for experiments with bioactive food components and natural 
(non-expensive) labeling. This diet will be implemented by two European research 
consortia, Mitofood and BIOCLAIMS, to ensure inter-laboratory comparability. 
disClosures
no conflict of interest or commercial interest are declared by the authors. 
Keywords: semi-purified diet, nutrient requirements, rat, mouse
112
BIOCLAIMS STAnDARD DIET (BIOSD): A REFEREnCE DIET FOR nUTRITIOnAL PHYSIOLOGY
6
introduCtion
nutrition will affect functional outcomes in many studies performed with rodent 
models. This may already be the case with strong pharmaceutical or toxicological 
interventions, or when dominant gene knock-outs or knock-ins are considered. When 
we take obesity, type 2 diabetes, or cardiovascular diseases into consideration, 
which are multifactorial diseases with a strong dietary background, nutrition 
becomes even more important. Indeed, dietary intervention studies in wildtype 
mice and rats were found to give relatively small effects on a variety of parameters 
such as lipoprotein profiles, biomarkers of inflammation and gene expression 
responses [1, 2]. In addition, ‘standard’ chow diets usually contain poorly specified 
ingredients that may strongly vary in composition between batches and between 
providers. For example, a 5000 fold difference in the level of phytoestrogens has 
been encountered [3, 4]. Moreover, when a chow diet is compared with a semi-
purified diet, a remarkable difference in digestibility and thus effective energy 
intake has been described [5].
To be able to compare functional effects of different nutrients, it is therefore 
important to use standardized, semi-purified diets; both as experimental as well as 
its reference, control diet. This necessity is now widely recognized among researchers 
employing rodents to unravel molecular mechanisms underlying functional effects of 
nutritional components [6, 7]. Indeed, semi-purified control and experimental diets 
based on the recommendations of the American Institute of nutrition (AIn93) are 
increasingly used. While of great importance, these guidelines leave substantial 
room for variation in a number of dietary constituents that are of significant relevance 
to molecular and health outcomes of dietary intervention studies [1].
A need to further standardize diets is strongly felt in order to improve comparison 
of study outcomes and to increase efficiency of resources and animals [8]. It is, 
however, difficult to reach consensus since it implies that individual laboratories have 
to perform additional initial comparative analyses in ongoing research lines. Despite 
this, partners in two European research consortia, Mitofood1 and BIOCLAIMS2, 
consisting of respectively 38 and 11 partners spread throughout 24 countries in 
Europe have proposed a common, defined semi-purified AIn93 based reference 
diet, the BIOCLAIMS Standard Diet (BIOsd), as well as an experimental high fat 
diet. Here, we present the choices that have been made, including the underlying 
rationale, as well as a number of dietary analyses that have been performed on the 
final formulation of the standard diet.
1 www.mitofood.eu
2 www.bioclaims.eu
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MAteriAls And Methods
Gross energy determination
Approximately 10 grams of BIOsd (Research Diets Services, Wijk bij Duurstede, nL) 
and standard chow (Teklad global 16% protein rodent diet, 2016) were grinded on 
a 1.0 mm sieve to prepare a homogenate sample for gross energy determination. 
Samples were left at room temperature for 24 hours to acclimatize for humidity. 
Samples were measured by IKA C7000 calorimeter (Staufen, Germany) in triplicate 
or until the deviation was less than 2%. Polyethylene bags were used as standard.
Kahl pellet hardness tester
Hardness of pellets was assessed by using a Kahl device (Amandus Kahl nachf., 
Reinbek/Hamburg, Germany). A pellet is inserted between two bars and due 
to increasing static pressure applied by a spring, the force (H, kg) necessary for 
breakage of the pellet is determined. The average of 12 measurements minus the 
hardest Hmax and the least hard Hmin of pellets randomly chosen from the batch, is 
referred to as ‘Kahl-hardness’ of the pellet, which is given by the following formulae:
Hardness (kg) = 
Σn1-12 Hardness (H)1-12 – Hmax – Hmin
10
Here, measured pellets differed however in shape. Regular chow is oval shaped 
(16 x 10 mm) while the semi-purified diet is round (9mm diameter). Chow was tested 
for breakage on the ‘flat’ side. 
Animal experiments
Male C57BL/6JRccHsd mice were delivered from Harlan Laboratories GmbH to 
the German Institute of Human nutrition (DIfE) at week 4 of age. Mice were housed 
individually with ad libitum access to food and water at a temperature of 22°C on a 
12h light-dark cycle. At 6 weeks of age mice were switched from standard chow diet 
(Ssniff) to the BIOsd (Research Diets Services, Wijk bij Duurstede, nL). Body weight and 
composition was determined weekly for 12 weeks using quantitative magnetic resonance 
(QMR; Bruker´s Minispec MQ10, Housten Texas, USA) as described (Klaus et al. 2005). 
Animal maintenance and experiments were approved by the animal welfare committee 
of the Ministry of Agriculture and Environment (State of Brandenburg, Germany).
Male and female C57BL/6J mice (Institute of Physiology Academy of Sciences 
of the Czech Republic) were maintained at 22°C on a 12 h light–dark cycle (light on 
from 06:00 hours) and fed Ssniff standard diet (extruded Ssniff R/M-H diet; Ssniff 
Spezialdieten GmbH, Soest, Germany; containing 25%, 9%, and 66% calories in the 
form of protein, fat, and carbohydrate, respectively) since weaning. At 6 months of age 
they were randomly assigned to either the Ssniff standard diet or BIOsd. After 7 weeks 
of the differential feeding, 10 breeding pairs on each diet were allowed for mating for 
1 week, and offspring were followed for 6 weeks. All experiments were performed in 
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accordance with the directive of the European Communities Council (68/609/EEC), 
and the Principles of Laboratory Animal Care (nIH publication no. 85-23, revised 1985).
Results and Discussion
An inventory of changes in nutrient composition compared to the original AIn93 
diet was made and the grounds for making these changes are given below. The 
general formula of the BIOsd in comparison with AIn diets is shown in table 1, and 
the mineral and vitamin mixes of the BIOsd are shown in tables 2 and 3 respectively.
table 1 BIOCLAIMSsd.
Composition g/kg diet AIN-93G AIN-93M BIOsd
Corn starch 397.486 465.692 -
Wheat starch - - 386.5
Casein 200 140 220
Dextrinized cornstarch 132 155 -
Maltodextrin - - 100
Sucrose 100 100 100
Dextrose - - 50
Soybean oil (no additives) 70 40 -
Fats1 - - 43
Fiber2 50 50 50
Mineral mix (AIn-93G-MX)3 35 35 35
Vitamin mix (AIn-93-VX)4 10 10 10
L-cysteine 3 1.8 3
Choline bitartrate 2.5 2.5 2.5
tert-Butylhydroquinone (TBHQ), mg 14 8 -
Total energy kcal/ kg diet 3766 3601 3865
% as carbohydrates 64.0 75.9 66.9
% as protein 19.3 14.1 23.1
% as fat1 16.7 10.0 10.0
1 Combination of sunflower oil (70%), coconut oil (18%) and flaxseed oil (12%)
2 Cellulose, 3 For composition see table 2, 4 For composition see table 3
table 2 Contribution of minerals. (Continued)
Essential mineral elements g/kg mix
Calcium, carbonate, anhydrous, 40.04% Ca 357
Potassium phosphate, monobasic, 22.76% P; 28.73% K1 196
Potassium citrate, tri-potassium, monohydrate, 36.16% K 70.78
Sodium chloride, 39.34% na; 60.66% Cl 74
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table 2 Contribution of minerals. (Continued)
Essential mineral elements g/kg mix
Potassium sulfate, 44.87% K; 18.39% S 46.6
Magnesium oxide, 60.32% Mg 24
Ferric citrate, 16.5% Fe 6.06
Zinc carbonate, 52.14% Zn 1.65
Manganous carbonate, 47.79% Mn 0.63
Cupric carbonate, 57.47% Cu 0.3
Potassium iodate, 59.3% I 0.011
Sodium selenate anhydrous, 41.79% Se 0.01025
Ammonium paramolybdate, 4 hydrate, 54.34% Mo 0.00795
Potential beneficial mineral elements
Sodium meta-silicate, 9 hydrate, 9.88% Si 1.45
Chromium potassium sulfate, 12 hydrate, 10.42% Cr 0.275
Lithium chloride, 16.38% Li 0.0174
Boric acid, 17.5% B 0.0815
Sodium fluoride, 45.24% F 0.0635
nickel carbonate, 45% ni 0.0318
Ammonium vanadate, 43.55% V 0.0066
Powdered sucrose (carrier) 221.026
1 This amount of potassium phosphate supplies only 1561mg P/kg diet. The remainder (1440mg) comes 
from casein, which contains an average of 0.72% P. The recommended amount of phosphorus in the 
diet is 3000mg/kg diet (Reeves et al. 1993).
table 3 Contribution of vitamins.
Vitamin g/kg mix
nicotinic acid 3
Ca Panthothenate 1.6
Pyridoxine-HCL 0.7
Thiamin-HCL 0.6
Riboflavin 0.6
Folic acid 0.2
D-Biotin 0.02
Vitamin B-12 (cyanocobalamin) (0.1% in mannitol) 2.5
Vitamin E (all-rac-α-tocopheryl acetate) (500 IU/g)1 15
Vitamin A (all-trans-retinyl palmitate) (500IU/g) 0.8
Vitamin D3 (cholecalciferol) (400IU/g) 0.25
Vitamin K (phylloquinone 0.075
Powdered sucrose (carrier) 974.655
1 Use of the dry, gelatin-matrix form of these vitamins is recommended
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Fiber. Cellulose is used at 50g/kg according to AIn-93G and AIn-93M (table 1).
Macro nutrients
Carbohydrates. In the BIOsd, corn starch has been replaced by wheat starch. This 
has been done due to a high prevalence of natural stable isotope 13C in corn. This 
change makes the diet suitable for metabolic tracer studies using natural enriched 
corn [9, 10]. Furthermore, a combination of maltodextrin, dextrose and sucrose has 
been used to obtain a pellet with a pleasant hardness for mice [11]; BIOsd vs. chow, 
table 4).
table 4 Pellet Hardness (kg).
Diet Pellet Hardness (kg)
Chow1 21.9 ± 0.6
BIOsd 28.3 ± 0.8
1 Harlan Laboratories, Teklad global 16% protein rodent diet (2016)
Values are means ± SEM
Protein. For the BIOsd a choice has been made to use 220g protein/kg diet, supplemented 
with 3g L-cysteine, corresponding to a total of 23en% of protein. This protein content 
avoids potential hyperphagia due to lower protein content [12]. L-cysteine is added 
to meet the requirements of sulfur amino acid levels [13]. The increase in casein also 
covers the increase in recommendation of sulfur amino acids according to the national 
Research Council nutrient requirements of Laboratory Animals [14].
Fat. The choice for fats was based on a number of criteria. First, the diet should 
provide a balance of the essential fatty acids, linoleic acid (omega-6 fatty acid, 
n-6;18:2) and linolenic acid (omega-3 fatty acid, n-3;18:3) acid. Bourre et al. suggest a 
minimal intake of 12g linoleic acid and 2g α-linolenic acid/kg diet for rats, which has 
been recommended after revision of the original AIn-93 [15, 16]. Secondly, a healthy 
polyunsaturated over saturated fat (P/S)-ratio of at least 2 should be attained [17]. 
Thirdly, we selected oils containing neither polyphenols nor carotenes to be able to 
sensitively intervene with these food bioactive compounds. To meet all these criteria, 
a combination of sunflower oil (70%), coconut oil (18%) and flaxseed oil (12%) has been 
selected. This results in a (n-6)/(n-3) ratio of 7.8 and a (P/S)-ratio of 3.1 (table 5). The 
use of soy oil was considered not appropriate due to its variable polyphenol content. 
In addition, it was decided to optionally add 30mg/kg cholesterol to the diet 
(investigator depended), since human diets usually contain cholesterol. This amount 
of cholesterol corresponds to the amount of cholesterol present in approximately 
30g lard/kg diet, and represents average Dutch human intake [18]. To our knowledge, 
there are no known side-effects if cholesterol is excluded from the diets.
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table 5 Fatty acid profile (% of gr/kg diet).
Coconut
18%
Sunflower
70%
Flaxseed
12%
Total
100%
C8:0 7 - - 1.3
C10:0 6 - - 1.1
C12:0 47 - - 8.5
C14:0 19 - - 3.4
C16:0 10 6 6 6.7
C18:0 3 4 4.5 3.9
C18:1 (n-9) 7 25 25 21.8
C18:2 (n-6) 1 64 17 47
C18:3 (n-3) - - 50 6
n-6/n-3 ratio
(P/S)-ratio
7.8
3.1
table 6 Gross energy content kJ/g.
Diet Calculated Measured
Chow1 12.6 16.8 ± 0.0478
BIOsd 16.2 17.5 ± 0.0016
1 Harlan Laboratories, Teklad global 16% protein rodent diet (2016)
Values are means ± SEM
Micronutrients
Vitamin and Mineral mix. Vitamin and mineral content follows AIn-93 recommendations 
and is specified in tables 2 and 3, respectively. The carbohydrate component that 
is used as a carrier for the vitaminmix provides 40 kcal/kg of energy which has been 
taken into account for calculating the carbohydrate energy contribution and total 
energy content (table 1).
Polyphenols and carotenoids. The oils that are used contain no carotenoids. Sunflower 
oil contains 1mg polyphenols per 100gr oil [19], according to the French national 
institute for agricultural research (InRA) Phenol Explorer Database [20]. This results 
in 0.3 mg of polyphenols/kg diet (3*10-5%), which is considered to be a negligible 
amount. Sunflower oil contains 41.08mg/100gr of α-tocopherol (vitamin E) [21]. 
Performance and development of mice
Using the diet during maintenance, similarly to the use of other purified diets, the mice 
initially lost some bodyweight, as a consequence of the diet switch. After this the mice 
displayed a fully normal development and behaviour. This was also the case for rats. 
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Fig. 1 shows the development of body composition of C57BL/6J mice which were 
fed the BIOsd diet from 6 weeks of age for 12 weeks. At 6 weeks (wk6) of age mice 
are not yet fully grown. During feeding of the BIOsd, mice gained body weight due 
to an increase of lean body mass as well as body fat as expected (body mass (g) wk5: 
19.95 ±0.24, wk18: 24.45±0.46; lean mass (g) wk5: 14.65±0.20, wk18: 17.29±0.34; 
body fat (g) wk5: 5.30±0.11, wk18: 7.16±0.17, data are mean ± SEM¸ n=12). 
For mice we also tested the immediate effect on breeding, after an adaptation 
period of seven weeks on the BIOsd. neither breeding performance nor sex ratio 
of offspring was affected by the BIOsd when compared with non-purified Ssniff 
standard diet. Thus, 9 of 10 female mice on each diet became pregnant, while 
average litter size (5.8.±1.1 and 6.0±0.8 pups/litter in the Ssniff diet-fed and BIOsd-
fed mice, respectively) and average sex ratio of offspring (2.3±0.5/3.5±0.7.and 
2.8±0.5/3.2±1.0.female/male mice born in total in the Ssniff diet-fed and BIOsd-fed 
mice, respectively) were not significantly different when compared to the BIOsd 
(data are mean ± SEM). Furthermore, body weight of mice (followed during 4 weeks 
of lactation and 2 weeks after weaning) was not significantly affected by the BIOsd 
(data not shown).
The emphasis on a purified diet to reduce experimental variation becomes 
more and more important due to the use of new technologies such as genomics, 
proteomics and metabolomics, where small differences can be of major significance 
for interpretation of the data. Enhanced standardization of general used diets is 
still necessary. For example, phytoestrogen content of equal open-formula diets can 
differ up to 3 fold depending on mill date and use of different commodities [4]. 
Genistein, a phytoestrogen present in soy for example, displays estrogen receptor 
activation properties which are an unwanted effect in dietary studies [22]. not only 
the protein fraction, but also the fat fraction can contain phytoestrogens. Traditional 
diets often contain soybean oil for its adequate (n-6)/(n-3) ratio. Furthermore, for a 
proper health and physiological state of the rodents, general rules for n-6 and n-3 
Figure 1 Body composition. Body weight and body composition development of C57BL/6J 
mice fed BIOsd ad libitum for 12 weeks from 6 weeks of age. Data are mean ± SEM, n=12.
Micronutrients
Vitamin and Min ral mix. Vitamin and mineral content follows AIN-93 re ommendations and is
specified in tables 2 and 3, respectively. The carbohydrate component that is used as a carrier
for  the  vitaminmix  provides  40  kcal/kg  of  energy  which  has  been  taken  into  account  for
calculating the carbohydrate energy contribution and total energy content (table 1).
Polyphenols  and  carotenoids.  The  oils  that  are  used  contain  no  carotenoids.  Sunflower  oil
contains  1mg  polyphenols  per  100gr  oil  ,  according  to  the  French  national  institute  for
agricultural research (INRA) Phenol Explorer Database . This results in 0.3 mg of polyphenols/kg
diet  (3*10-5%),  which  is  considered  to  be  a  negligible  amount.  Sunflower  oil  contains
41.08mg/100gr of α-tocopherol (vitamin E) . 
Performance and development of mice
Using the diet during maintenance, similarly to the use of other purified diets, the mice initially
lost som  bodyweight, as a consequence of the diet switch. After this the mice displayed a fully
normal development an  behav our. This was lso the ca for rats. 
Fig. 1 shows the development of body composition of C57BL/6J mice which were fed the BIOsd
diet from 6 weeks of age for 12 weeks. At 6 weeks (wk6) of age mice are not yet fully grown.
During feeding of the BIOsd, mice gained body weight due to an increase of lean body mass as
well as body fat as expected (body mass (g) wk5: 19.95 ±0.24, wk18: 24.45±0.46; lean mass (g)
wk5:  14.65±0.20, wk18:  17.29±0.34;  body fat  (g)  wk5:  5.30±0.11,  wk18:  7.16±0.17, data are
mean ± SEM¸ n=12). 
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Figure 1 Body composition. Body weight and body composition development of C57BL/6J mice fed BIOsd ad libitum 
for 12 weeks from 6 weeks of age. Data are mean ± SEM, n=12.
For mice we also tested the immediate effect on breeding, after an adaptation period of seven
weeks on the BIOsd. Neither breeding performance nor sex ratio of offspring was affected by
the BIOsd when compared with non-purified Ssniff standard diet. Thus, 9 of 10 female mice on
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fatty acids and (P/S)-ratio exclude usage of for instance palm oil as sole dietary fatty 
acid ingredient due to a (n-6)/(n-3) ratio of 25:1, which is considered to increase the 
probability of a number of diseases [23].
As many partners are interested in the use of a high fat diet, we also propose a 
high fat diet based on the BIOsd, in which part of the carbohydrate content of wheat 
starch will be replaced by fat to mimic average daily western human intake (40en% 
fat, 4700kcal/kg). 
The initial studies that were performed, and those that are still ongoing, show that 
the diet can be used for maintenance. Preliminary data suggest no direct adverse 
effects on mouse breeding using the BIOsd. We have not examined long term or 
trans-generational effects and therefore at present we do not advise to use the diet 
as a standard diet in breeding unless further tested. We cannot exclude adverse 
effects on breeding of other rodent species. 
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disCussion
In this thesis three basic questions which are of importance for the understanding of 
adipose tissue functioning were investigated. namely:
1. Does a body weight set-point exist? 
2. How is the diet-induced metabolic response affected by housing at 
thermoneutrality?
3. Does oxygen restriction induce inflammation in white adipose tissue?
All of these questions explore the metabolic adaptive capacity of the adipose 
tissue. This chapter reflects on the results of the previous chapters and places the 
findings in the broader context of weight balance, thermoneutrality and adipose 
tissue. Finally the implications of our research and main conclusion are provided.
Weight balance
The number of people who are obese is still rising globally. In 2012 approximately 
53% of the Dutch male population, above the age of 20, and 44% of the Dutch 
female population was overweight (body mass index (BMI) >25 kg/m2). While more 
male are overweight, more females are obese (BMI>30 kg/m2): 14% females and 11% 
males [1]. High prevalence of overweight and obesity increases the number of people 
attempting to lose body weight. Unfortunately, the main problem with dieting is 
mostly not the achievement of short term weight loss, but long term body weight 
maintenance after body weight reduction. Body weight reduction is considered 
significant when 5-10% of initial body weight is lost as this is associated with an 
improvement of metabolic and cardiovascular parameters [2, 3]. This is achieved in 
many instances within 3-18 months [4]. However, long term success rate is substantial 
lower. After 2.5 year follow-up, participants from four different intervention groups 
aiming to lose body weight, only lost 1.7 kg compared to their body weight at the 
start of the intervention [5]. This shows that dieters are not in the advantage in the 
long run. In the nHAnES study 35% of people with significant reduced body weight 
regained body weight after one year [6]. This is thought to be due to the body 
retaining a body weight set-point. 
In homeostasis, a set-point is a target value of a controlled variable that is 
maintained by an automatic control system. This is analogues to a cruise control 
system in which a certain target speed is programmed; when driving up a mountain, 
the internal control system of the car will hit the gas to retain the target speed, but 
when driving down the car will hit the brakes to return to its target speed. One big 
difference between a physiological set-point and the cruise control system is that 
you can tune the cruise control to your own desire but a physiological set-point is 
fixed. The fixed set-point also contrasts with the rise in obesity; did we all suddenly 
released the fixed point and increased our ‘fixed’ set-point upwards?
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In chapter 2 we showed that alterations of purified diets did not result in a 
persistent elevated body weight set-point. The last consumed diet, either high or low 
in fat content, determined energy intake, energy expenditure, body weight, body fat 
store mass and circulating hormones and metabolites. Therefore we concluded that 
all these parameters ‘settle’ into a new flexible point determined by energetic input 
and output which is in contrast with the fixed set point as defined in homeostasis. 
We thus rejected the set-point theory and support the settling point theory as 
introduced in the introduction. nevertheless, also in the settling point theory the 
question remains: which factors are responsible for establishment of the settling 
point, in other words: which factors are responsible for keeping a weight balance? It 
is unlikely that this is a single parameter. Most likely it is the optimal balance, within a 
certain sphere, between a number of evolutionary determined parameters driven by 
metabolic rate, energy and nutrient availability, palatability of feed, and homeostatic 
maintenance of the organism. This is visualised in Figure 1.
theory as introduced in the introduction.  Nevertheless,  also in  the settling point theory the
question remains: which factors are responsible for establishment of the settling point, in other
words: which factors are responsible for keeping a weight balance? It is unlikely that this is a
single  parameter.  Most  likely  it  is  the  optimal  balance,  within  a  certain  sphere,  between a
number of evoluti nary determined parameters driven by metabolic rate, energy and nutrient
availability, palatability of feed, and homeostatic maintenance of the organism. This is visualised
in Figure 1.
Figure  1 Visualisation of possible forces which are able to influence the dynamic equilibrium of the settling point
within this sphere. The position of the settling point represents optimal functioning for a certain set of input forces.
Effects of different forces which are able to influence the settling point such as energy and
nutrient availability,  metabolic rate, and maintenance of the organism in terms of metabolic
flexibility and hedonism will be discussed further. 
From the study described in  chapter 2 we learned that diet  itself  has a major influence on
weight balance. There was a diet specific (either high fat or low fat) response for all measured
parameters. In chapter 3 we found that body weight loss can be achieved via two standard used
strategies: reduction of portion size (30% energy restriction of previous high fat diet intake) or
restriction of fat intake (change from ad libitum high fat diet to ad libitum low fat diet). These
interventions were performed with purified diets containing the same ingredients, with only the
amounts (but not the type) of carbohydrate and fat differing between the diets. Both strategies
reduced energy intake, with the low fat diet being fed ad libitum compared to the high fat diet
Figure 1 Visualisation of possible forces which are able to influence the dynamic equilibrium 
of the settling point within thi sphere. The p sition of t settling po nt represents optimal 
functioning for a certain set of input forces.
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Effects of different forces which are able to influence the settling point such as 
energy and nutrient availability, metabolic rate, and maintenance of the organism in 
terms of metabolic flexibility and hedonism will be discussed further. 
From the study described in chapter 2 we learned that diet itself has a major 
influence on weight balance. There was a diet specific (either high fat or low fat) 
response for all measured parameters. In chapter 3 we found that body weight 
loss can be achieved via two standard used strategies: reduction of portion size 
(30% energy restriction of previous high fat diet intake) or restriction of fat intake 
(change from ad libitum high fat diet to ad libitum low fat diet). These interventions 
were performed with purified diets containing the same ingredients, with only the 
amounts (but not the type) of carbohydrate and fat differing between the diets. Both 
strategies reduced energy intake, with the low fat diet being fed ad libitum compared 
to the high fat diet which was fed in a restricted manner. Our choice for comparing 
two widely used interventions, rather than focusing on equal energy intake, has led 
to a different energy intake between the two weight loss groups, in addition to the 
inherently different macronutrient composition. This is unfortunate as both energy 
density and macronutrients have been shown to be able to affect energy intake 
[7]. This was highlighted in a study performed with female mice where reduction of 
dietary energy density reduced body weight regain after energy restriction [8]. In 
this study, the energy density of the feed was reduced by the addition of cellulose, 
which thus resulted in a reduction of net energy intake but also a probable reduction 
in macro- and micronutrients as well as possible effects on feed transition time. 
This example indicates the difficulty to really separate all parameters of interest in a 
dietary intervention study, which is also true for our own intervention as described 
in chapter 3. Our findings suggests that it would have been beneficial to add a 
pair-fed control group (fed the same amount of calories of the low fat diet as the 
high fat restricted diet) to be able to determine separate effects of energy density 
and macronutrients. Assessment of the influence of various dietary factors on body 
weight and body weight loss and regain is already difficult in mice, most likely this is 
even more so in humans. 
Mice [9] and humans [10-16] display reductions in metabolic rate below the level 
that would be expected based on their lower body weight as a result of energy 
restriction. This drop in metabolic rate promotes the conservation of body energy 
by sparing lean and fat mass. This may predispose them to a positive weight balance 
when there is no compensation in energy expenditure by for example an increase 
in physical activity. These body weight loss mediated reductions in metabolic rate 
have been suggested to remain present in humans for up to six years after body 
weight loss [17] and perhaps even indefinitely [18]. However, if the new metabolic 
rate suits the new body weight and when food intake will match metabolic rate it 
will not predispose to body weight regain [19]. A balanced diet will therefore be 
of utmost importance. next to a disproportional reduction of metabolic rate in 
reaction to energy restriction, leptin levels have also been shown to reduce more, 
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than predicted by the reduction in body weight [20, 21]. Rosenbaum et al. suggested 
that this disproportional reduction of leptin would lead to a deficiency of leptin in the 
brain, which creates as risk for increased appetite in the weight-reduced state [22]. 
Outcomes of the study performed in chapter 3 however, sketch a different picture. 
Epididymal fat mass in this study is reduced by 55% and 73% respectively, in the ad 
libitum low fat diet and restricted high fat diet group, while leptin levels are reduced 
by 73% and 76%. This may suggest that the response in mice could be somewhat 
differently regulated compared to the response in humans. However, also other 
factors such as the change in diet composition (macronutrients) may have played a 
role in the different results obtained. The results of our study amplify the importance 
of our understanding of the duration of these kind of disproportional reductions of 
metabolic rate or/and leptin levels.
Due to the different body weight loss approaches described in chapter 3, mice 
which were exposed to high fat diet restriction experienced longer daily fasting 
periods than mice fed an ad libitum low fat diet. To cope with this major discontinuous 
supply of energy, mice have to be able to utilize lipid and carbohydrate fuels and 
transition between them. This feature characterizes the healthy state and can be 
termed metabolic flexibility [23]. When mice would be metabolically flexible (the 
ability to switch to appropriate fuel preference in the face of metabolic changes), 
they should be able to increase lipolysis and fat oxidation. In humans a lower rate of 
fat oxidation has been shown as a predictor of body weight gain [24]. In chapter 3 
we saw that on a molecular level transcription of fatty acid synthase (Fasn) was 
increased in high fat diet restricted mice but not in ad libitum low fat fed mice. This 
suggests an increase in fat biosynthesis, but no effect was found on import of fatty 
acids via carnitine palmitoyltransferase 1a (Cpt1a) and carnitine palmitoyltransferase 
1b (Cpt1b) into the mitochondria to increase β-oxidation. next to that, no effect 
was found on lipolysis transcripts patatin-like phospholipase domain containing 
2 (Pnpla2) and hormone sensitive lipase (Lipe). Together this suggests that there 
was no effect of the longer fasting periods compared to ad libitum intake on these 
parameters, which are indicative for lipolysis and fatty acid beta oxidation. Thus, 
there seems to be no difference in metabolic flexibility between the two diet groups 
from a molecular point of view. 
Besides the underlying regulatory mechanisms, behaviour can also influence 
the weight balance. Food intake can be recognized as a form of behaviour. You 
can recognize its structure in frequency of eating and size of portions. The pattern 
of behaviour (frequency and portion size), nutrient content, and energy density 
determine the amount of energy that is ingested [25]. Therefore, it seems that we 
have control of what we eat; however, humans have a hedonistic mind-set. We like to 
pursuit happiness. Foods rich in sugar and fat are potent rewards [26], which promote 
eating even without energetic requirements for food [27]. To some extent this is true 
for mice as well, which, as can be seen in chapters 2-5, gain body weight on a high fat 
diet. On the other hand, rats remain as lean on a standard chow diet as when they are 
fed a pelleted high fat chow diet, when followed for 15 weeks [28]. However, rats gain 
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body weight when given a cafeteria diet, a diet in which a free choice of different food 
items which differ in macro nutrient composition. Thus, in mice and rats the pleasure 
achieved from eating, like in humans, is an important component in body weight 
gain [29], although species may have a different hedonistic threshold, which seems 
lower for mice than for rats. This rat example implicates that dietary variation or food 
texture might be as much of influence on the weight balance as is food composition.
As visualised in figure 1, many parameters are able to influence the location of the 
settling point. One of the key experiments to understand the weight balance will be 
to define the duration of compensating energy loss by an energy saving metabolism. 
Most mouse experiments are performed in a fixed environment with no choices of 
food and a standard ambient temperature set to around 22°C. This is clearly not 
reflective of humans under free living conditions. However, these fixed conditions 
will result in experiments that unravel underlying mechanisms of weight balance. 
Mapping the influence of all individual pieces of the puzzle called weight balance will 
result in understanding the whole picture. This eventually will offer us handles for the 
discovery of a solution to the obesity epidemic.
Thermoneutrality
An aspect of homeostasis is thermoregulation. Humans, like all mammals are capable 
of keeping their core body temperature within tight boundaries, independent of 
environmental temperature. When humans are exposed to temperatures below their 
Figure 2 Body temperature of humans is kept as stable as possible to avoid hypothermia or 
hyperthermia. In the classical heat diagram the influence of ambient temperature (x-axis) on 
metabolic rate (y-axis) of an endotherm like the mouse is shown. Between the lower critical 
temperature (LCT) and upper critical temperature (UCT) metabolic rate is equal to the obliga-
tory energy needed for whole body maintenance (BMR). Below LCT and above UCT metabolic 
regulation and active heat dissipation keep body temperature within the boundaries of thermal 
homeostasis. Adapted from Hill [32]
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thermal neutral zone (<28°C) the body will first respond by an insulative adjustment via 
peripheral vasoconstriction (blood flow through the skin) to decrease heat loss from 
the skin. To further protect the body from the cold a metabolic response in the form 
of heat production is necessary. This can be achieved via shivering thermogenesis, 
non-shivering thermogenesis, and / or activity-induced thermogenesis, an ultimately 
at even lower temperatures, by shivering thermogenesis [30]. In terms of energetics, 
metabolic rate increases when we are below or above our thermoneutral zone and 
energy costs rise, as shown in figure 2 [31]. 
Adaptive thermogenesis has been defined as heat production in response to 
environmental temperature or diet to protect the organism from cold or regulating 
energy balance after a change in diet [33]. When we look at the effects of diet on 
metabolism, we saw in chapter 4 that diet was able to induce large differences in 
adiposity at thermoneutrality. However, almost no differential effects on serum 
parameters were observed with the exception of leptin, a peptide hormone that is 
secreted proportional to adipose tissue mass. Also no changes were seen in a number 
of metabolic parameters in liver and muscle. Metabolic efficiency appeared increased 
in mice fed the high fat diet at thermoneutrality as increased storage of fat took place. 
Remarkably, the increased amount of adipose tissue mass did not influence health 
status (there were no signs of adipose tissue dysregulation or tissue inflammation). 
When we investigated the effect of ambient temperature on metabolism by a 
reduction from 29°C to 22° , we saw an increase in energy expenditure due to 
an increased metabolic rate (figure 3A). A shift takes place from energy deposition 
to energy release from the adipose tissue upon this shift from thermoneutrality to 
standard housing conditions.
Part of this increased energy expenditure can be explained by activity induced 
thermogenesis. Physical activity expressed as counted total beam breaks per 
Figure 3 Total energy expenditure and physical activity over 24hours. A The reduction in 
ambient temperature from 29°C to 22°C raised energy expenditure significantly (P<0.01, mean 
± SEM, n=12). B Mean physical activity was increased due to the reduction of ambient tem-
perature (P<0.05, n=8). Grey area indicates night phase in which mice are active. 
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13 minutes was increased in mice exposed to normal housing conditions (Figure 2B). 
This significant increase in physical activity was also present during both day and 
night separately (data not shown). These results clearly show that a reduction in 
ambient temperature from thermoneutral zone to standard housing temperature for 
mice increases metabolic rate in C57BL/6J mice; here, a mean 78% increase over 
24 hour. This supports previous estimation at an additional ~50% to 100% above 
basal metabolic rate [34]. Microarray studies of brown adipose tissue and liver have 
recently shown that metabolic reactions (such as oxidoreductase activity, iron ion 
binding, endoplasmic reticulum function, lipid metabolic processes and protease 
inhibitor activity) were reduced by a reduction in ambient temperature from 22°C 
to 8°C [35]. These studies conclude that mice decrease their energy expenditure on 
certain metabolic processes to increase energy expenditure for heat production. This 
was also shown by an increase in expression of key genes involved in thermogenesis 
being, uncoupling protein 1 (Ucp-1), peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha (Pgc1a) and CCAAT/enhancer-binding protein beta (C/ebp 
beta) in brown adipose tissue. The question that follows is: what do these metabolic 
effects on mouse physiology mean for modelling human homeostasis and disease?
Murine models are extensively used for investigating genetic and physiological 
traits as they closely resemble human metabolism. However, it has become clear that 
the mouse is not always perfect as a model. Despite promising treatment results in 
pre-clinical trials with certain drugs, the same drugs are not always translatable to 
humans. This was also shown by comparing the genetic and proteomic response 
to acute inflammatory stress between humans and mice, which did not correspond 
with each other [36]. Although mice might not be perfect as a model, much scientific 
knowledge has been gained by using mice and rats. An easy improvement for using 
the mice as a model would be to take housing temperature into account. Temperature 
is the universal engine which affects all life processes and it is functionally linked to 
maintenance of body weight. It has become clear that ambient housing temperature 
influences outcomes via thermoregulation in interventions as shown in chapter 4 
and in figure 1. Several perspectives on housing temperatures have been postulated 
recently in literature. 
In classical non-shivering thermogenesis, Cannon and nedergaard propose 
that brown adipose tissue is fully responsible for the elevated metabolic rate when 
exposed to cold [34]. To mimic a human situation more closely they propose to house 
mice at thermoneutrality [34]. By doing so, it omits the possibility to be misled by false 
positive observations when approaching studies of metabolism. This is supported by 
several occasions; i.e. the fatty acid elongase Elovl3 knock out mouse was described 
to have an increased metabolic rate. However, this model had fur trouble which led to 
increased metabolism at normal housing temperatures due to decreased insulation. 
Upon housing at thermoneutrality it became clear that not the genetic defect was 
responsible, but the fur [37]. Of course the reverse is also possible, for example when 
a (mutant) animal shows the same metabolic rate as a wild-type mouse at normal 
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housing temperature, but metabolism is reduced when housed at thermoneutrality. 
A specific example is the Ucp1-ablated mouse which does not show an obesity 
phenotype at normal housing temperature when fed either chow or a high fat diet 
[38], but it does become obese –even to a higher degree- at thermoneutrality [39]. 
Many features of mice metabolism become more similar to humans when housed at 
thermoneutrality; these include control of heart activity changes from sympathetic 
to vagal tone [40], serum lipid patterns being more alike to humans [34], and effects 
of pyrogens which are only visible at thermoneutrality [41]. Furthermore, it has been 
shown that humans also possess brown adipose tissue [42-44]. Therefore, rodent 
studies performed at thermoneutrality are evidently important for understanding 
human metabolism.
Speakman and Keijer [45] agree that attempting to mimic human thermal 
physiology is of importance to model normal human physiology. However, they 
question if housing within the thermoneutral zone is really the solution. normal 
free living humans make use of insulation via clothing which lowers the lower critical 
temperature by ~5.1°C which results in apparent lower critical temperature of 22.9°C 
[46]. normally we do not function at maintenance/basal metabolic rate, but we also 
have some adaptive thermogenesis. A temperature of 22.9°C would then inflict heat 
stress, implicating that the apparent lower critical temperature lies even lower, by 
about 3°C. This results in an ambient preference temperature of 19.9°C in humans. 
If this observation is extrapolated to mice, this means that they should be housed 
at 23-25°C, which is approximately 3°C below their lower critical temperature, but 
mimics the human ambient temperature preference. A further decrease in housing 
temperature as low as 20-22°C might even be necessary when mice are group 
housed [47], or are given nesting material as this will reduce heat loss/increase 
thermal insulation [48].
From these two views it is clear that thermoregulation matters. A clear 
difference between the two views is whether the mice should be compared at their 
basal metabolic rate or whether a lower temperature in accord with the human 
preference to be below the lower critical temperature should be used, so whether 
30°C or between 23-25°C is most comparable to the human situation. In a recently 
performed titration experiment with temperature and nesting material it was shown 
that mice prefer temperatures around 26-29°C and 10 grams of nesting material [49]. 
Unfortunately, only behaviour was investigated and not the effects on the level of 
metabolic rate which could maybe confirm the view of Speakman and Keijer. From 
the data presented in figure 3A we can conclude that temperature does not has to be 
adapted between day and night time as difference in energy expenditure between 
22°C and 29°C is constant over 24hours. 
For future mouse experiments, it is therefore necessary to also think about the 
effects that ambient housing temperature will have on metabolism and if this is likely 
in the human situation. Too low ambient temperatures speeds up metabolic rate and 
may result in thermoregulation dependent effects. In contrast, too high ambient 
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temperatures may slow down metabolism in such a way that you are looking at basal 
metabolic rate which is not comparable to normal human living conditions either.
Adipose tissue
Adipose tissue was first only recognized as a passive organ in which adipocytes 
were considered just as an energy storage place for lipids. It has become clear that 
adipocytes and the other components present in adipose tissue play an important 
role in health and obesity. Adipose tissue has a critical role in metabolic control and 
endocrine functioning [50, 51]. It is however unclear how the tissue turns from healthy 
and functional to unhealthy and dysregulated in most obese subjects. Like Sun and 
Scherer we think that dysregulation of adipose tissue is a multi-step process in which 
several factors could be responsible for the initiation of inflammation in adipose 
tissue [52, 53]. The existence of a metabolically healthy subset of obese subjects [54, 
55] suggests that there must be a certain trigger present in white adipose tissue, 
which initiates inflammation. A number of factors play a role. One of these factors 
may be the increase in exposure to free fatty acids in the serum of diabetics [56]. 
Another harmful factor is the deregulated secretion of adipokines. Most adipokines 
with pro-inflammatory properties are overproduced with increasing adipose tissue 
mass [57], while some adipokines with anti-inflammatory, or insulin sensitizing 
properties, like adiponectin are decreased [58]. Possibly, during extensive growth 
of adipose tissue mass, adipocytes can reach the diffusional limit of oxygen which 
can result in local tissue hypoxia [59]. Or hypoxia can develop due to a lag in the 
development of the vasculature [60], which will stimulate inflammation to promote 
angiogenesis and increased blood flow. Local tissue hypoxia could also promote 
oxidative stress and reactive oxygen species (ROS) formation in the cytosol [61, 62]. 
Alternatively, increased cell death in obese humans and db/db mice has been shown 
to be of influence. It attracts macrophages to clear the debris which increases the 
inflammatory state of the adipose tissue [63]. Furthermore, macrophages are able 
to produce ROS [64] and therefore, infiltration of macrophages can also lead to 
increased ROS production in adipose tissue during the obese state [65]. Indirectly, 
mitochondrial ROS formation has been shown to increase endoplasmic reticulum (ER) 
stress [62], and ER stress has been identified to have a direct link with obesity and the 
development of type 2 diabetes and may contribute to obesity comorbidities [66]. 
However, which of these steps is first in the delineation process to the development 
of adipose tissue inflammation is still unknown. Some important determinants in this 
process which will be discussed below are: protective role of adipose tissue, storage 
capacity, ER-stress, oxidative stress and adipocyte modulation.
The importance of possessing adipose tissue was shown clearly in a mouse 
model which lacks adipose tissue [67]. This pathological condition, lipodystrophy, 
is associated with insulin resistance and hyperglycemia. Likewise, insulin resistance 
and hyperglycemia is also seen when adipose tissue is extremely enlarged as in 
obesity. Transplantation of donor fat reversed the diabetic phenotype by increasing 
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insulin sensitivity, lowering serum insulin, and decreasing amounts of ectopic fat 
accumulation. This indicates that the absence of adipose tissue is detrimental for 
health [67]. This has also been shown in humans as recently reviewed by Vatier et al 
[68]. To visualize this phenomenon in figure 4 the U-shaped relationship between BMI 
and the relative risk of death is shown. Individuals with a low fat mass and individuals 
with a high fat mass have an increased risk of death. 
The common link between obesity and lipodystrophy probably is a defect in 
storage capacity either due to a lack of adipose tissue or due to saturation of storage 
capacity [70]. Extensive growth in obesity makes use of two processes, hyperplasia 
and hypertrophy, to accommodate triglycerides storage. The ability of the adipose 
tissue to cope with this expansion determines how ‘healthy’ the tissue is. When coping 
fails, adipose tissue dysregulates. The adipose tissue can expand via hypertrophy, 
hyperplasia, or a combination of these two [71]. Hypertrophy is an increase in cell size 
from pre-existing mature adipocytes, while in hyperplasia the amount of adipocytes 
increases via adipogenesis from pre-adipocytes present in the stromal tissue. The 
size and number of adipocytes are of interest as they determine the storage capacity 
of the adipose tissue. In chapters 2 and 3 of this thesis we show that adipose tissue 
mass and adipocyte size of white adipose tissue are able to increase and decrease via 
hypertrophy and hyperplasia dependent on dietary intake. Which expansion method 
is the best is from a health perspective discussable. Pharmacological remodelling of 
adipose tissue by anti-diabetic drugs of the family of thiazolidinediones has shown 
to promote pre-adipocyte recruitment and adipogenesis by activating peroxisome 
proliferator activated receptor gamma (PPAR-gamma) in a rodent model which 
resulted in improved adipose tissue health and glucose homeostasis [72]. Therefore, 
the presence of more small adipocytes recruited via hyperplasia is suggested to be 
Figure 4 Relative risk of death as a function of body mass index (BMI). Adapted from R. Fogel 
The common link between obesity and lipodystrophy probably is a defect in storage capacity
either due to a lack of adipose tissue or due to saturation of storage capacity . Extensive growth
in  obesity  makes  use  of  two  processes,  hyperplasia  and  hypertrophy,  to  accommodate
triglycerides storage. The ability of the adipose tissue to cope with this expansion determines
how ‘healthy’ the tissue is. When coping fails, adipose tissue dysregulates. The adipose tissue
can expand via hypertrophy, hyperplasia, or a combination of these two . Hypertrophy is an
increase in cell size from pre-existing mature adipocytes, while in hyperplasia the amount of
adipocytes increases via adipogenesis from pre-adipocytes present in the stromal tissue. The
size and number of adipocytes are of interest as they determine the storage capacity of the
adipose  tissue.  In  chapters  2  and  3  of  this  thesis  we  show  that  adipose  tissue  mass  and
adipocyte size of white adipose tissue are able to increase and decrease via hypertrophy and
hyperplasia dependent on dietary intake. Which expansion method is the best is from a health
perspective discussable. Pharmacological remodelling of adipose tissue by anti-diabetic drugs of
the  family  of  thiazolidinediones  has  shown  to  promote  pre-adipocyte  recruitment  and
adipogenesis by activating peroxisome proliferator activated receptor gamma (PPAR-gamma) in
a rodent model which resulted in improved adipose tissue health and glucose homeostasis .
Therefore, the presence of more small adipocytes recruited via hyperplasia is suggested to be
healthier. However, another hypothesis postulated is that the number of adipocytes remains
constant  throughout  adulthood, even after  excessive  body weight loss or body weight gain,
meaning that the number of adipocytes can only increase during childhood and adolescence via
hypertrophy . This hypothesis leaves no room for hyperplasia in adulthood but suggest that the
rapid turnover of the adipocytes is a target for therapeutics. Another possibility is that the down
regulation of PPAR-gamma and the inhibition of adipocyte recruitment in a low O2 environment
in adipose tissue mass provides a brake on fat cell recruitment in obesity . 
Due to the large size of the adipocytes in obesity a low O2 environment is expected. In chapter 5
we hypothesized that the first step to development of white adipose tissue inflammation would
be  the  existence  of  adipose  tissue  hypoxia.  However,  we  did  not  find  an  increase  in
inflammation of white adipose tissue after exposure to mild oxygen restriction for 5 days. This
could be due to some limitations of the study. From the results of the microarray we saw that a
specific set of genes was regulated which could be classified as ‘response to hypoxia’. In this
group we found regulation of  a  target  gene  of  Hif1α (master  regulator  of  O2  homeostasis),
Ankrd37, and also genes indicating presence of systemic hypoxia such as  Beta-s and  Hba-a1.
Unfortunately, we were not able to confirm these findings on a protein level for main regulatory
Figure 4 Relative risk of death as a function of body mass index (BMI). Adapted from R. Fogel 
[69]
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healthier. However, another hypothesis postulated is that the number of adipocytes 
remains constant throughout adulthood, even after excessive body weight loss or 
body weight gain, meaning that the number of adipocytes can only increase during 
childhood and adolescence via hypertrophy [73]. This hypothesis leaves no room 
for hyperplasia in adulthood but suggest that the rapid turnover of the adipocytes 
is a target for therapeutics. Another possibility is that the down regulation of PPAR-
gamma and the inhibition of adipocyte recruitment in a low O2 environment in 
adipose tissue mass provides a brake on fat cell recruitment in obesity [74]. 
Due to the large size of the adipocytes in obesity a low O2 environment is expected. 
In chapter 5 we hypothesized that the first step to development of white adipose 
tissue inflammation would be the existence of adipose tissue hypoxia. However, we 
did not find an increase in inflammation of white adipose tissue after exposure to 
mild oxygen restriction for 5 days. This could be due to some limitations of the 
study. From the results of the microarray we saw that a specific set of genes was 
regulated which could be classified as ‘response to hypoxia’. In this group we found 
regulation of a target gene of Hif1α (master regulator of O2 homeostasis), Ankrd37, 
and also genes indicating presence of systemic hypoxia such as Beta-s and Hba-a1. 
Unfortunately, we were not able to confirm these findings on a protein level for main 
regulatory proteins HIF1 and GLUT1, which are known indicators of the local tissue 
hypoxia response. To asses local tissue hypoxia immunohistochemically, mice were 
injected with hypoxyprobe-1. Binding of the probe is an indication for presence of 
hypoxia. Unfortunately, we were not able to make a distinction between the exposed 
and control mice after the staining. We think that this is due to the starting point of our 
study, both groups of mice had a diet induced obese phenotype before we exposed 
them to mild oxygen restriction. Another possibility would be the sensitivity of the 
probe, which only stains when the partial pressure of oxygen is below 10 mmHg. 
Besides the presence of a hypoxia response in the microarray, there was also a group 
of genes regulated which was directed at down regulation of metabolism (i.e. Gys2, 
Bcat1, and Atp1a4). This suggests a clear adaptive metabolic response to the oxygen 
restriction exposure. While this confirms expected responses to oxygen restriction 
exposure, this did not provide the answer to the question what the initiator of the 
inflammatory cascade was. So, what else could go wrong in the adipose tissue? 
There are indications for some other determinants which could be of influence in the 
development of the inflammatory state such as ER stress, oxidant stress, and size or 
storage location of adipocytes. These parameters will be discussed below.
The ER is a central organelle which is responsible for the biosynthesis of protein 
and lipid components of a cell. Genetic and environmental factors can cause an 
accumulation of misfolded proteins in the ER. This causes ER-stress and induces an 
unfolded protein response [75]. ER-stress and the unfolded protein response are 
linked to inflammation via JnK-AP1 and nF-kB-IKK pathways [76]. ER-stress and a 
consequent inflammatory response were recently found in mice fed a high fat diet 
for 16 weeks [77]. This showed that there indeed is a relation between ER-stress 
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and inflammation in obesity. However, whether ER-stress is first in the cascade 
to induce inflammation is at present unclear. To check if ER stress is the trigger 
for inflammation we checked ER stress in the microarray performed in chapter 5. 
The markers that were analysed were all shown to be increased in white adipose 
tissue of mice fed a high fat diet for 16 weeks [77]. In table 2, we show that in 
our study only one transcript, Chop, is increased. However, to conclude that ER 
stress is the activator of the inflammatory response is impossible as no inflammation 
was present yet. This data might suggest that ER-stress is a secondary reaction to 
oxygen restriction as there is also a tendency in up regulation of Atf4, which is the 
transcriptional activator of Chop. 
table 2 Fold change of ER stress markers of control and oxygen restriction exposed mice.
Full name
Gene 
symbol
Official gene 
symbol
Fold 
change P-value
Binding immunoglobin protein Bip Hspa5 1.0 0.659711
c/EBP-homologous protein Chop Ddit3 1.2 0.016196
activating transcription factor 4 Atf4 Atf4 1.1 0.075765
ER degradation enhancer mannosidase Edem Edem1 1.0 0.336277
ER DnaJ homolog 4 Erdj4 Dnajb9 -1.1 0.234516
protein disulfide isomerase Pdi Pdia3 1.1 0.218959
Another possible ‘first step in inflammation’ trigger could be oxidative stress. 
Oxidative stress results from an accumulation of reactive oxygen species (ROS) 
which exceeds the cell’s ability to detoxify [78]. normally ROS is formed as a by-
product during oxygen metabolism and is known to have a role in cell signalling 
and homeostasis [79]. The production of ROS has also been found in white adipose 
tissue and shown to induce dysregulated production of adipokines and increased 
systemic oxidative stress which results in development of insulin resistance [80]. Also 
elevated levels of free fatty acids, as found in the obese state, are able to induce ROS 
generation [81]. In the study described in chapter 5 mice were exposed to oxygen 
restriction which leads to a reduction in oxygen availability. Since O2 is a necessary 
substrate for the formation of ROS, an increase in ROS production during oxygen 
restricted conditions seems contradictory. How could lower oxygen availability 
possibly lead to increased formation of ROS? In a hypoxic environment it is possible 
that accumulation of nADH, substrate to the oxidative phosphorylation, occurs. This 
results in an increase in the proton gradient across the inner mitochondrial membrane 
and ROS production occurs more easily upon sudden exposure to O2 during re-
oxygenation [82]. Alternatively, electrons are not able to donate their energy to final 
electron acceptor oxygen at complex IV. This may result in a discontinuation of the 
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chain and electrons at complex II, coenzyme Q or complex III will leak from the 
usual route and create ROS by binding to oxygen directly. Since ROS production 
mainly occurs in the mitochondria, mitochondrial membranes are prone to sustain 
damage through increased oxidative stress. This may eventually result in a decrease 
in mitochondrial density within white adipose tissue. To test this hypothesis, markers 
of mitochondrial ROS production and mitochondrial density can be measured to 
assess the level of oxidative stress within the tissue.
Also the size of adipocytes or the storage location are of influence in the process 
of becoming unhealthy. Before the maximum expandability of the tissue is reached 
there is the question where to store the fat preferentially: subcutaneously or visceral? 
Visceral fat has been more strongly associated with a higher risk for insulin resistance 
compared to subcutaneous adipose tissue [83, 84]. Besides anatomical differences 
between the two fat depots there are also physiological differences present which 
help in the explanation why visceral adipose tissue is an increased metabolic risk 
factor [85]. normally, lipids are stored in white adipose tissue. But, when adipose 
tissue has reached its maximal expandability, fat has to be stored somewhere else, 
for example in non-adipose tissues such as liver, skeletal muscle or pancreatic β-cells. 
First storage of triacylglycerols will take place but when this is not possible anymore 
lipids will enter non-oxidative pathways which produce toxic reactive lipid species. 
This has been shown to contribute to impaired insulin secretion, insulin resistance 
and to mediate obesity related cardiovascular disease [86]. Our data in chapter 4 
show that there was no ‘spilling’ of lipids to the liver after 14 weeks of high fat feeding 
although body weight and epididymal adipose tissue body weight of mice housed at 
thermoneutrality was higher than body weight and epididymal adipose tissue weight 
at standard housing conditions. Besides the presence of storage locations also the 
adipocyte themselves have to be able to expand. Expansion of adipose tissue mass in 
obesity results in remodelling of the extra cellular matrix which involves stromal cells, 
preadipocytes, immune cells and endothelial cells. It has been shown that extracellular 
matrix components are up-regulated during metabolically challenging conditions (i.e. 
diabetic state) [87]. When the extracellular matrix does not permit expansion and 
becomes ‘stiff’, this might lead to higher susceptibility to necrosis, and angiogenesis 
might be impaired [88]. In chapter 5 adipocytes enlarged to around 6619µm2. But 
we did not see significant increase of transcript levels of genes associated with 
increased fibrosis in the microarray. Actually, we found a down regulation of 18 genes 
associated with adipocyte cytoskeleton and matrix proteins. This suggests that in this 
study adipocytes had not reached their maximum expandability yet.
We discussed multiple factors, (i.e. hypoxia, ER-stress, oxidative stress and 
adipocyte modulation) which could possibly lead to the initiation of inflammation in 
adipose tissue. We concluded from our study as described in chapter 5 that local tissue 
hypoxia was not the trigger for initiation of inflammation. These mice were housed at 
thermoneutrality which implies that their metabolic rate is at their lowest, basal, level. 
As no indicators were found for increased inflammation due to oxygen restriction, it 
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might be possible that an increased metabolic flux is a necessity for development of 
inflammation. For example in COPD patients, an increase in resting energy expenditure 
is associated with increased levels of inflammatory cytokines [89]. A recent hypothesis 
focusses on adipose tissue lipid flux [90]. In this hypothesis a reduced lipid flux in and 
out of adipocytes, but in particular a lower lipid recycling is thought to underlie the 
metabolic complications associated with obesity. It would therefore be interesting to 
repeat the experiment with an extra group housed at standard housing conditions to 
investigate the effect of metabolic fluxes on initiation of inflammation.
Implications of our research and main conclusions
It is clear that many factors are able to influence adipose tissue health. Due to the 
increasing prevalence of obesity it is of great importance to understand and control 
fat accumulation. As many biological and molecular processes which determine how 
white adipose tissue functions and responds are still unclear. With this thesis we 
investigated three basic questions which are involved in adipose tissue metabolism.
 
1. Does a body weight set-point exist? 
2. How is the diet-induced metabolic response affected by housing at 
thermoneutrality?
3. Does oxygen restriction induce inflammation in white adipose tissue?
We started off with showing that there is no effect of diet history on current 
metabolism. The major determinant of metabolic outcome in the study presented in 
chapter 2 was diet composition. Therefore, we concluded that metabolic outcome 
parameters such as body weight, body fat stores and levels of circulating hormones 
and metabolites ‘settle’ into a new active multi-parameter equilibrium in which 
all competing influences (i.e. genetics, energy density, metabolic rate, metabolic 
flexibility and cognition) are balanced. This implies that we reject the hypothesis that 
there is a body weight set-point.
Secondly, we investigated how housing temperature at thermoneutrality affects 
the diet induced metabolic response. Here we saw that nothing happens on measured 
parameters of metabolism, although there is a more pronounced obese phenotype 
present. We concluded that the combination of a low metabolic rate with a high fat 
diet results in a healthy obese phenotype (there is no indication of inflammation). 
This model together with a diet induced obese mouse model at standard housing 
temperature could be used for investigating potential effects of body weight loss 
on adipocyte morphology and turnover to make a link between morphology and 
metabolic risk factors.
For the third question we challenged the healthy diet induced obese mouse 
model with mild oxygen restriction to determine if hypoxia was an initial factor in 
the development of adipose tissue inflammation. Inflammatory status of the white 
adipose tissue did not change, when measured as white adipose tissue transcripts 
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Figure 5 
 
Temperature 
and morphology. Therefore, we concluded that inflammation was not the initial 
factor in the development of adipose tissue inflammation. However, many other 
metabolic changes indicated that hypoxia influences metabolic functioning of the 
adipose tissue. Here, as well as for the set-point theory, it seems that there is a multi-
parameter equilibrium in which hypoxia, ER-stress, oxidative stress and adipocyte 
modulation, play a part in the development of the inflammatory state.
These findings result in recommendations for the execution of future mice 
experiments. We propose when investigating the body weight balance to think about 
the composition of the diet as energy density as well as energy composition (levels 
of macronutrients, fat, carbohydrate and protein) determine outcomes. next to that, 
ambient housing temperature of the mice has a big influence on metabolic rate. For 
comparison with the human situation housing at an elevated temperature, whether 
at 23-25°C or at thermoneutrality might be better, because then mice metabolism 
behaves more like human metabolism.
To finish up, this thesis was focused on the metabolic adaptive capacity of white 
adipose tissue to nutritional and environmental challenges. We can conclude that 
Figure 5 Visualisation of the multi-parameter dynamic equilibrium. Showing the three main 
effectors of adipose tissue functioning described in this thesis.
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in the adipose tissue a multi-parameter dynamic equilibrium of functioning exists, 
this is captured in figure 5. Three main effectors, diet composition, ambient housing 
temperature and oxygen availability are shown. However many more processes 
i.e. storage capacity, ER-stress, oxidative stress and adipocyte modulation are able 
to influence adipose tissue functioning. This shows the complexity of an organ which 
is of great interest for obesity and cardiovascular disease research. 
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suMMAry oF MAin Findings
When adipose tissue is present in excessive amounts, as in obesity, it predisposes 
to a number of pathologies. Obesity is a complex, multifactorial condition as it 
influences many endogenous genetic, endocrine, and inflammatory pathways. 
Excess dietary intake is one of the important factors which is responsible for the 
increasing prevalence of obesity. For the understanding of the reciprocity between 
consumed diet and excessive amounts of adipose tissue, it is essential to investigate 
underlying functioning. In this thesis, I have addressed three important aspects that 
play a role in the development of diet induced obesity and its pathologies with a 
focus on adipose tissue metabolism. 
1. Does a body weight set-point exist? 
2. How is the diet-induced metabolic response affected by housing at 
thermoneutrality?
3. Does oxygen restriction induce inflammation in white adipose tissue?
The first aspect investigated was the existence of a body weight set point. A body 
weight set point is defined as a pre-determined or preferred level of body weight 
which is preserved by an internal feedback control mechanism. In chapter 2, a dietary 
intervention with none, one, or two diet alterations of purified diets was performed 
in C57BL/6J mice to investigate if a long lasting effect on body weight persistence 
was present. Diets contained equal protein content and source of ingredients but 
differed in the fat-to-sugar ratio. Therefore, energy content and amount of fat 
was different for either the low fat diet or the high fat. In the intervention the last 
consumed diet of the mice determined energy intake, energy expenditure, body 
weight, body fat stores, circulating hormones and metabolites. These data support 
the settling point theory as body weight and metabolic parameters ‘settle’ based on 
current energetic input and output and do not support the set point theory. next to 
that it underlines the importance of diet choice in intervention studies focusing on 
aspects on the crossroads of nutrition and physiology. 
In chapter 3 adipose tissue physiology and molecular regulation was further 
investigated by exposure to more metabolic stress in the form of a weight loss 
challenge with different purified diets. Diet-induced obese C57BL/6J mice were 
fed a high fat diet restricted to 70% intake of previous ad libitum high fat diet 
intake or they were changed to ad libitum low fat diet for 5 weeks. Beneficial effects 
were seen in both interventions regarding physiological parameters. However, 
molecular parameters in white adipose tissue differed between the two restriction 
interventions, with increased activation of mitochondrial carbohydrate and fat 
metabolism in high fat diet restricted mice. When extrapolated to the human 
situation this may suggest that a reduction of portion size is the best method for 
weight loss.
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It is standard practice to house mice at ambient temperature during physiological 
intervention studies. Unfortunately mice are then exposed to a temperature below 
their thermal neutral zone. This implies that their metabolism is chronically increased 
which is known to influence study outcomes. In chapter 4 the second question; “how 
is the diet-induced metabolic response affected by housing at thermoneutrality?” 
was investigated. A 14-week dietary intervention with two semi-purified diets, a 
low fat diet and a moderately high fat diet, was performed at 28°C in C57BL/6J 
mice. This resulted in a large diet-induced difference in bodyweight, adipose tissue 
mass, adipocyte size, and serum leptin level. But no differential effects of the diets 
were seen on serum glucose, free fatty acids, triacylglycerides, insulin, a panel of 
cardiovascular markers, and a number of (metabolic) parameters in liver and muscle. 
Although adipose tissue mass and adipocyte size was increased significantly, there 
was no sign of inflammation or dysfunction in the adipose tissue. This study suggests 
that diet-induced obesity of C57BL/6J mice at thermoneutrality results in a suitable 
model for the metabolically ‘healthy’ obese (people who are significantly overweight 
but show none of the usual metabolic problems). next to that, this study emphasizes 
the importance of consideration and control of housing temperature for mice, as it 
has profound effects on study outcomes.
The third and last question investigated was if oxygen restriction is able to 
induce inflammation in white adipose tissue. There is substantial evidence that white 
adipose tissue becomes hypoxic when excessively enlarged. Due to fast expansion 
of white adipose tissue the vasculature is not able to keep pace with growth. next to 
that, adipocytes are able to increase in size beyond the limit of oxygen diffusion. To 
investigate if hypoxia was able to induce inflammation in white adipose tissue, the 
model for healthy obese adipocytes (developed in chapter 4) was used and exposed 
to ambient oxygen restriction (13%) to challenge adipose tissue metabolism. This 
resulted in the presence of systemic oxygen restriction as shown by increased levels 
of haemoglobin and haematocrit. Furthermore a switch to glycolytic metabolism, 
which is indicative for tissue hypoxia, was present. no differences in adipose tissue 
macrophage infiltration (as marker for inflammation) were found. But, serum branched 
chain amino acids and adipokines were affected. Branched chain amino acids were 
increased in mice exposed to oxygen restriction which shows resemblance with 
findings in humans where increased levels were found in lean versus obese people. 
The peptide hormone adiponectin was increased in serum, without differences in 
WAT expression. On the other hand, the peptide hormones CCDC3 and CCK showed 
decreased transcript levels in white adipose tissue without significant change in 
serum levels, although for CCDC3 a trend was seen. Together these results suggest 
that oxygen restriction does not induce inflammation in adipose tissue. However, it 
does affect adipokine regulation.
After performing these studies it was clear that composition of the diet has a major 
influence on outcome parameters of physiological studies as shown in chapter 2. To 
compare functional effects of different nutrients, it is important to use standardized 
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purified diets. not only the experimental intervention diet is of importance but also 
the reference control diet can influence outcomes. For example, when an intervention 
is performed with a high fat purified diet and the reference diet is chow this will lead 
to a difficult comparison. The content of chow is variable as it is grain or cereal based 
(ground corn, ground oats alfalfa meal, soybean meal and ground wheat). nutritional 
adequacy is ensured by addition of vitamins, minerals, and fat. However, the exact 
amount of the various ingredients is frequently kept secret by the manufacturer. 
next to that, due to the plant based origin of chow it will contain nutritive (protein, 
carbohydrate, fat) components but also non-nutritive components (phytochemicals). 
The content of the chow diet will vary from batch to batch as the nutritive and non-
nutritive value will change between harvests. When using a chow reference diet in 
comparison to a purified diet you will never know exactly what you are comparing, 
i.e. difference in amino acids or effects of phytochemicals etc. Therefore, a reference 
diet for physiology was designed (chapter 6) to improve comparison of study 
outcomes and to increase efficiency of resources and material. A key feature of the 
diet is the fixed protein concentration, which allows for an exchange of carbohydrate 
and fat in a high fat version of the diet. 
To conclude, the work presented in this thesis provides clear insight in factors that 
are of importance for improvement of translatability of mouse studies to the human 
situation. It was shown that when investigating the weight balance many parameters, 
i.e. genetics, metabolic rate, environmental factors like ambient housing temperature 
and light, and cognitive behaviour, besides the diet and its composition are able 
to influence the outcome parameters. As most mouse experiments are performed 
in a fixed environment with no choices of food and a standard temperature set to 
22°C. This is clearly not reflective of humans under free living conditions. However, 
these fixed conditions are able to result in experiments that unravel underlying 
mechanisms of weight balance, which form the basis for discovering a solution to the 
obesity epidemic. 
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Verkeerde voeding kan leiden tot overgewicht. Problemen in het overtollige vetweefsel 
zoals ontstekingen kunnen mogelijk zelfs leiden to hart –en vaat ziekten, diabetes en 
sommige vormen van kanker. Obesitas is een complexe aandoening die verschillende 
processen kan beïnvloeden zoals de hormoonhuishouding, ontstekingsprocessen 
en activatie of inactivatie van verschillende genen. Overconsumptie van voeding 
is een van de belangrijkste factoren die verantwoordelijk is voor de toenemende 
prevalentie van obesitas. Om de wisselwerking tussen geconsumeerde voeding en 
het functioneren van overmatig vetweefsel te doorgronden is het essentieel om 
het werkings mechanisme te begrijpen. In dit proefschrift heb ik drie belangrijke 
aspecten onderzocht die een rol spelen in de ontwikkeling van overwicht door 
verkeerde voeding met een focus op het metabolisme van vetweefsel.
1. Heeft lichaamsgewicht een set-point?
2. Wordt de dieet-geïnduceerde metabole respons beïnvloed door huisvesting bij 
thermoneutraliteit?
3. Veroorzaakt beperking van zuurstof een ontstekings proces in vetweefsel?
Als eerste hebben we onderzocht of er zoiets als een lichaamsgewicht setpoint 
bestaat. Een lichaamsgewicht setpoint is een soort thermostaat in je hoofd die regelt 
dat het gewicht op een constant niveau wordt gehouden. In hoofdstuk 2 hebben we 
een voedingsinterventie met geen, een of twee dieet veranderingen uitgevoerd in 
C57BL/6J-muizen om te onderzoeken of er een lichaamsgewicht setpoint aanwezig 
is. De gebruikte diëten bevatten een gelijke hoeveelheid eiwit, maar verschilden 
in de vet - tot- koolhydraat verhouding. Daardoor is de hoeveelheid totale energie 
(kcal) en de hoeveelheid vet anders voor het vet-arme dan voor het vet-rijke dieet. 
Tijdens de interventie bepaalde het laatst gegeten dieet de uiteindelijke energie-
inname, energie-uitgave, lichaamsgewicht, vetmassa, circulerende hormonen en 
metabolieten. Deze data ondersteunen een andere theorie dan de setpoint theorie. 
Hierin passen metabole parameters zich aan naar gelang de omstandigheden. 
Dit zorgt voor een beweegbaar setpoint in plaats van een vast setpoint. Ook 
laat deze studie zien dat de keuze voor een specifiek dieet bepalend is voor de 
uitkomsten van een onderzoek op het kruispunt van voeding en fysiologie. 
De fysiologie en moleculair regulatie van vetweefsel is verder onderzocht in 
hoofdstuk 3. Gewichtsverlies werd gebruikt om metabole stress te vergroten. Om 
dit te bereiken werden obese C57BL/6J-muizen beperkt tot 70% inname van het 
vet-rijke dieet of gewisseld naar een onbeperkt vet-arm dieet gedurende 5 weken. In 
beide interventies werden gunstige effecten gezien met betrekking tot fysiologische 
parameters zoals een afname in lichaamsgewicht. Echter, regulatie van moleculaire 
markers in vetweefsel verschilde tussen de twee interventies. Muizen die het beperkte 
vetrijke dieet kregen hadden een hoger mitochondriaal (de energiefabriekjes van de 
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cel) koolhydraat en vet metabolisme. Wanneer deze data geëxtrapoleerd wordt naar 
de menselijke situatie betekend dit dat een verkleining van portiegrootte de beste 
methode is om gewicht te verliezen. 
Het is gebruikelijk om muizen te huisvesten bij kamertemperatuur tijdens 
fysiologische interventiestudies. Helaas worden muizen dan blootgesteld aan een 
omgevings temperatuur die beneden hun thermisch neutrale zone is. Dit betekent 
dat het metabolisme van de muizen altijd verhoogd is om zichzelf warm te houden. 
Hiervan is bekend dat dit studieresultaten kan beïnvloeden. In hoofdstuk 4 wordt de 
tweede vraag onderzocht, “of de dieetgeïnduceerde metabole respons beïnvloedt 
wordt door huisvesting bij thermoneutraliteit“. Hiervoor is een 14 weken durende 
interventie uitgevoerd bij 28°C waarbij C57BL/6J-muizen een vet-arm dieet of een 
matig hoog vet dieet werden gevoerd. Dit resulteerde in grote dieetgeïnduceerde 
verschillen in lichaamsgewicht, vetweefselmassa, vetcel grootte, en serum 
leptine -niveaus. Maar er was geen verschil op serum glucose, vrije vetzuren, 
triacylglyceriden, insuline, een panel van cardiovasculaire markers, en een aantal 
(metabole) parameters in de lever en spieren. Hoewel vetmassa en vetcel grootte 
aanzienlijk waren verhoogd, was er geen teken van ontsteking of dysfunctie in het 
vetweefsel aanwezig. Deze studie suggereert dat dieet-geïnduceerde zwaarlijvigheid 
van C57BL/6J-muizen gehuisvest bij thermoneutraliteit resulteert in een geschikt 
model voor metabool ‘gezonde’ obese (mensen met aanzienlijk overgewicht die 
geen van de gebruikelijke stofwisselingsproblemen vertonen). Daarnaast benadrukt 
deze studie het belang van de huisvestings temperatuur voor muizen, aangezien die 
een grote invloed op de uitkomst van de studieresultaten heeft.
Met de derde en laatste vraag hebben we onderzocht of zuurstof beperking 
ontstekingen kan induceren in vetweefsel. Er is substantieel bewijs dat er een 
te laag zuurstof gehalte in vetweefsel ontstaat wanneer de vetcellen overmatig 
vergroten. Omdat de uitbreiding van het vetweefsel zeer snel gaat is het vaatstelsel 
niet in staat om een gelijke groei te vertonen, wat ook kan leiden tot een te laag 
zuurstofgehalte in het vetweefsel. Daarnaast kunnen de vetcellen zo groot worden 
dat zuurstof transport over de vetcel niet meer mogelijk is en daardoor een te laag 
zuurstofgehalte ontstaat. Om te onderzoeken of een zuurstof tekort in vetweefsel in 
staat is om ontstekingen te starten in vetweefsel hebben we het model voor gezonde 
obese vetcellen (ontwikkeld in hoofdstuk 4) gebruikt en deze muizen blootgesteld 
aan zuurstof beperking (13% in plaats van 21%) om zo het vetweefselmetabolisme 
uit te dagen. Dit resulteerde in verhoogde hemoglobine en hematocriet niveaus wat 
wijst op verlaging van het zuurstof niveau in het gehele lichaam. Daarnaast schakelt 
het lichaam van aerobe naar anaerobe glycolytische verbanding wat indicatief is 
voor zuurstof verlaging in het weefsel. Er werd geen verschil gevonden in indringing 
van macrofagen (marker voor ontstekingen) in vetweefsel. Echter, de niveaus van 
vertakte keten aminozuren en adipokines in serum waren veranderd. Het niveau 
van vertakte keten aminozuren was verhoogd in muizen die waren blootgesteld aan 
zuurstof beperking. Dit vertoont gelijkenis met de bevindingen bij de mens, waar 
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verhoogde gehaltes gevonden zijn in magere tegenover zwaarlijvige mensen. Het 
peptide hormoon adiponectine was verhoogd in serum, zonder dat er verschillen 
waren in gen expressie in vetweefsel. Anderzijds vertoonden de peptide hormonen 
CCDC3 en CCK juist verlaagde gen expressie niveaus in vetweefsel zonder 
verandering in serum niveaus, hoewel er voor CCDC3 een trend werd waargenomen. 
Samen suggereren deze resultaten dat zuurstof beperking niet de onwikkeling van 
ontstekingen in vetweefsel start. Echter, het beïnvloedt wel adipokine regulatie.
na het uitvoeren van bovenstaande studies was het duidelijk dat de samenstelling 
van het voer een grote invloed heeft op de uitkomsten van fysiologische studies, 
zoals is weergegeven in hoofdstuk 2. Om functionele effecten van verschillende 
voedingsstoffen te vergelijken, is het belangrijk gestandaardiseerde gezuiverde 
diëten te gebruiken. niet alleen het experimentele dieet is van belang, maar ook het 
controle dieet kan de resultaten beïnvloeden. Bijvoorbeeld, wanneer een interventie 
wordt uitgevoerd met een hoog vet dieet dat gezuiverd is en vergleken wordt met 
een referentie (chow) dieet. De samenstelling van chow is variabel omdat het op 
basis is van granen zoals gemalen maïs, gemalen haver, sojameel en gemalen tarwe). 
Voedzaamheid wordt verzekerd door toevoeging van vitaminen, mineralen en vet. 
Echter, de exacte samenstelling van de verschillende ingrediënten wordt vaak geheim 
gehouden door de fabrikant. Daarnaast zorgt de plantaardige oorsprong van het 
referentie (chow) dieet dat het de nutritieve componenten (eiwitten, koolhydraten, 
vetten), maar ook niet–nutritieve bestanddelen zoals fotochemicaliën bevat. De 
samenstelling van het chow dieet variëert van partij tot partij aangezien de nutritieve 
en niet-nutritieve waarde verandert tussen oogsten. Wanneer er gebruik gemaakt 
wordt van een chow dieet in vergelijking met een gezuiverd dieet zul je nooit precies 
weten wat je aan het vergelijken bent, bijvoorbeeld een verschil in aminozuren of de 
gevolgen van fytochemicaliën etc. Daarom is er een gezuiverd referentie dieet voor 
fysiologische interventies ontworpen (hoofdstuk 6) zodat een  vergelijking tussen 
verschillende studies mogelijk wordt. Een belangrijk kenmerk van het referentie 
dieet is de vaste eiwitconcentratie. Dit zorgt ervoor dat er alleen een uitwisseling 
van koolhydraten en vetten plaatsvindt in een vetrijke versie van het dieet.
In conclusie geeft het werk beschreven in dit proefschrift inzicht in factoren die 
van belang zijn voor de verbetering van de vertaalbaarheid van muis studies naar de 
menselijke situatie. Er werd aangetoond dat bij het onderzoek van de gewichtsbalans 
(setpoint) vele factoren zoals, genetica, metabolisme, omgevingsfactoren zoals 
huisvestingstemperatuur en cognitief gedrag, naast de voeding en de samenstelling 
van het voer uitkomstparameters kunnen beïnvloeden. De meeste muisexperimenten 
worden uitgevoerd in een vaste omgeving zonder keuze in voer en een standaard 
omgevings temperatuur ingesteld op 22°C. Dit is duidelijk geen afspiegeling van 
de mens bij vrije leefomstandigheden. Echter, deze vaste condities kunnen leiden 
tot experimenten die de onderliggende mechanismen van de gewichtsbalans 
ontrafelen. Wat ons uiteindelijk een stap dichter bij de ontdekking van de oplossing 
voor de obesitas epidemie brengt.
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